KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
के लिए फिर से शुरू Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl: आँकड़ों को प्रभावित करें
रिपोर्ट चलाएं
| Concept | World rank |
|---|---|
| hiit nox2 activity | #1 |
| cb11 fragment | #1 |
| transient joint inflammation | #1 |
| respiratory burst severity | #1 |
| insulitis strains | #1 |
| igg2a vivo | #1 |
| regulates severity | #1 |
| lew1w rt1u | #1 |
| nonglycosylated peptide | #1 |
| m1j | #1 |
| chromosome arthritis severity | #1 |
| ability gut protection | #1 |
| ftirm ciic1 | #1 |
| obs electrophoresis | #1 |
| transgenic nadph oxidase | #1 |
| ll37 rcramp | #1 |
| cia collagen | #1 |
| antibody responses cii | #1 |
| tolerance arthritis protection | #1 |
| p47phox ncf1 | #1 |
| autoimmune diseases identification | #1 |
| oestrogen lupus disease | #1 |
| experimental chromosomes | #1 |
| thps cii | #1 |
| immunologic animals arthritis | #1 |
| presence sex hormones | #1 |
| psa mip | #1 |
| hyaluronanreceptor | #1 |
| cia reduction | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| p47phoxv232 | #1 |
| h2w17 | #1 |
| cartilage damage vivo | #1 |
| experimental collagen type | #1 |
| downregulating oestradiol | #1 |
| ul1 ciif4 | #1 |
| susceptible strain cross | #1 |
| inflammatory arthritis assessment | #1 |
| arthritis experimental | #1 |
| plasminogendeficient mice arthritis | #1 |
| tolerance collagen | #1 |
| injection adjuvant oils | #1 |
| mannaninduced | #1 |
| immunization mouse cii | #1 |
| epitope cartilage | #1 |
| mem lglutamine | #1 |
| c3hq mice cii | #1 |
| kgf thymus | #1 |
| heterologous cii | #1 |
| pc4 pc117 | #1 |
| caia model | #1 |
| glycosylated epitope structures | #1 |
| targeted mutation ncf4 | #1 |
| cii polymer | #1 |
| mice interferon gamma | #1 |
| l012 vivo imaging | #1 |
| arthritis suppression | #1 |
| ros mip | #1 |
| experimental arthritis articular | #1 |
| ifa rats | #1 |
| g6pi acute arthritis | #1 |
| oxa backcrosses | #1 |
| antitype collagen | #1 |
| cii h2p | #1 |
| exacerbation arthritis | #1 |
| genes antibodies | #1 |
| joint proteins | #1 |
| clever1 type macrophages | #1 |
| ncf1 ncf1m1j mutation | #1 |
| paamcryogel | #1 |
| ciic1 ciif4 | #1 |
| autoimmune response cii | #1 |
| arthritis pnipaam | #1 |
| cd43expressing cells | #1 |
| fpr1 agonist neutrophils | #1 |
| ncf1 | #1 |
| cia oia | #1 |
| ltabncr3 | #1 |
| arthritis | #1 |
| rat rt1ba genes | #1 |
| cia congenic arthritis | #1 |
| citrullinated collagen arthritis | #1 |
| susceptibility cia | #1 |
| surface redox levels | #1 |
| cartilage explants m2139 | #1 |
| cartilagespecific protein | #1 |
| arthritis autoimmune | #1 |
| collagen immunization | #1 |
| disease c4bp | #1 |
| functional nox2 complex | #1 |
| glycosylated cii | #1 |
| pathogenesisis | #1 |
| collagen chains antibody | #1 |
| lpr mice granulocytes | #1 |
| polychondritis autoimmune disease | #1 |
| cii development | #1 |
| methodspurified | #1 |
| rs201802880 | #1 |
| nasal treatment ctbcii | #1 |
| nzb dth | #1 |
| cii256−270 | #1 |
| h2q h2r | #1 |
| flss tlr3 expression | #1 |
| collagen iiinduced arthritis | #1 |
| avridine arthritis | #1 |
| cells heterologous cii | #1 |
| cia caia | #1 |
| mmc transgene | #1 |
| cxi 6 | #1 |
| nss1 | #1 |
| denidritic cells | #1 |
| immunization rat cii | #1 |
| chronic pristane | #1 |
| genes ncf1 | #1 |
| new arthritis therapy | #1 |
| cia il10 | #1 |
| anticii response | #1 |
| cii259273 peptide | #1 |
| nod nss1 loci | #1 |
| nfr origin | #1 |
| dba1 mice | #1 |
| oestrogen‐induced | #1 |
| expression ncf1 | #1 |
| comp arthritis models | #1 |
| ciif4 cartilage explants | #1 |
| minimal glycopeptide core | #1 |
| pepsin immunization | #1 |
| pia cix | #1 |
| chick cii cii | #1 |
| olive oil arthritis | #1 |
| function single | #1 |
| pc4 pc8 | #1 |
| ncf1 polymorphism | #1 |
| caia induced | #1 |
| cia cii | #1 |
| arthritis pristane | #1 |
| cia homologous cii | #1 |
| cii pia | #1 |
| compdeficient mice | #1 |
| prevents arthritis | #1 |
| cxi arthritis | #1 |
| genetic association ncf1 | #1 |
| joint inflammatory phase | #1 |
| hexadecane induce arthritis | #1 |
| h‐2q | #1 |
| mhc class injections | #1 |
| effects ciif4 | #1 |
| epitopes cb11 fragment | #1 |
| cii cartilage | #1 |
| ncf1m1j mice function | #1 |
| pepsin cii | #1 |
| arthritis tlr3 upregulation | #1 |
| collagen epitope expression | #1 |
| sle‐prone mrl | #1 |
| dapia6 | #1 |
| cia induced | #1 |
| socalled collagen antibody | #1 |
| caia cia | #1 |
| arthritis locus | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| new loci controlling | #1 |
| hyaluronanreceptor cd44 | #1 |
| ecm mab | #1 |
| pia experimental chromosomes | #1 |
| celldependent disease | #1 |
| rats ncf1 allele | #1 |
| neonatal mortality milk | #1 |
| severity ides | #1 |
| vpba pnipaam | #1 |
| arthritis epitopes | #1 |
| cii mhc | #1 |
| ciispecific cell responses | #1 |
| rats comp | #1 |
| arthritis immunisation | #1 |
| vivo monoclonal | #1 |
| pia rheumatoid arthritis | #1 |
| chemiluminescent probe l012 | #1 |
| mab cb268 | #1 |
| mediate pulmonary inflammation | #1 |
| h2p cia | #1 |
| act389949 | #1 |
| arthritis incidence | #1 |
| topoisomerase antagonist | #1 |
| lymphocytes cartilage | #1 |
| arthritis development severity | #1 |
| daxlewf1 | #1 |
| developed arthritis | #1 |
| eae b10riii mice | #1 |
| haplotype ltab | #1 |
| rats severity | #1 |
| alpha type collagen | #1 |
| ncf4 mip | #1 |
| pristane primed | #1 |
| susceptible collagen | #1 |
| cathelicidin expression blood | #1 |
| major antigenic epitope | #1 |
| arthritis naive mice | #1 |
| cia ifa | #1 |
| presence arthritogenic mabs | #1 |
| mice ros | #1 |
| phytol rna | #1 |
| dba mouse epitopes | #1 |
| male mice arthritis | #1 |
| constant light order | #1 |
| mhc‐congenic mouse strains | #1 |
| damage type collagen | #1 |
| animal models complexity | #1 |
| mir144 tlr2 expression | #1 |
| single bout hiit | #1 |
| chronic relapsing arthritis | #1 |
| u1 epitope | #1 |
| mip ncf4 | #1 |
| disease suggestive locus | #1 |
| keratinocytes dth reaction | #1 |
| arthritogenic mab ciic1 | #1 |
| humanized models disease | #1 |
| acpas specificity | #1 |
| nod loci genes | #1 |
| functional selective fpr1 | #1 |
| rt1l haplotypes | #1 |
| denatured cii | #1 |
| locus cia development | #1 |
| mab ciif4 ciic1 | #1 |
| disease collagen | #1 |
| ncf1m1j mice ncf1 | #1 |
| cii ros | #1 |
| large numbers hybridomas | #1 |
| eae39 locus cia | #1 |
| suppression collagen arthritis | #1 |
| major cii | #1 |
| cix disease | #1 |
| protective alleles eae2 | #1 |
| nox2 complex ncf4 | #1 |
| cia b10q | #1 |
| dnp epitopes lysine | #1 |
| cii treatment | #1 |
| antibody binding vivo | #1 |
| ncf1m1j mice | #1 |
| qtl animal genes | #1 |
| susceptibility collageninduced arthritis | #1 |
| c57bl 10q | #1 |
| dth nzb mice | #1 |
| tolerance arthritis | #1 |
| collagen arthritis progesterone | #1 |
| 270 peptide | #1 |
| arthritis susceptibility mice | #1 |
| arthritis darkness | #1 |
| ifnbeta experimental arthritis | #1 |
| reactivity cb268 | #1 |
| ncf1339 allele | #1 |
| ciif4 mab | #1 |
| rats chronic disease | #1 |
| chromosome f1 males | #1 |
| pia7 | #1 |
| cia pia | #1 |
| anticd4 treatment immunization | #1 |
| cii 256 | #1 |
| environments mice | #1 |
| wo2012127214 | #1 |
| m2139 ciic1 | #1 |
| arthritis monoclonal | #1 |
| arthritogenic mabs cii | #1 |
| ncf1 genes | #1 |
| cia11 | #1 |
| cartilage explants mabs | #1 |
| cartilaginous joints | #1 |
| oestrogen‐induced suppression | #1 |
| genetic variants ncf1 | #1 |
| rabeximod inflammatory cells | #1 |
| collagen epitopes | #1 |
| cia opportunities | #1 |
| immunodominant cii | #1 |
| models rheumatoid | #1 |
| carcinoma tumors ros | #1 |
| type epitopes | #1 |
| antibodies pc4 | #1 |
| selfcii | #1 |
| phytol arthritis | #1 |
| spread psoriasis | #1 |
| immune cartilage | #1 |
| molecule aq | #1 |
| h2w3 | #1 |
| role major epitopes | #1 |
| incidence arthritis | #1 |
| cd200 btla | #1 |
| controlling onset | #1 |
| peritonitis transgenic | #1 |
| rabeximod arthritis | #1 |
| b10dr4ncf1 mice cii | #1 |
| confers arthritis susceptibility | #1 |
| development collagen | #1 |
| acute phase arthritis | #1 |
| polymorphism ncf1 | #1 |
| genetic background rats | #1 |
| cii cb fragments | #1 |
| autoimmune arthritis apcs | #1 |
| pepsin arthritis | #1 |
| oxidases polymers | #1 |
| immunospecific reactions | #1 |
| periodontitis rats pia | #1 |
| elevated th17 cells | #1 |
| tlr3 tlr3 expression | #1 |
| dominant hypersensitivity | #1 |
| epitopes cb10 fragment | #1 |
| cxi rats | #1 |
| mcaia ncf1 | #1 |
| disease transgenic models | #1 |
| arthritis ncf1 allele | #1 |
| rats terpenes | #1 |
| experimental autoantibodies | #1 |
| treatment physiological doses | #1 |
| citrulline collagen | #1 |
| peripheral cells alphachains | #1 |
| arthritis monoclonal arthritis | #1 |
| thymectomy transgenes | #1 |
| concentrations cii | #1 |
| arthritis control mice | #1 |
| role ncf1 | #1 |
| cartilage collagen type | #1 |
| sialadenitis incidence | #1 |
| cells galactosylated peptide | #1 |
| estrogen immune responses | #1 |
| m1s1a | #1 |
| rt1f haplotype | #1 |
| concentrations rat cii | #1 |
| kgf cia | #1 |
| ciiinduced | #1 |
| rats cxi | #1 |
| congenic | #1 |
| cii ncf1 | #1 |
| collagens antibody | #1 |
| il10 cia | #1 |
| hufcgammariia | #1 |
| glycoprotein alpha1microglobulin | #1 |
| rats synthetic peptide | #1 |
| aq glycopeptide | #1 |
| arthritis tlr3 | #1 |
| genistein collagen | #1 |
| beta 812 | #1 |
| β1helix | #1 |
| dominant susceptibility loci | #1 |
| frequency chronic arthritis | #1 |
| rats ncf1 gene | #1 |
| dba 1jpfp | #1 |
| polymorphism autoimmune diseases | #1 |
| arthritis anticii abs | #1 |
| glycosylated epitope | #1 |
| f1 males influence | #1 |
| collagen hybridomas | #1 |
| lew avridineinduced arthritis | #1 |
| experimental autoimmunity cells | #1 |
| collagen induced | #1 |
| cii 256270 peptide | #1 |
| fls ppt medium | #1 |
| critical restriction site | #1 |
| antibody response cii | #1 |
| collagen antibodies | #1 |
| cii mab | #1 |
| autologous type collagen | #1 |
| arthritis b10q mice | #1 |
| cia animal epitopes | #1 |
| lnchc cholesterol metabolism | #1 |
| eae2 locus | #1 |
| ncf1 mutant mice | #1 |
| methods | #1 |
| aq molecule | #1 |
| caia riiis segment | #1 |
| extraarticular cartilage | #1 |
| nodp nod | #1 |
| chromosome cia | #1 |
| rheumatoid arthritis cia | #1 |
| hladrβ10402 | #1 |
| arthritis males | #1 |
| lewis oia | #1 |
| collagen reactivity cxi | #1 |
| synovial cells macrophages | #1 |
| cia melatonin | #1 |
| cells ncf1 | #1 |
| tlr3 expression flss | #1 |
| induced relapsing | #1 |
| dba 1jpfp cia | #1 |
| cxb10qf2 | #1 |
| development aureus arthritis | #1 |
| argltgrpgda | #1 |
| citrullination cii | #1 |
| human gpi protein | #1 |
| increased salt exposure | #1 |
| cii induced | #1 |
| mice h2q | #1 |
| pia cia | #1 |
| cii dendritic cells | #1 |
| blocking arthritis | #1 |
| p47phox mutant | #1 |
| rats antibody response | #1 |
| severity arthritis | #1 |
| collagen type‐ii epitope | #1 |
| cageeffects | #1 |
| diabetes sialadenitis | #1 |
| mutant p47phox | #1 |
| formation arthritis | #1 |
| dependent autoimmune arthritis | #1 |
| ncf1 339 | #1 |
| immunization heterologous cii | #1 |
| m2139 arthritogenic mab | #1 |
| cii rats | #1 |
| mediating arthritis | #1 |
| stromal cells osteoclasts | #1 |
| cii ciif4 | #1 |
| citrullinated type collagen | #1 |
| driven psoriatic arthritis | #1 |
| cii human | #1 |
| b10q dba 1f1 | #1 |
| cxi pia | #1 |
| ros antigens | #1 |
| h2r h2q | #1 |
| immune priming events | #1 |
| bb2bb3 regulation | #1 |
| nox2 complex addition | #1 |
| cii antibody | #1 |
| human cii cartilage | #1 |
| induction cii | #1 |
| kgf chondrocytes | #1 |
| cii severe arthritis | #1 |
| lewis rats pepsin | #1 |
| dominant traits | #1 |
| antibody ciic1 | #1 |
| cii heterologous cii | #1 |
| cia5 region | #1 |
| cia21 cia22 | #1 |
| h2p susceptibility | #1 |
| riiis alleles eae2 | #1 |
| inflammation caia | #1 |
| locus arthritis | #1 |
| immunisation cells | #1 |
| kupffer cells mir144 | #1 |
| melatonin release pinealectomy | #1 |
| cii comp | #1 |
| induction phase cia | #1 |
| arthritis amino | #1 |
| cii chronic | #1 |
| cells mouse cii | #1 |
| dendritic cells collagen | #1 |
| animal genetic predisposition | #1 |
| cii256270 | #1 |
| ciiglycopeptides | #1 |
| models rheumatoid arthritis | #1 |
| modified glycopeptides | #1 |
| anti comp | #1 |
| cii responsiveness | #1 |
| tlr3 expression fls | #1 |
| congenic fragment | #1 |
| oxidative burst disease | #1 |
| qa2 gene clusters | #1 |
| rat cb11 immunization | #1 |
| immunological transmitter | #1 |
| flss polyi | #1 |
| development humanized models | #1 |
| comp cii | #1 |
| pathogenesis cia | #1 |
| native cii | #1 |
| vivo monoclonal mouse | #1 |
| congenic arthritis | #1 |
| cia oestrogen | #1 |
| ym1 alternative activation | #1 |
| rats hfdmets | #1 |
| dth dba 1 | #1 |
| ncf4 mice | #1 |
| homologous type collagen | #1 |
| mice cii immunization | #1 |
| homologous cii | #1 |
| pc8 pc117 | #1 |
| breeding capacity | #1 |
| clec4b activation | #1 |
| cii induced arthritis | #1 |
| disease glycoproteins | #1 |
| tumor colonization | #1 |
| expression liver receptor | #1 |
| ncf1 deficient | #1 |
| polymorphic fragment | #1 |
| suggestive locus chromosome | #1 |
| scarce clinical samples | #1 |
| eae39 study | #1 |
| chromosome 17 mhc | #1 |
| cell recognition cii | #1 |
| rat comp | #1 |
| fecq4 fragment | #1 |
| congenic strains cia | #1 |
| mbq mouse | #1 |
| mabs monoclonal arthritis | #1 |
| arthritis animal | #1 |
| animal histocompatibility | #1 |
| psoriasis spread | #1 |
| myeloid effector functions | #1 |
| rats rt1 | #1 |
| cia13 | #1 |
| citrullinated type | #1 |
| h2p h2q | #1 |
| collagen type cii | #1 |
| increase ncf1 | #1 |
| caia kgf | #1 |
| induction postpartum flare | #1 |
| snat proteins | #1 |
| congenic mice genes | #1 |
| ciispecific antibodies | #1 |
| chemical collagen | #1 |
| cia5 cia21 | #1 |
| frequency igaproducing cells | #1 |
| act389949 fpr2 | #1 |
| mice salt intake | #1 |
| caia cii | #1 |
| adjuvant oils | #1 |
| autoantibody formation cia | #1 |
| activation cii | #1 |
| defined polymeric adjuvant | #1 |
| anti type | #1 |
| potent disease accelerator | #1 |
| ncf1 mice wt | #1 |
| estrogenmediated suppression | #1 |
| pia eae | #1 |
| cryogel matrix cells | #1 |
| cii histocompatibility complex | #1 |
| strains polychondritis | #1 |
| c3hnb | #1 |
| cii cix | #1 |
| caia experimental arthritis | #1 |
| arthritis humans | #1 |
| aq class | #1 |
| ncf1m1j | #1 |
| epitope type | #1 |
| 2 nox2 | #1 |
| b10qbalb | #1 |
| experimental arthritis antibodies | #1 |
| cnbr‐fragment | #1 |
| placental mhc class | #1 |
| cii immunization treatment | #1 |
| rat cb10 cb11 | #1 |
| kgf treatment onset | #1 |
| autoantibody responses cii | #1 |
| single monoclonal | #1 |
| chromosome congenic strains | #1 |
| re04001activatedfpr1 | #1 |
| hg6pi | #1 |
| realtime pcr flss | #1 |
| ncf1 mutant | #1 |
| cii disease | #1 |
| cia lysine | #1 |
| arthritis synovial tlr3 | #1 |
| impact topoisomerase antagonist | #1 |
| dimethyl6n | #1 |
| treatment cii immunization | #1 |
| genetic control sialadenitis | #1 |
| mice mutated cii | #1 |
| cii matrix protein | #1 |
| eae strains severity | #1 |
| recognition lysine | #1 |
| melatonin cia | #1 |
| tumor models ncf1 | #1 |
| b10q mice | #1 |
| cii acpa | #1 |
| glycosylated determinant peptides | #1 |
| cia comp | #1 |
| 339 polymorphism | #1 |
| predominant selection | #1 |
| mumt mice oestrogen | #1 |
| rheumatoid arthritis eae | #1 |
| comp cxi | #1 |
| b10qacb | #1 |
| mab mab ciic1 | #1 |
| rats ncf1 | #1 |
| qtl positional cloning | #1 |
| rats pristaneinduced arthritis | #1 |
| ciispecific | #1 |
| collagen dendritic cells | #1 |
| function p47phox | #1 |
| h2p h2q haplotype | #1 |
| pia3 chromosome | #1 |
| arthritis mhc | #1 |
| mip cia | #1 |
| maintenance arthritis | #1 |
| mouse cii reactivity | #1 |
| arthritis qtl pia7 | #1 |
| ftirm mice | #1 |
| established sialadenitis | #1 |
| loci controlling diabetes | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| sialadenitis strains | #1 |
| disease genotype immunoglobulin | #1 |
| hfdmets expression | #1 |
| rats adjuvant oil | #1 |
| pristane tlr3 expression | #1 |
| tissue attack | #1 |
| cii response | #1 |
| chromosomes eae loci | #1 |
| stages arthritis | #1 |
| region eae2 | #1 |
| lew ztm ncf1 | #1 |
| pia cia13 pia7 | #1 |
| ciif4 adverse effects | #1 |
| disease affinity | #1 |
| susceptible cia | #1 |
| pc117 | #1 |
| ox8 monoclonal | #1 |
| cia32 | #1 |
| elimination carbohydrates | #1 |
| arthritis intraperitoneal injection | #1 |
| immune response mbp | #1 |
| ncf4 | #1 |
| eae mtx | #1 |
| b10qc5δ | #1 |
| collagen langerhans cells | #1 |
| emulsions induction | #1 |
| developed severe | #1 |
| tlr3 expression tnfα | #1 |
| reproductive performance identification | #1 |
| pia9 | #1 |
| phagocytic nox2 complex | #1 |
| differences ncf1 | #1 |
| sialadenitis cell phenotypes | #1 |
| serum chromosome | #1 |
| presentation arthritis | #1 |
| ncf1mutation | #1 |
| new therapy arthritis | #1 |
| complex aq molecules | #1 |
| innate rats | #1 |
| estrogen physiological doses | #1 |
| cii experimental autoantigens | #1 |
| dr4 glycopeptides | #1 |
| hfdmets | #1 |
| congenic cia40 | #1 |
| chronic arthritis mice | #1 |
| ncf1m1j m1j mice | #1 |
| mice cii epitopes | #1 |
| oxazolone inflammatory response | #1 |
| cells arthritogenicity | #1 |
| differential susceptibility cia | #1 |
| ciilysdnp | #1 |
| rats rt1f mhc | #1 |
| 6 cii | #1 |
| ncf1 association | #1 |
| genes congenic | #1 |
| drb10401 col2259 | #1 |
| cii major epitope | #1 |
| immunization heterologous | #1 |
| ros glucose transporter | #1 |
| ncf1m1j mutation | #1 |
| cia mtx | #1 |
| cryogel column antibodies | #1 |
| cii259 273 | #1 |
| cartilage cii | #1 |
| nod incidence | #1 |
| tlr3 upregulation flss | #1 |
| nodq×b10q | #1 |
| arthritogenicity cells | #1 |
| presence mhv | #1 |
| polyi pia rats | #1 |
| beta 10b beta | #1 |
| cii triple | #1 |
| rat cii cii | #1 |
| ctbcii | #1 |
| nox2 functionality | #1 |
| chronicity arthritis | #1 |
| arthritis cia | #1 |
| day ciispecific cells | #1 |
| peptide agonist fmlf | #1 |
| genetic regions | #1 |
| cii experimental arthritis | #1 |
| insulitis nodq | #1 |
| cii mabs | #1 |
| backcrosses nzb mice | #1 |
| immunization rat | #1 |
| citrullinated variants | #1 |
| h2q c3hnb | #1 |
| ciipeptide | #1 |
| chronic intervention | #1 |
| ciic1 antibody | #1 |
| arthritis susceptibility rats | #1 |
| vivo experimental arthritis | #1 |
| cii261 | #1 |
| w33t | #1 |
| expressions cyp7a1 | #1 |
| hla–dr1 | #1 |
| active arthritis complex | #1 |
| tcell hybridomas cells | #1 |
| cii peptide molecules | #1 |
| c3hq mice | #1 |
| function ncf1 gene | #1 |
| epitopes collagen | #1 |
| protein ncf1m1j mice | #1 |
| inbred strains severity | #1 |
| glycosylation hla | #1 |
| dapia3 | #1 |
| macrophages cii degradation | #1 |
| enhanced autoimmunity arthritis | #1 |
| mannan mice | #1 |
| c3bireceptors | #1 |
| haplotypes h2q | #1 |
| type collagens rats | #1 |
| cia2 cia9 | #1 |
| arthritismodulating | #1 |
| striking phenotypic similarities | #1 |
| nzb mice trait | #1 |
| ifa cii ifa | #1 |
| antigenic adjuvant | #1 |
| homologous type | #1 |
| role eosinophilia | #1 |
| dth response mrl | #1 |
| type cii | #1 |
| impact etoposide | #1 |
| cb268 cii | #1 |
| anticcp2negative patients | #1 |
| cia h2p | #1 |
| established pia disease | #1 |
| beta haplotype | #1 |
| collagen antibody arthritis | #1 |
| cia12 | #1 |
| liver contributes hfdmets | #1 |
| anti collagen | #1 |
| oestradiol suppression | #1 |
| eae39 control disease | #1 |
| increased incidence cia | #1 |
| chemical cartilage | #1 |
| ncf1 ptpn22 | #1 |
| cells caia | #1 |
| arthritis estrogen | #1 |
| cell determinants cii | #1 |
| immunization type | #1 |
| arthritis cell | #1 |
| cb11 sequence cii | #1 |
| cii ecm | #1 |
| tlr3 rna interference | #1 |
| comp disease monitoring | #1 |
| beta 10b mrl | #1 |
| cd2 human cells | #1 |
| cii induce | #1 |
| complex cia | #1 |
| rats pristane | #1 |
| antiidiotypic antibodies cd4 | #1 |
| cartilage antibody | #1 |
| b10q mice authors | #1 |
| ifnbeta deficiency | #1 |
| cia antibody response | #1 |
| comp mabs | #1 |
| phase arthritis | #1 |
| urokinase enzyme | #1 |
| illness terpenes | #1 |
| ncf1 gene | #1 |
| arthritis injection | #1 |
| arthritis rheumatoid arthritis | #1 |
| synovium pia rats | #1 |
| ftirm cii | #1 |
| mcia1 | #1 |
| immunization autologous peptide | #1 |
| cells dba mouse | #1 |
| nox2 complex | #1 |
| cix cartilage | #1 |
| promoter regions antigens | #1 |
| cia caia model | #1 |
| enhanced autoimmunity | #1 |
| b10riii | #1 |
| deficient ncf1 | #1 |
| mice developed | #1 |
| chromosome pia | #1 |
| nonglycosylated epitope | #1 |
| rats established pia | #1 |
| arthritis male | #1 |
| diagnostic accuracy acpa | #1 |
| congenic polymorphism | #1 |
| cii lewis rats | #1 |
| arthritis mcaia | #1 |
| ifn signature mice | #1 |
| ncf1 p47phox | #1 |
| chronic active arthritis | #1 |
| arthritis b6n mice | #1 |
| cell recognition carbohydrates | #1 |
| collagen arthritis iii | #1 |
| mice l012 | #1 |
| mice th1 cytokines | #1 |
| hybridomas multispecific antibodies | #1 |
| monoclonal arthritis arthritis | #1 |
| fcbinding | #1 |
| ros experimental arthritis | #1 |
| therapeutic cleavage igg | #1 |
| positional identification | #1 |
| endos hydrolyzed igg | #1 |
| cii monoclonal arthritis | #1 |
| fecq4 | #1 |
| intracellular processing cii | #1 |
| superovulation rate | #1 |
| major epitopes | #1 |
| arthritis driven | #1 |
| greater osteoclasts | #1 |
| cii h2q | #1 |
| mhc influence | #1 |
| mhc genetic region | #1 |
| mannan joints | #1 |
| ides treatment severity | #1 |
| ciipeptide cells | #1 |
| j1 epitope | #1 |
| cartilage stability cartilage | #1 |
| ciispecific cells | #1 |
| pinealectomy exposure | #1 |
| saline arthritis | #1 |
| mechanism autoimmune | #1 |
| cxi cii | #1 |
| type collagen cii256−270 | #1 |
| phemagelatin | #1 |
| nodq nod | #1 |
| collagen‐induced arthritis | #1 |
| acute arthritis neutrophils | #1 |
| plcpip | #1 |
| bqncf1m1j | #1 |
| salivary glands antigen | #1 |
| galactosylated peptide | #1 |
| inflammatory tissue attack | #1 |
| cii citrullinated | #1 |
| arthritis transfer | #1 |
| targeted deletion ncf1 | #1 |
| daf2cross | #1 |
| caia mutant mice | #1 |
| mabs cii | #1 |
| cii peptides | #1 |
| cii256 270 | #1 |
| nodq nod nodp | #1 |
| evokes peptide | #1 |
| specificity arthritis | #1 |
| oestrogen cia | #1 |
| genome b10riii | #1 |
| arthritis genetics | #1 |
| rat pristaneinduced arthritis | #1 |
| nadph activation | #1 |
| native comp | #1 |
| eae2 resistant locus | #1 |
| antibody induced | #1 |
| response splenocytes | #1 |
| pristane stimulation | #1 |
| protein expression genes | #1 |
| contrast nodq | #1 |
| t‐cell epitope cii260‐270 | #1 |
| pia4 | #1 |
| fpr act389949 | #1 |
| cia ul1 mab | #1 |
| function targeted deletion | #1 |
| induced arthritis | #1 |
| animal models polychondritis | #1 |
| h2q mice | #1 |
| inclusion negative predictive | #1 |
| glycopeptide stimulation | #1 |
| receptor γ pparγ | #1 |
| synthetic peptides cii | #1 |
| acpa general population | #1 |
| function acpas | #1 |
| innate immunity mip | #1 |
| rat recombinants | #1 |
| mhc cii | #1 |
| cii recognition | #1 |
| arthritis toe stiffness | #1 |
| partial advanced intercross | #1 |
| nodq locus | #1 |
| ciid3 | #1 |
| visual signs arthritis | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| collagen ii‐induced | #1 |
| polychondritis mice | #1 |
| transgenic nadph | #1 |
| tcell congenic arthritis | #1 |
| vivo treatment | #1 |
| innate‐associated disease | #1 |
| cia antigens haplotypes | #1 |
| b10q1 | #1 |
| da1u rats expression | #1 |
| sensitive wkymvm | #1 |
| mutation ptdins3pbinding site | #1 |
| inbred dba pepsin | #1 |
| decreasing activation | #1 |
| chronic stage arthritis | #1 |
| maintained pregnancy levels | #1 |
| lpscaia | #1 |
| daiu | #1 |
| 15a11 | #1 |
| features arthritis | #1 |
| cii olive oil | #1 |
| recombinant vaccine inflammation | #1 |
| igg1 igg2b isotypes | #1 |
| oestradiol exacerbation | #1 |
| cia13 pia7 | #1 |
| rt1bβ | #1 |
| mice salt concentrations | #1 |
| cells rat cii | #1 |
| ciic1 mabs | #1 |
| mbp c5a | #1 |
| onset animals arthritis | #1 |
| autoimmune diseases cnvs | #1 |
| rats mhc genes | #1 |
| oestrogen treated | #1 |
| arthritis mutant strains | #1 |
| mrl mice estrogen | #1 |
| suppressive development | #1 |
| cia olive oil | #1 |
| rat cii arthritis | #1 |
| h‐2b | #1 |
| alphachains cell surface | #1 |
| cii immunization | #1 |
| arthritis promoting | #1 |
| specific cii | #1 |
| inconsistent susceptibility | #1 |
| region ncf1 | #1 |
| rheumatoid collagen | #1 |
| cxi | #1 |
| post‐partum exacerbation | #1 |
| pia5 | #1 |
| cd68‐expressing cells | #1 |
| arthritis adjuvants | #1 |
| pia3 | #1 |
| arthritis severity rats | #1 |
| cia animal models | #1 |
| pia experimental arthritis | #1 |
| therapeutic c4bp | #1 |
| terpenes toll | #1 |
| lymphocytes collagen | #1 |
| milk titers | #1 |
| rabeximod | #1 |
| new arthritis | #1 |
| loci arthritis | #1 |
| pia rats tlr3 | #1 |
| lack arthritis | #1 |
| cia cells | #1 |
| elisagenetyping | #1 |
| pia disease | #1 |
| rheumatoid arthritis complexity | #1 |
| idd5 loci | #1 |
| c3hq | #1 |
| homologous type pia | #1 |
| induce arthritis | #1 |
| spleen pristane injection | #1 |
| cia ros | #1 |
| cia mhc | #1 |
| arthritis ncf1 | #1 |
| cii caia | #1 |
| rats rheumatoid | #1 |
| ncf4 gene | #1 |
| eae2 chromosome | #1 |
| cartilage specific | #1 |
| non‐mhc genes | #1 |
| mcaia | #1 |
| mice mutated type | #1 |
| lower capacity ros | #1 |
| collagen citrullination | #1 |
| induced arthritis cia | #1 |
| animal epitopes | #1 |
| models collagen | #1 |
| transgenic mice mhcii | #1 |
| arthritogenic antibody | #1 |
| clonal expansion arthritis | #1 |
| ncf1 mutated | #1 |
| nrc ova | #1 |
| pia model | #1 |
| ncf1 mutation | #1 |
| cia7 chromosome | #1 |
| cia21 lymph nodes | #1 |
| ncf1da | #1 |
| disease dba 1jpfp | #1 |
| hladrbound peptides | #1 |
| functional ncf1 | #1 |
| nox2complex | #1 |
| cia21 | #1 |
| cia rheumatoid arthritis | #1 |
| wt ncf1 | #1 |
| position 264 | #1 |
| caia mab | #1 |
| mouse chromosome eae39 | #1 |
| sod3 peritonitis | #1 |
| cii cell | #1 |
| macrophages cii | #1 |
| psicoch2 | #1 |
| patients china cohort | #1 |
| immunization lathyritic cii | #1 |
| tolerance arthritis susceptibility | #1 |
| estrogeninduced suppression | #1 |
| gia expansion | #1 |
| ciispecific cells day | #1 |
| mice anticd4 treatment | #1 |
| cii swr mice | #1 |
| fecq3 locus | #1 |
| dth antibody response | #1 |
| emerging glyco‐based strategies | #1 |
| il10 mmc | #1 |
| antibodies cii | #1 |
| mice burkholderia cepacia | #1 |
| mgpi325 | #1 |
| act389949 fpr | #1 |
| cii vivo | #1 |
| mice functional ncf1 | #1 |
| congenic polymorphism illness | #1 |
| ala261gly262 | #1 |
| oestradiol dth | #1 |
| idiotype‐specific binding | #1 |
| dba 1 mouse | #1 |
| cb268 | #1 |
| antibody cartilage blymphocyte | #1 |
| ii‐induced arthritis | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| mice cryogels | #1 |
| 4 histone deacetylases | #1 |
| cia22 | #1 |
| role nox2derived ros | #1 |
| fecq4 locus | #1 |
| oxoethyl6h | #1 |
| rfig lambda | #1 |
| proteins gay | #1 |
| rheumatoid arthritis cii | #1 |
| ros rheumatoid humans | #1 |
| lps caia | #1 |
| hydrolyzed igg | #1 |
| arthritis congenic | #1 |
| copy variation ncf1 | #1 |
| collagen cxi | #1 |
| ciic1 m2139 | #1 |
| human α‐enolase | #1 |
| inbred strains cia | #1 |
| sialadenitis arthritis | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| tnfα tlr3 expression | #1 |
| pia3 pia4 | #1 |
| disease development effects | #1 |
| cii epitope | #1 |
| arthritis independent | #1 |
| cia dominant epitope | #1 |
| toxin‐1‐producing staphylococci | #1 |
| development pristaneinduced arthritis | #1 |
| macrophages mannans | #1 |
| cia pathogenesis | #1 |
| hdac3 pparγ | #1 |
| congenic strains rats | #1 |
| cii lewis | #1 |
| monoclonal cartilage cattle | #1 |
| cii259 | #1 |
| double deficiency qa2 | #1 |
| cia induced arthritis | #1 |
| experimental arthritis autoimmune | #1 |
| autoantibodies cii | #1 |
| arthritis qtl chip | #1 |
| ros immunohistochemistry implants | #1 |
| b10q | #1 |
| pia8 | #1 |
| cia compdeficient mice | #1 |
| ciif4 cartilage damage | #1 |
| cia40 | #1 |
| anticii autoantibodies | #1 |
| cii vaccination | #1 |
| existence periodontitis | #1 |
| dba 1 background | #1 |
| mice ncf1m1j mutation | #1 |
| preformed cartilage | #1 |
| findings new therapy | #1 |
| b10q h2q | #1 |
| rabeximod treatment | #1 |
| pv cd4 cells | #1 |
| cia12 pia4 | #1 |
| disease monitoring rats | #1 |
| functional nox2 | #1 |
| muscle nox2 | #1 |
| hydrocarbon oil structure | #1 |
| cells autologous cii | #1 |
| mice deficient ncf1 | #1 |
| macrophages hladr1transgenic mice | #1 |
| cia | #1 |
| experimental carcinogens | #1 |
| reduced oxidative burst | #1 |
| congenic c57bl mice | #1 |
| humans animals arthritis | #1 |
| cia tsc transgenic | #1 |
| cii cxi | #1 |
| arthritis rat strains | #1 |
| rheumatoid disease models | #1 |
| cii immunization mice | #1 |
| dba 1 | #1 |
| animal models arthritis | #1 |
| ccp2 negative | #1 |
| heterologous peptide response | #1 |
| cii immunisation | #1 |
| cii epitopes | #1 |
| controlling collagen | #1 |
| wild type ncf1 | #1 |
| presentation cii | #1 |
| tolerance immunodominant | #1 |
| ciiderived | #1 |
| eae3 chromosome | #1 |
| anticardiolipin antibodies p005 | #1 |
| h‐2q mice | #1 |
| h2p mice cia | #1 |
| c3hnb h2p | #1 |
| gergaagiagpk | #1 |
| arthritis collagen | #1 |
| collageninduced arthritis loci | #1 |
| ox8 antibodies | #1 |
| cii articular cartilage | #1 |
| polymorphism mitochondrial genome | #1 |
| ros rns inflammation | #1 |
| region eae3 | #1 |
| arthritis rabeximod | #1 |
| chromosome caia | #1 |
| cii rheumatoid autoantibodies | #1 |
| cia vivo priming | #1 |
| cell‐deficient mice | #1 |
| caia monoclonal | #1 |
| relapsing arthritis | #1 |
| restricted role fcγr | #1 |
| recombinants rt1u | #1 |
| cii severity | #1 |
| minor cartilage proteins | #1 |
| acpa discriminate | #1 |
| pristane hexadecane | #1 |
| cix cii | #1 |
| position ros production | #1 |
| c57bl strains loci | #1 |
| bb2bb3 | #1 |
| arthritis caia | #1 |
| arthritis development cross | #1 |
| rat cii response | #1 |
| pc117 extracellular structures | #1 |
| b10q b10riii | #1 |
| rt1u lew1w | #1 |
| chronic development | #1 |
| cia rheumatoid autoantibodies | #1 |
| valphachain | #1 |
| type disease | #1 |
| rat type collagen | #1 |
| oxidases receptors | #1 |
| leukosialin rats | #1 |
| antibodies consensus motif | #1 |
| bond requirements | #1 |
| severity cia | #1 |
| arthritis estrus cycle | #1 |
| skg mutation | #1 |
| b10dr4ncf1 mice | #1 |
| autologous cii | #1 |
| phase cia | #1 |
| synovial membranes joints | #1 |
| ncf1 mice | #1 |
| ncf1 spread | #1 |
| sterically privileged | #1 |
| cia molecular basis | #1 |
| nod nss1 | #1 |
| h2q haplotype | #1 |
| nzw parental | #1 |
| cia ul1 | #1 |
| cii specific | #1 |
| rats phytol | #1 |
| ncf4 nox2 complex | #1 |
| comp lack | #1 |
| genetically segregating crosses | #1 |
| qa2 natural mutations | #1 |
| nzw parental strain | #1 |
| cia experimental autoantibodies | #1 |
| arthritis pia | #1 |
| cia model strains | #1 |
| reactivity cii | #1 |
| ciilysdnp mice | #1 |
| dependent autoimmune | #1 |
| ncf1 sle | #1 |
| cii antibodies | #1 |
| inbred dba prolactin | #1 |
| peptides aq | #1 |
| mbq mouse macrophages | #1 |
| inflammatory phase cia | #1 |
| effects fab2 | #1 |
| mice arthritis | #1 |
| cii260 | #1 |
| sialadenitis nodq | #1 |
| fibroblast induced arthritis | #1 |
| ppt medium | #1 |
| b10q mice ncf1 | #1 |
| chondrocytes kgf | #1 |
| congenic arthritis rats | #1 |
| drb10401positive | #1 |
| g6pi peptide | #1 |
| ifnbeta arthritis | #1 |
| b10dr4ncf1 | #1 |
| model rheumatoid arthritis | #1 |
| cii antigen presentation | #1 |
| riiis segment chromosome | #1 |
| congenic fragments | #1 |
| rp autoimmune disease | #1 |
| cartilage explants ciic1 | #1 |
| pia model rats | #1 |
| established arthritis | #1 |
| ul1 vivo | #1 |
| citc1iiip | #1 |
| interacting subloci | #1 |
| oia induction | #1 |
| ul1 ciif4 mab | #1 |
| manifestations lupus disease | #1 |
| cii rat cii | #1 |
| incidence nod | #1 |
| da1f | #1 |
| concentrations mouse cii | #1 |
| caia acute arthritis | #1 |
| rat pia | #1 |
| pia cii | #1 |
| cd4 treatment | #1 |
| rats congenic arthritis | #1 |
| ciif4 ciic1 | #1 |
| nox2 complex–derived ros | #1 |
| tlr3 pristane | #1 |
| ciic1 fab | #1 |
| spread induced psoriasis | #1 |
| mhv runting neonates | #1 |
| arthritis castration | #1 |
| antigen presentation cii | #1 |
| cia eae39 | #1 |
| cia31 | #1 |
| ros continental ancestry | #1 |
| carbohydrates cii | #1 |
| deficient neonatal | #1 |
| pepsin lewis | #1 |
| rat comp arthritis | #1 |
| pristane cell death | #1 |
| phytol molecular pathways | #1 |
| eae2 | #1 |
| ros adaptive immunity | #1 |
| autoimmune priming | #1 |
| glut4dependent glucose transport | #1 |
| mice c3h background | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| anti cii acpa | #1 |
| rat cii | #1 |
| cia mip | #1 |
| ccp positive patients | #1 |
| sialadenitis congenic mice | #1 |
| induced arthritis rats | #1 |
| representative swedish | #1 |
| heterologous cii cells | #1 |
| immunization cii | #1 |
| cii 6 | #1 |
| dancf1da rats | #1 |
| disease susceptibility castration | #1 |
| disease lew | #1 |
| peritonitis sod3 | #1 |
| e3xda | #1 |
| inability collagen | #1 |
| fecq3 | #1 |
| rats antibody cartilage | #1 |
| mucosal tolerance cii | #1 |
| arthritis onset severity | #1 |
| 17βestradiolregulation | #1 |
| pristaneprimed cells | #1 |
| oestrogen induced | #1 |
| c1iii type collagen | #1 |
| b10qnfr | #1 |
| qtl chip | #1 |
| immunization mouse | #1 |
| cells arthritis progression | #1 |
| mannan immune | #1 |
| injection mannan | #1 |
| comp experimental autoantibodies | #1 |
| chronic arthritis rats | #1 |
| mcii707 | #1 |
| cii immunodominant | #1 |
| collagen 256 | #1 |
| compsufficient mice | #1 |
| partial advanced | #1 |
| treatment pia | #1 |
| female preponderance development | #1 |
| nucleotide reactive | #1 |
| cii anticd4 treatment | #1 |
| collagen reactive | #1 |
| proteolipoprotein peptide | #1 |
| position mouse cii | #1 |
| cii sera | #1 |
| dth nzb | #1 |
| major role rp | #1 |
| b10b | #1 |
| cxi comp | #1 |
| mouse cii | #1 |
| inbred dba cii | #1 |
| cells cb11 | #1 |
| nephritis nodq | #1 |
| streptococcal endo | #1 |
| abetachains | #1 |
| cartilage‐specific | #1 |
| cii260‐270 | #1 |
| pristaneinduced arthritis pia | #1 |
| liver histone deacetylase | #1 |
| pparγ cbrh7919 cells | #1 |
| ciiinduced arthritis | #1 |
| ncf1 allele | #1 |
| autoantibodies collagen | #1 |
| experimental collagen | #1 |
| development oia | #1 |
| loci sialadenitis | #1 |
| encephalomyelitis arthritis | #1 |
| effects cia | #1 |
| animal immunosuppressive agents | #1 |
| u1 antibodies patients | #1 |
| ztmrhd | #1 |
| mice ncf1 | #1 |
| eae2 eae3 | #1 |
| cii saline | #1 |
| g6pi chronic arthritis | #1 |
| spleen cluster | #1 |
| ym1 pneumonitis | #1 |
| cia recognition | #1 |
| development collageninduced arthritis | #1 |
| arthritis loci | #1 |
| collageninduced arthritis | #1 |
| pia4 chromosome | #1 |
| cia9 | #1 |
| injection lewis rat | #1 |
| arthritis‐susceptibility loci | #1 |
| cii cartilage explants | #1 |
| fumia | #1 |
| functional ncf1 macrophages | #1 |
| day cii immunisation | #1 |
| ros autoimmune diseases | #1 |
| cia2 arthritis | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| biodegradation cryogels | #1 |
| etoposide topoisomerase antagonist | #1 |
| arthritogenic mabs | #1 |
| tregs ros | #1 |
| histology vaccination | #1 |
| dominant hypersensitivity dth | #1 |
| autoimmunity mineral oils | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| arthritogenic antibodies | #1 |
| arthritis collagen arthritis | #1 |
| cxiia | #1 |
| rats clec4b | #1 |
| severe arthritis | #1 |
| cxi chronic arthritis | #1 |
| arthritis multiple | #1 |
| ncf1deficient mice | #1 |
| cii | #1 |
| rheumatoid drug evaluation | #1 |
| phenotypes ncf1m1j mice | #1 |
| citrullinated cii | #1 |
| ciispecific monoclonal | #1 |
| collagen autoantibody | #1 |
| strong response epitopes | #1 |
| act389949 agonist | #1 |
| arthritis antibody | #1 |
| cells mgps | #1 |
| psich2nh2 | #1 |
| genes arthritis | #1 |
| oils induce | #1 |
| cell specificity cii | #1 |
| severe arthritis immunization | #1 |
| type collagen cxi | #1 |
| dba 1j | #1 |
| rns type collagen | #1 |
| compia | #1 |
| phagocyte oxidative burst | #1 |
| pathway arthritis | #1 |
| olive oil cii | #1 |
| qa2 ncf1 | #1 |
| vridine‐induced arthritis | #1 |
| cholera toxin study | #1 |
| cia chromosome | #1 |
| macrophages autoimmune priming | #1 |
| rt1ba | #1 |
| bcell activities | #1 |
| ncf1 m1j | #1 |
| cia5 qtl | #1 |
| lathyritic cii | #1 |
| ncf1 copy variation | #1 |
| swr nfr | #1 |
| multiple sclerosis rabeximod | #1 |
| tlr3 flss | #1 |
| animal models acpa | #1 |
| strains nodq | #1 |
| cii arthritis | #1 |
| cia rat cii | #1 |
| cia swr mouse | #1 |
| arthritis chronic | #1 |
| ncf1 nos2 | #1 |
| estrogen differential outcome | #1 |
| 256 270 | #1 |
| m1j mice | #1 |
| h2g7 haplotype nod | #1 |
| early onset development | #1 |
| arthritis encephalomyelitis | #1 |
| pia rats arthritis | #1 |
| cells cii | #1 |
| normal cartilage arthritis | #1 |
| arthritis ul1 | #1 |
| mab ecm | #1 |
| epitopes arthritis | #1 |
| arthritis rat | #1 |
| cells cia | #1 |
| 237 females | #1 |
| arthritis ides | #1 |
| susceptibility collagen | #1 |
| arthritis animals | #1 |
| arthritis gene regions | #1 |
| pregq2 fragment | #1 |
| development chronic arthritis | #1 |
| cii cross reactivity | #1 |
| physiological doses development | #1 |
| hg6pi325 | #1 |
| substrains ztmrhd | #1 |
| collagen cii | #1 |
| illness cia | #1 |
| estrogen manifestations | #1 |
| fcγr3 | #1 |
| cii carbohydrates | #1 |
| suppression collagen | #1 |
| cii pepsin | #1 |
| eae chromosomes | #1 |
| polyi arthritis | #1 |
| serum interferon activity | #1 |
| mutated ncf1 | #1 |
| epitopes vivo | #1 |
| animals arthritis | #1 |
| 22 variant r620w | #1 |
| tlr3 synovium | #1 |
| arthritis induced | #1 |
| bal cells work | #1 |
| arthritis incidence severity | #1 |
| cia experimental arthritis | #1 |
| induction oia | #1 |
| dth dominant hypersensitivity | #1 |
| arthritis immunization | #1 |
| heterologous collagen | #1 |
| autoimmune accelerating | #1 |
| mhc mbp | #1 |
| pristaneinduced arthritis | #1 |
| eae39 | #1 |
| c3hnb mice | #1 |
| plasminogen deficiency cia | #1 |
| csfspecific | #1 |
| marginal ankylosis | #1 |
| pristane macrophages | #1 |
| siliac | #1 |
| major epitopes patients | #1 |
| authors hgpi325339 peptide | #1 |
| mice ncf4 | #1 |
| arthritis estrogen treatment | #1 |
| cells synthetic glycopeptides | #1 |
| cia development | #1 |
| glycosylation cell recognition | #1 |
| cells chronic arthritis | #1 |
| tracheolaryngeal | #1 |
| specific antibody protection | #1 |
| da1u rat liver | #1 |
| c4bp alternative pathway | #1 |
| naive experimental chromosomes | #1 |
| ethylene isostere | #1 |
| animal epitopes injections | #1 |
| mhc aq | #1 |
| rat congenic data | #1 |
| tracheolaryngeal cartilage | #1 |
| cia f1 males | #1 |
| dth mice trait | #1 |
| collagen‐induced | #1 |
| tumors immunosuppressive leukocytes | #1 |
| nox2derived ros | #1 |
| rheumatoid arthritis immunization | #1 |
| protective role cia | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| effector phase arthritis | #1 |
| mice b10q | #1 |
| selected anti‐t‐cell | #1 |
| b10qnss1 | #1 |
| igg response cii | #1 |
| tolerance cia | #1 |
| engagement fcgammar | #1 |
| nox2derived ros mice | #1 |
| ncf1 ncf1 mice | #1 |
| identification genetic regions | #1 |
| cii molecule | #1 |
| psiechch | #1 |
| disease arthritis | #1 |
| autologous peptide cells | #1 |
| ciic1 mab ciif4 | #1 |
| pristane induced | #1 |
| arthritis protection | #1 |
| animal genes cia | #1 |
| specificity ros rns | #1 |
| ros ncf1 | #1 |
| satellite encephalomyelitis | #1 |
| b10riii riiis | #1 |
| model rheumatoid | #1 |
| swr mice immunization | #1 |
| psoriasis single locus | #1 |
| severity pia | #1 |
| citrullinated collagen | #1 |
| caia lps | #1 |
| mice chronic arthritis | #1 |
| major locus cia | #1 |
| autoimmune arthritis activation | #1 |
| nox2 function | #1 |
| emission tomography mannan | #1 |
| spontaneous tissue inflammation | #1 |
| resistance collageninduced arthritis | #1 |
| epitopes cii | #1 |
| headache paradigm | #1 |
| signaling characterization | #1 |
| data act389949 | #1 |
| isolated fragment chromosome | #1 |
| hladr1transgenic mice | #1 |
| nox2 agonists | #1 |
| inflammation living mice | #1 |
| pristane hydrocarbon oils | #1 |
| ncf1 lyme arthritis | #1 |
| cii cells | #1 |
| chronic arthritis development | #1 |
| oxa nzb mice | #1 |
| pregq2 | #1 |
| anticlever1 antibody treatment | #1 |
| lys264 | #1 |
| arthritis development immunisation | #1 |
| aq molecules | #1 |
| ros nox2 complex | #1 |
| ym1deficient mice | #1 |
| antibodies citrullinated peptide | #1 |
| 2 months beta | #1 |
| strains developed | #1 |
| mhc cia | #1 |
| mir144 tlr2 | #1 |
| caia effects | #1 |
| adjuvanticity autoimmunity | #1 |
| mice darkness | #1 |
| rats pia | #1 |
| b10q strain | #1 |
| macrophage ros | #1 |
| position cii256270 | #1 |
| human immunopeptidome lung | #1 |
| adaptive immunity fcγrs | #1 |
| cia cartilage | #1 |
| oxidative burst inducers | #1 |
| murine psoriasis model | #1 |
| transgenic tolerance tlymphocytes | #1 |
| publication animals arthritis | #1 |
| spe acute phase | #1 |
| cia rat | #1 |
| phosphatase 22 | #1 |
| polymer adjuvant activity | #1 |
| clec4b | #1 |
| glycosylated cii259 | #1 |
| δ228 | #1 |
| cii256 | #1 |
| disease th1 immunity | #1 |
| tlr2 tlr2 regulation | #1 |
| autoantibodies cartilage | #1 |
| strains b10q | #1 |
| ncf1 knockout | #1 |
| arthritis arthritis loci | #1 |
| arthritis traits | #1 |
| tcell experimental cartilage | #1 |
| cartilage‐specific antibodiesis | #1 |
| chlorophyll component | #1 |
| cii cia | #1 |
| position ciilysdnp | #1 |
| aplec locus | #1 |
| cii u1 | #1 |
| pristaneinduced arthritis rats | #1 |
| rat placenta uterus | #1 |
| anticii antibody response | #1 |
| rats arthritis | #1 |
| c1iii | #1 |
| anticii antibodies | #1 |
| arthritis animal mice | #1 |
| lew mol strain | #1 |
| f1 hybrids disease | #1 |
| cuiiidaligands | #1 |
| gene ncf1 | #1 |
| upregulation tlr3 | #1 |
| cell tolerance cii | #1 |
| pia2–8 | #1 |
| disease cd8 deficiency | #1 |
| mbpc5a | #1 |
| genetic crossbreeding | #1 |
| genetic control pia | #1 |
| clec4b ncf1 | #1 |
| inflammatory phase arthritis | #1 |
| peptide characterisation | #1 |
| rats pia9 alleles | #1 |
| caia gene segments | #1 |
| genes animal models | #1 |
| antitlr3 antibody | #1 |
| ncf1 mutation mice | #1 |
| arthritis aim | #1 |
| tolerance induction cii | #1 |
| day acute arthritis | #1 |
| development inflammatory attack | #1 |
| therapeutic cleavage | #1 |
| ncf1 ros | #1 |
| loci cia2 | #1 |
| cxi collagen fibers | #1 |
| 1 ncf1 | #1 |
| loci eae39 | #1 |
| pia11 | #1 |
| congenic mice vdr | #1 |
| ciic1scfv | #1 |
| tlr expression synovium | #1 |
| severe polyarthritis | #1 |
| arthritis pepsin | #1 |
| cia locus | #1 |
| fab2 ciic1 | #1 |
| immunization heterologous peptide | #1 |
| response cii | #1 |
| pia blocking arthritis | #1 |
| development cia | #1 |
| ncf1 polymorphisms | #1 |
| experimental autoantigens | #1 |
| type collagen cia | #1 |
| healthy nzw | #1 |
| arthritis autoantibody | #1 |
| anticii abs | #1 |
| col2259 | #1 |
| function nox2 | #1 |
| cii mouse | #1 |
| vivo imaging l012 | #1 |
| lewis rat cia | #1 |
| nodq | #2 |
| c2ta genetic polymorphisms | #2 |
| eosinophilia arthritis | #2 |
| oestrogen suppressive | #2 |
| binding sites autoimmune | #2 |
| immunocap isac performance | #2 |
| human lung nox2 | #2 |
| acpa reactivities | #2 |
| chitosanagarosegelatin | #2 |
| macrophages enhances | #2 |
| igke | #2 |
| eae cia | #2 |
| arthritis gender | #2 |
| rats ifngamma | #2 |
| influence chromosome | #2 |
| antibody cartilage | #2 |
| cd8 cells incidence | #2 |
| wtc5a | #2 |
| b10qncf1 mice cia | #2 |
| comp cartilage | #2 |
| psoriatic disease models | #2 |
| g6pi arthritis | #2 |
| fpr1 agonist | #2 |
| tolerance cii | #2 |
| collagen ii‐induced arthritis | #2 |
| sera rheumatoid arthritis | #2 |
| 034positive | #2 |
| ros peroxide | #2 |
| receptor‐specific manner | #2 |
| transgenic protein processing | #2 |
| l10d9 | #2 |
| endoglycosidase treatment | #2 |
| severity collagen | #2 |
| oxidation increased severity | #2 |
| mhciii | #2 |
| arthritis progression | #2 |
| adjuvant oils arthritis | #2 |
| aetiology2–4 | #2 |
| alp monoclonal arthritis | #2 |
| congenic mice autoimmune | #2 |
| mabs collagen | #2 |
| ifngamma spinal cord | #2 |
| arthritis models rats | #2 |
| elastaseinduced emphysema nox2 | #2 |
| igg glycosylation arthritis | #2 |
| arthritis development rats | #2 |
| fpr1 signaling | #2 |
| ncf1gene | #2 |
| arthritis oia | #2 |
| gender rats | #2 |
| mph ros | #2 |
| disease humanized mice | #2 |
| arthritis female | #2 |
| antibodies cep1 | #2 |
| agonist fpr2 | #2 |
| m2139 | #2 |
| i‐a molecule | #2 |
| symptoms antibodies | #2 |
| exclusive reactivity | #2 |
| citcii311 | #2 |
| neutrophil fpr2 | #2 |
| dr4 cii259 | #2 |
| arthritogenic | #2 |
| kinloch | #2 |
| collagen antibody | #2 |
| ncf1 oxidation | #2 |
| ncf1 ean6 | #2 |
| ß62 | #2 |
| sle nadph oxidase | #2 |
| severity collagen arthritis | #2 |
| cep1 fibß62 | #2 |
| castrated mice day | #2 |
| ncf1 mutants | #2 |
| utility comp | #2 |
| caia | #2 |
| h2q response | #2 |
| dxeb | #2 |
| control subjects samples | #2 |
| anticd4 treatment | #2 |
| antibodies disease onset | #2 |
| rats utility | #2 |
| sialadenitis animals | #2 |
| mbp 87110 peptide | #2 |
| ptpn22 ncf1 | #2 |
| eae dxea strain | #2 |
| monodeoxygenation | #2 |
| l10d9 antibody cartilage | #2 |
| antibody response development | #2 |
| cpg2088 | #2 |
| antitoxin immunoglobulin | #2 |
| higher levels anas | #2 |
| agonist study | #2 |
| arthritis scoring | #2 |
| immunization sch | #2 |
| da1u rats | #2 |
| intrinsic tolerance | #2 |
| anti cii | #2 |
| h12919 | #2 |
| animal model arthritis | #2 |
| citrullinated peptides development | #2 |
| selective fpr1 | #2 |
| cia day | #2 |
| arthritis g6pi | #2 |
| nox2 macrophages | #2 |
| biologicals 24 months | #2 |
| ptpn22 disulfide | #2 |
| arthritis treatment | #2 |
| cia monkeys | #2 |
| congenic polychondritis | #2 |
| rp animal ear | #2 |
| dxea strain | #2 |
| neutrophil functions modulation | #2 |
| oestrogen ean | #2 |
| antibody‐mediated arthritis | #2 |
| allelic variant type | #2 |
| bmd caia | #2 |
| das28 values p001 | #2 |
| single nucleotide rats | #2 |
| oestradiol cia | #2 |
| h2q | #2 |
| osteoclastogenesis endogenous dna | #2 |
| lack functional nox2 | #2 |
| macrophagespecific nox2 development | #2 |
| pia rats | #2 |
| ean6 | #2 |
| incidence insulitis | #2 |
| antipan | #2 |
| cia mice mice | #2 |
| beta 10b | #2 |
| lymphoproliferative gene | #2 |
| autoimmune membrane proteins | #2 |
| injection w3 13 | #2 |
| murine locus eae2 | #2 |
| genetic encephalomyelitis | #2 |
| dancf1da | #2 |
| fibβ36 | #2 |
| hydroxyethylene | #2 |
| c2ta genetic | #2 |
| disease genotype hybridization | #2 |
| oestrogen pregnancy | #2 |
| antibodies fibß62 | #2 |
| disease promoting | #2 |
| chain l10d9 antibody | #2 |
| collagen arthritis cii | #2 |
| ciif4 | #2 |
| 12 590 | #2 |
| c1epitope | #2 |
| circulating medium | #2 |
| ability arthritis | #2 |
| nadph oxidase elevations | #2 |
| linomide homologous cia | #2 |
| igkeegfp lentivirus | #2 |
| positive anticcp2 test | #2 |
| nox2 complex sle | #2 |
| oestrogen myelin | #2 |
| symptoms anti ccp2 | #2 |
| analyses comp | #2 |
| l10d9 antibody | #2 |
| mog rats | #2 |
| tgfbeta spinal cord | #2 |
| glycan activation | #2 |
| pathogenic igg antibodies | #2 |
| caia effector phase | #2 |
| c5ay35 | #2 |
| cii ciic1 | #2 |
| da1u | #2 |
| vaccination strategy c5a | #2 |
| skg model | #2 |
| cartilage proteins sera | #2 |
| cartilage respiratory tract | #2 |
| raloxifene estradiol treatment | #2 |
| c129s mutant disulfide | #2 |
| maintenance induced resistance | #2 |
| p47phoxmutated | #2 |
| etoposide serum concentrations | #2 |
| lymphocytelike | #2 |
| chronic relapsing disease | #2 |
| rats heterologous cii | #2 |
| micro dams transgenic | #2 |
| peptides chronic eae | #2 |
| apc naïve cells | #2 |
| immunization mbp89 | #2 |
| 18fbicyclo610nonyne | #2 |
| mycobacteria granulomas | #2 |
| design glycopeptides | #2 |
| arthritis ethanol | #2 |
| transgenic oxidases zymosan | #2 |
| heterologous collagens arthritis | #2 |
| mice collagen | #2 |
| autoimmune recognition | #2 |
| glycopeptides histocompatibility | #2 |
| mbp peptides immunization | #2 |
| suggestive locus | #2 |
| b10g | #2 |
| matrilin 1 | #2 |
| putative vulnerability locus | #2 |
| diseases collagen | #2 |
| nox2 neuropathological alterations | #2 |
| mitochondria polymorphism | #2 |
| sle cgd | #2 |
| ptpn22 c129s | #2 |
| functional ncf1 variants | #2 |
| snp position | #2 |
| lack ifngamma | #2 |
| multiple sclerosis maps | #2 |
| cii citrullination | #2 |
| anticcp2negative | #2 |
| oestradiol induction phase | #2 |
| sialadenitis mice | #2 |
| mog79 | #2 |
| flow cytometry ovx | #2 |
| models autoimmune | #2 |
| ides treatment | #2 |
| neuroendocrine profile | #2 |
| cii311 | #2 |
| derived ros | #2 |
| genotypes ovx | #2 |
| mrl joints stages | #2 |
| oxidation c129s | #2 |
| granulomas cgd mice | #2 |
| mab cii | #2 |
| rats arthritogenic challenge | #2 |
| liver histone | #2 |
| redox regulation ptpn22 | #2 |
| collageninduced arthritis mice | #2 |
| cia arthritis | #2 |
| cia anti | #2 |
| altered formation | #2 |
| rats da1u rats | #2 |
| cd19 cells egfp | #2 |
| das28 24 months | #2 |
| genetic regions psoriasis | #2 |
| arthritis raloxifene | #2 |
| eno5 | #2 |
| immunological requirements | #2 |
| antileukoproteinase modulation | #2 |
| arthritogenic capacity | #2 |
| terpenes animals | #2 |
| ros tregs | #2 |
| sequence analysis indel | #2 |
| mbp peptide eae | #2 |
| knockout illness | #2 |
| sequences mbp89 | #2 |
| celldependent phase | #2 |
| class immunoenzyme | #2 |
| transgenic osteoporosis oestradiol | #2 |
| comp cia | #2 |
| rno12 | #2 |
| arthritis heterologous cia | #2 |
| rheumatoid binding | #2 |
| ptpn22 protein disulfide | #2 |
| fibß62 | #2 |
| synovial immune reactions | #2 |
| mrl mice stages | #2 |
| pnipaam vpba | #2 |
| 18ffluoromannan | #2 |
| immunization mouse collagen | #2 |
| rats lymphocytes | #2 |
| lymphocytes animals | #2 |
| chronic arthritis treatment | #2 |
| vivo cii | #2 |
| mbp89 | #2 |
| homologous cia | #2 |
| induction cia | #2 |
| implanted melanoma | #2 |
| antibody fine | #2 |
| disease development presence | #2 |
| macrophagespecific nox2 | #2 |
| paws mice | #2 |
| matrilin cartilage proteins | #2 |
| cartilage‐specific autoimmunity | #2 |
| lew mol | #2 |
| chronic autoimmune polyarthritis | #2 |
| chromosome rats | #2 |
| eae protein rna | #2 |
| tcells recognition | #2 |
| das28 acpa reactivities | #2 |
| psychosocial stress hpaaxis | #2 |
| alterations neuroendocrine profile | #2 |
| species susceptible haplotypes | #2 |
| hiit skeletal | #2 |
| b10qf1 | #2 |
| ere activation treatment | #2 |
| toe stiffness | #2 |
| smash recommendations | #2 |
| antileukoproteinase alp | #2 |
| ciic1 | #2 |
| hkatpasecontaining vesicles | #2 |
| tlymphocyte arthritis arthritis | #2 |
| experimental cloning | #2 |
| igke promoter | #2 |
| igsecretors | #2 |
| m2139 ciif4 | #2 |
| antibodies development | #2 |
| mhc iii | #2 |
| w3 13 | #2 |
| cell tolerance c5a | #2 |
| type collagen cii | #2 |
| mice genistein treatment | #2 |
| cia mechanisms | #2 |
| iaexpressing cells | #2 |
| collagen citrullination adhesion | #2 |
| multiple antibody reactivities | #2 |
| fil307 | #2 |
| epitopes rat | #2 |
| fibα580 | #2 |
| l10d9 antibody cxi | #2 |
| immunosuppressive leukocytes | #2 |
| α3xi | #2 |
| tregs mph ros | #2 |
| rats da1u | #2 |
| mhc congenic | #2 |
| dominant suppressive | #2 |
| microscopic scoring arthritis | #2 |
| pia rat | #2 |
| percentage peripheral cells | #2 |
| anticcp2negative presence | #2 |
| arthritis fb | #2 |
| salt intake vivo | #2 |
| glut4dependent | #2 |
| cartilage respiratory | #2 |
| cells arthritis | #2 |
| caia eae | #2 |
| pristane rats | #2 |
| glycopeptide complexes | #2 |
| adjuvant rats | #2 |
| ccp2 diagnostic accuracy | #2 |
| arthritogenic challenge | #2 |
| animal haplotypes | #2 |
| cxi l10d9 antibody | #2 |
| animal granulomatous disease | #2 |
| arthritis mice | #2 |
| rats disease onset | #2 |
| myelin ppd | #2 |
| enhanced arthritis | #2 |
| mhcii experimental arthritis | #2 |
| fibroblast induced | #2 |
| human animal models | #2 |
| eae caia | #2 |
| snecs neutrophils | #2 |
| re04 | #2 |
| tregs mph | #2 |
| mabs comp | #2 |
| ros source | #2 |
| epitope glycosylation | #2 |
| cii depletion | #2 |
| nadph oxidase deficiency | #2 |
| cms eae | #2 |
| integrin‐binding‐domain | #2 |
| raloxifene oestradiol | #2 |
| collagen arthritis immunization | #2 |
| tracheolaryngeal cartilage rp | #2 |
| galactosyl moiety | #2 |
| ala261 | #2 |
| pristane injection | #2 |
| antibodies cartilage | #2 |
| rats polymorphism | #2 |
| cgd mice kynurenine | #2 |
| dxeb strain immunization | #2 |
| mice bacterial infections | #2 |
| suppressive oestrogen | #2 |
| conditions igke promoter | #2 |
| granulomas macrophages | #2 |
| prophylactic treatment linomide | #2 |
| c57bl 10 background | #2 |
| shared epitope cxi | #2 |
| new immunomodulatory drug | #2 |
| increased severity development | #2 |
| rt1bb | #2 |
| igke promoter expression | #2 |
| hiit skeletal muscle | #2 |
| c2ta mhcii expression | #2 |
| development combination | #2 |
| autoimmune congenic arthritis | #2 |
| comp titers | #2 |
| disease 111 | #2 |
| early onset severity | #2 |
| fibα563 | #2 |
| induction p47phoxmutated mph | #2 |
| arthritogenic mab cii | #2 |
| citc1359 | #2 |
| anticii antibody | #2 |
| igkeegfp lentivirus expression | #2 |
| 111 vivo treatment | #2 |
| staphylococcal infections mice | #2 |
| cell dependent | #2 |
| osteoclasts flow cytometry | #2 |
| liver mice rna | #2 |
| dxea strain tgfbeta | #2 |
| mph induction | #2 |
| titres ccp2 | #2 |
| autoimmunity autoantibodies | #2 |
| cii injection | #2 |
| granulocytes alp | #2 |
| hladr2dq6 | #2 |
| wildtype mice macrophages | #2 |
| arthritis antibody response | #2 |
| egfp cd19 cells | #2 |
| citcii | #2 |
| matrilin vivo | #2 |
| ovx ncf1 mice | #2 |
| clever1 tumor | #2 |
| mannan induced | #2 |
| caia oestradiol | #2 |
| mbp89 peptides | #2 |
| epitope‐specific recognition | #2 |
| granulomas ros | #2 |
| h2q mice mice | #2 |
| fpr1 neutrophils | #2 |
| cia disease | #2 |
| disease cyclosporin treatment | #2 |
| nadph oxidase 2 | #2 |
| b10qncf1 mice | #2 |
| mice susceptible | #2 |
| ros granulomas | #2 |
| cytosolic ros production | #2 |
| binding cartilage | #2 |
| incidence nephritis | #2 |
| cia animals | #2 |
| eae5 pia4 | #3 |
| type c2ta | #3 |
| model arthritis | #3 |
| genotype knowledge | #3 |
| advanced intercross eae5 | #3 |
| autoimmunity pia | #3 |
| inflamed synovial tissues | #3 |
| acpapositive twins | #3 |
| acpa combination | #3 |
| arthritis animal model | #3 |
| female immunoenzyme | #3 |
| autoimmune models | #3 |
| female preponderance | #3 |
| total abrogation | #3 |
| c2ta | #3 |
| multiple sclerosis hladr2 | #3 |
| arthritis levels | #3 |
| disease genotype immunity | #3 |
| vivo control mice | #3 |
| arthritogenicity | #3 |
| mice environments | #3 |
| mice rheumatoid | #3 |
| eae5 ncf1 | #3 |
| pfp mice | #3 |
| points acs | #3 |
| binding aq | #3 |
| mice constant light | #3 |
| development acpas | #3 |
| transgenic osteoporosis | #3 |
| disease development contribution | #3 |
| combination acpa | #3 |
| disease disease development | #3 |
| animal glycosylation humans | #3 |
| cia hdac1 | #3 |
| immunization addition | #3 |
| pia | #3 |
| citrulline inflammation | #3 |
| acpas human serum | #3 |
| rs729749 ncf4 | #3 |
| arthritis autoimmunity | #3 |
| antigen monoclonal arthritis | #3 |
| isotypes acpas | #3 |
| early phase disease | #3 |
| day disease duration | #3 |
| acpas fine specificities | #3 |
| patients monoclonal chimeric | #3 |
| development collagen arthritis | #3 |
| mice copolymers | #3 |
| dthreaction | #3 |
| neutrophil cytosolic factor | #3 |
| h2p mice | #3 |
| disease immunization | #3 |
| antibodies specific sets | #3 |
| h2qbearing | #3 |
| acpa specificities presence | #3 |
| arthritis effects | #3 |
| presence drb104 | #3 |
| mice development | #3 |
| cia strains | #3 |
| height disease | #3 |
| cia animals arthritis | #3 |
| reactive idiotope | #3 |
| disease risk subsets | #3 |
| ncf1 cldn4 | #3 |
| acpas plasma | #3 |
| acpas genetic factors | #3 |
| human cii | #3 |
| cep1 filaggrin | #3 |
| subspecificities associations | #3 |
| ros deficiency | #3 |
| lew ztm | #3 |
| eae17 genetic heterogeneity | #3 |
| low production | #3 |
| allogeneic pregnancy | #3 |
| cbrh7919 cells | #3 |
| rats mog | #3 |
| ifngamma neurons | #3 |
| antigen presentation mhcii | #3 |
| ciic1 cii | #3 |
| 81b | #3 |
| treatment arthritis | #3 |
| immuniozation | #3 |
| carriers hladrb104 | #3 |
| rt11 rats | #3 |
| cdk6 padi4 | #3 |
| arthritis resistance | #3 |
| arthritis susceptibility | #3 |
| allopregnancy | #3 |
| fibα591 | #3 |
| cvrelated death adjustment | #3 |
| activated cells mice | #3 |
| clever1 macrophages | #3 |
| hfdmets rats | #3 |
| major cell epitope | #3 |
| oxidases reactive | #3 |
| rodents6 | #3 |
| cyp7a1 abca1 | #3 |
| antigens collagen | #3 |
| common mouse model | #3 |
| cd4∶cd8 lineage | #3 |
| antibodies induce | #3 |
| swedish patients antibodies | #3 |
| incidence antinuclear antibodies | #3 |
| anticollagen antibodies | #3 |
| arthritis review | #3 |
| monoclonal cartilage sections | #3 |
| anti‐type | #3 |
| fibα573 fibβ74 | #3 |
| rheumatoid crosses | #3 |
| eae31 | #3 |
| 95 cvrelated death | #3 |
| aureus arthritis mice | #3 |
| chronic collagen | #3 |
| ean mca | #3 |
| natural alleles genes | #3 |
| antigens keratinocytes | #3 |
| eae17 chromosome | #3 |
| class antigens keratinocytes | #3 |
| db1 treatment day | #3 |
| ctla4 deletion | #3 |
| anticollagen antibody | #3 |
| lupus nets | #3 |
| eae1 | #3 |
| disease anti lymphocyte | #3 |
| citrullinated cyclic | #3 |
| rats rheumatoid arthritis | #3 |
| arthritis susceptible | #3 |
| hladrb104 mann whitney | #3 |
| cd8 cells ean | #3 |
| lew1f | #3 |
| citc1iii | #3 |
| pristane‐induced arthritis | #3 |
| mmc mice | #3 |
| oxidase 2 | #3 |
| nadph oxidase complex | #3 |
| pia6 | #3 |
| fibα573 fibα591 | #3 |
| c57bl mice illness | #3 |
| fibβ74 | #3 |
| nox2 pathogenesis | #3 |
| antibodies vim60 | #3 |
| differences citrullinated peptides | #3 |
| acpa multiplex | #3 |
| stroke cvrelated death | #3 |
| minimal adjuvant requirement | #3 |
| macroporous gel particles | #3 |
| hydrocarbon oils | #3 |
| cii species | #3 |
| role ros | #3 |
| levels fibα591 | #3 |
| cii elisa | #3 |
| cells naïve mice | #3 |
| hdac1 rheumatoid arthritis | #3 |
| pnippam | #3 |
| arthritis model | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| ifngammali | #3 |
| recombination rt1a | #3 |
| eae16 | #3 |
| bcg ros | #3 |
| development arthritis | #3 |
| crossreactive idiotope | #3 |
| acpa subspecificities | #3 |
| citrullinated peptides multiplex | #3 |
| h2aalpha | #3 |
| igl genes | #3 |
| restricted role | #3 |
| sialadenitis | #3 |
| spe dce | #3 |
| neutrophils eae | #3 |
| autoimmunity cartilage | #3 |
| disease w3 13 | #3 |
| cd4∶cd8 lineage commitment | #3 |
| dual manner | #3 |
| loci antibodies | #3 |
| cvrelated death association | #3 |
| subspecificities occurrence | #3 |
| genetic influence susceptibility | #3 |
| acpa titers | #3 |
| twins acpapositive | #3 |
| cvrelated death | #3 |
| processing cii | #3 |
| nerve terminallike profiles | #3 |
| models arthritis | #3 |
| glycosylated type | #3 |
| osteoclasts release | #3 |
| rats disease | #3 |
| pathogenesis pia | #3 |
| arthritogenic mab | #3 |
| occurrence subspecificities | #3 |
| complex genetic control | #3 |
| fibα573 | #3 |
| dnfb ears | #3 |
| cystatin cdeficient mice | #3 |
| apc cia | #3 |
| dxea | #3 |
| acpas twins | #3 |
| citrullinated peptides time | #3 |
| origin suggestive linkage | #3 |
| eae5r1 | #3 |
| ctla4 adult mice | #3 |
| rheumatoid arthritis complement | #3 |
| cytotoxic t‐lymphocyte | #3 |
| hdac1 pathogenesis | #3 |
| nox2 cgd | #3 |
| endogenous ifnbeta | #3 |
| keratinocytes langerhans cells | #3 |
| cartilage proteins | #3 |
| mca ean | #3 |
| twins acpas | #3 |
| rt1a tap2 | #3 |
| fibα591 vim60 | #3 |
| fibβ74 onset | #3 |
| antibodies citrullinated | #3 |
| experimental cell | #3 |
| type collagen vivo | #3 |
| fibβ62 81b | #3 |
| rtlu | #3 |
| cii reactive | #3 |
| ifnbetadeficient mice | #3 |
| induced immunospecific tolerance | #3 |
| citc1iii fibα573 | #3 |
| mhc class betachain | #3 |
| ifngammali neurons | #3 |
| vim60 | #3 |
| complex autoimmune diseases | #3 |
| citcii355 | #3 |
| ncf4 rs729749 | #3 |
| antibodies citc1iii | #3 |
| dce spe | #3 |
| rs729749 | #3 |
| dancf1e3 | #3 |
| experimental arthritis | #3 |
| macrophages involvement | #3 |
| wildtype mice granulomas | #3 |
| db1 treatment | #3 |
| rheumatoid cloning | #3 |
| citc1iii filaggrin | #3 |
| eae17 | #3 |
| mnc salivary glands | #3 |
| cryogel bioreactor | #3 |
| response immune response | #3 |
| chromosome eae17 | #3 |
| species lymphocytes | #3 |
| rheumatoid autoimmune | #3 |
| disease height | #3 |
| genes disease development | #3 |
| onset combination | #3 |
| targeting toll | #3 |
| knowledge genetic association | #4 |
| ox8 | #4 |
| cia b10q mice | #4 |
| multispecific antibodies | #4 |
| treg cells ctla4 | #4 |
| autoantibodies type collagen | #4 |
| mhc eae | #4 |
| cii ifa | #4 |
| genetic association vav1 | #4 |
| genistein addition | #4 |
| dth reaction | #4 |
| locus mouse chromosome | #4 |
| fpr2 recognition | #4 |
| sh3gl1 | #4 |
| cia lia | #4 |
| type collagen rat | #4 |
| parathyroid antibodies | #4 |
| glend2 | #4 |
| interaction monoclonal antibody | #4 |
| krönke | #4 |
| fcγr regulation | #4 |
| c129s | #4 |
| cytosolic ros | #4 |
| antitype collagen antibodies | #4 |
| rheumatoid arthritis rats | #4 |
| k8 k8 mice | #4 |
| pristane‐induced | #4 |
| experimental genetic | #4 |
| immunoglobulin deficient | #4 |
| rs682626 | #4 |
| adjuvant oil | #4 |
| endos igg | #4 |
| cia suppression | #4 |
| mp‐lpr | #4 |
| tcell activation development | #4 |
| collagen type | #4 |
| autoimmunity rats | #4 |
| experimental arthritis humans | #4 |
| cell response immunization | #4 |
| inbred dba peptides | #4 |
| estrogen levels levels | #4 |
| mrl b6 | #4 |
| smoking antibodies | #4 |
| cellular transfer | #4 |
| mip mice | #4 |
| type collagen autoimmunity | #4 |
| species regulate | #4 |
| ethylene isosteres | #4 |
| cb10 fragment | #4 |
| vav1 rheumatoid arthritis | #4 |
| cd4 cells stage | #4 |
| estrogen cia | #4 |
| collagen immune | #4 |
| stages disease development | #4 |
| fibβ62 | #4 |
| development sialadenitis | #4 |
| lxrα pparγ | #4 |
| dth mrl | #4 |
| mutation ncf1 | #4 |
| strain eae | #4 |
| autoimmune mrl | #4 |
| subsets presence | #4 |
| tnfα p38 mapk | #4 |
| tsc mice | #4 |
| cryogel matrix | #4 |
| epitope collagen | #4 |
| autoimmune experimental phenotype | #4 |
| experimental cattle cells | #4 |
| potent immunomodulator | #4 |
| antibodies citrullinated peptides | #4 |
| arthritis collageninduced arthritis | #4 |
| elimination cd8 cells | #4 |
| arthritis defined | #4 |
| estrus cycling | #4 |
| congenic c57bl | #4 |
| anti‐t‐cell | #4 |
| cells maternal origin | #4 |
| mice etoposide | #4 |
| mrl dth | #4 |
| dae3 | #4 |
| positional cloning genes | #4 |
| immune response cii | #4 |
| rs12979659 | #4 |
| synovial endothelium | #4 |
| il‐4‐deficient mice | #4 |
| onset clinical arthritis | #4 |
| cathelicidins ll37 | #4 |
| cyclic software | #4 |
| variance animals arthritis | #4 |
| peptide mbp | #4 |
| inpp4b474r 548p | #4 |
| strains arthritis | #4 |
| citrullinated protein antibodies | #4 |
| type collagen arthritis | #4 |
| response arthritis | #4 |
| affinity case | #4 |
| normal mouse igg | #4 |
| arthritis comp | #4 |
| glands sialadenitis | #4 |
| cells cryogel column | #4 |
| catabolism kynurenine | #4 |
| cells cryogel | #4 |
| cia6 | #4 |
| arthritis mouse | #4 |
| shared autoimmunity | #4 |
| antibody response mog | #4 |
| placental mhc | #4 |
| cii peptide | #4 |
| macrophages mycobacteria | #4 |
| rp sle | #4 |
| bxsb chromosome | #4 |
| dead cell remnants | #4 |
| pathogenic antibody | #4 |
| antigen sequence deletion | #4 |
| α1ii chain | #4 |
| cii animal epitopes | #4 |
| collagen rheumatoid | #4 |
| arthritis severity | #4 |
| acpas serum | #4 |
| experimental arthritis cii | #4 |
| pathogenesis histone | #4 |
| type‐ii collagen | #4 |
| citrullinated peptides autoantibodies | #4 |
| diseases rheumatoid | #4 |
| elevated th1 | #4 |
| immunodominant cell | #4 |
| collagen glycopeptides | #4 |
| congenic rats rats | #4 |
| candidate genes rats | #4 |
| lnchc | #4 |
| cia mouse | #4 |
| cia model | #5 |
| streptococcus pyogenes ides | #5 |
| recovery ean | #5 |
| antileukoproteinase | #5 |
| monoclonal antibody alpha | #5 |
| tbb infection | #5 |
| oestradiol vehicle | #5 |
| chick cii | #5 |
| severe arthritis mice | #5 |
| congenic nod | #5 |
| symptom onset frequency | #5 |
| rt1eu | #5 |
| dba mouse | #5 |
| rats developed | #5 |
| multiplex analyses | #5 |
| exercise hiit | #5 |
| severe sialadenitis | #5 |
| swr mouse | #5 |
| wellknown role | #5 |
| higher levels melatonin | #5 |
| α10i | #5 |
| cgd hyperinflammation | #5 |
| autologous type | #5 |
| overexpression hdac3 | #5 |
| tlr3 macrophages | #5 |
| tcell mrl | #5 |
| glycopeptide | #5 |
| citrullinated peptides ccp | #5 |
| measurement nox activity | #5 |
| oxidative radicals | #5 |
| glycopeptide fragment | #5 |
| autoimmune disease models | #5 |
| oia | #5 |
| o2• h2o2 nox | #5 |
| ros mca | #5 |
| antibodies filaggrin | #5 |
| collageninduced arthritis cia | #5 |
| igg endos | #5 |
| multiparous mice | #5 |
| cd8 deficiency | #5 |
| b‐cell epitope | #5 |
| smoking prior | #5 |
| backcrossed | #5 |
| ovalbumin pepsin | #5 |
| development acpa | #5 |
| position type collagen | #5 |
| absence c5 | #5 |
| immunized animals controls | #5 |
| regulating rat | #5 |
| chromosome cia7 | #5 |
| raloxifene disease activity | #5 |
| lipidomic remodeling | #5 |
| tcell hybridomas | #5 |
| egfp flow cytometry | #5 |
| asparaginelinked glycan | #5 |
| osteoclasts stromal cells | #5 |
| beta 11 cells | #5 |
| cbrh7919 | #5 |
| mice acpa | #5 |
| experimental breeding | #5 |
| arthritis rats | #5 |
| symptoms development | #5 |
| uterus cells | #5 |
| commonly model | #5 |
| c‐glycoside analogue | #5 |
| cia type collagen | #5 |
| multiplex array | #5 |
| puccetti | #5 |
| lew1n | #5 |
| ly female | #5 |
| il4deficient mice | #5 |
| collagen anti | #5 |
| immunological involvement | #5 |
| eae5 | #5 |
| arthritis onset | #5 |
| lethal inflammatory disorder | #5 |
| cgd mice | #5 |
| tlr3 expression | #5 |
| delayed immunization rats | #5 |
| avridineinduced arthritis | #5 |
| pathogenesis autoimmune arthritis | #5 |
| nox o2• h2o2 | #5 |
| hydroxynorvaline | #5 |
| immunization male | #5 |
| citrullinated peptides | #5 |
| classical adjuvant | #5 |
| epitope cii | #5 |
| symptoms rheumatoid arthritis | #5 |
| patients acpa levels | #5 |
| nox complex | #5 |
| pineal gland development | #5 |
| field nox | #5 |
| ii‐induced | #5 |
| interaction cartilage | #5 |
| glycopeptidomimetics | #5 |
| nox animal models | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| arthritogenic cells | #5 |
| apc cii | #5 |
| subsets rheumatoid arthritis | #5 |
| ros macrophages | #5 |
| low dose tolerance | #5 |
| painlike behavior | #5 |
| aureus arthritis | #5 |
| immunization type collagen | #5 |
| dba 1 mice | #5 |
| cartilage type | #5 |
| tsst1producing | #5 |
| mrvalues | #5 |
| type collagen cix | #5 |
| resistance cia | #5 |
| tubule cells kidney | #5 |
| cd4∶cd8 | #6 |
| peptides arthritis | #6 |
| treatment oestradiol | #6 |
| metabolic nuclear receptors | #6 |
| recombinant rat interferongamma | #6 |
| k8 mice | #6 |
| arthritis antibodies | #6 |
| data ros | #6 |
| acpa anti | #6 |
| experimental postmenopausal | #6 |
| activity neuroinflammation | #6 |
| ccp2 positive | #6 |
| staphylococcus aureus arthritis | #6 |
| lys270 | #6 |
| mice sialadenitis | #6 |
| pyramidal neurons loss | #6 |
| b10 mouse | #6 |
| relapsing polychondritis rp | #6 |
| rheumatoid arthritis model | #6 |
| igg autoantibodies sera | #6 |
| disease protective | #6 |
| rheumatoid arthritis comp | #6 |
| mice congenic | #6 |
| functional selective | #6 |
| glycoproteins nadph | #6 |
| cells affinity surface | #6 |
| rcramp | #6 |
| cia26 | #6 |
| mrna tgfbeta | #6 |
| female lymphocyte | #6 |
| erosive polyarthritis | #6 |
| affinity ligand protein | #6 |
| macrophages mph | #6 |
| collagen cells | #6 |
| mhcii alleles | #6 |
| arthritis autoantibodies | #6 |
| cartilage collagens | #6 |
| heterogeneous stock mice | #6 |
| joints rats | #6 |
| eae mhc | #6 |
| isotypes patients | #6 |
| collagen arthritis | #6 |
| pathogenic events | #6 |
| autoimmune experimental genes | #6 |
| immunization peptides | #6 |
| dominant suppression | #6 |
| nox2 mediates | #6 |
| knockout receptors igg | #6 |
| murine loci | #6 |
| collagen cia | #6 |
| active arthritis | #6 |
| pristane squalene | #6 |
| anti ccp2 | #6 |
| rheumatoid arthritis collagen | #6 |
| complex mhc | #6 |
| loci controlling | #6 |
| glycopeptide specificity | #6 |
| mice investigated | #6 |
| arthritis models | #6 |
| monoclonal encephalomyelitis autoimmune | #6 |
| betaoestradiol | #6 |
| tsst1 mice | #6 |
| develop arthritis | #6 |
| controls arthritis | #6 |
| contrasting roles | #6 |
| c57bl 6 background | #6 |
| acpa specificities | #6 |
| autoimmunity arthritis | #6 |
| l3t4positive cells | #6 |
| cell recognition | #6 |
| hdac1 class | #6 |
| ltab | #6 |
| transgenic mice arthritis | #6 |
| cia cd4 cells | #6 |
| pv loss | #6 |
| induced psoriasis | #6 |
| animal genetic | #6 |
| mediated vasculitis | #7 |
| mbp peptide | #7 |
| transgenic class | #7 |
| antigens differentiation arthritis | #7 |
| psoriasiform skin disease | #7 |
| murine psoriasis | #7 |
| animal immunization injections | #7 |
| snecs | #7 |
| mice constant darkness | #7 |
| cab3 | #7 |
| role raloxifene | #7 |
| citrullinated peptide antigens | #7 |
| isomerase peptide | #7 |
| collagen epitope | #7 |
| locus chromosome | #7 |
| effector phase | #7 |
| arthritis strains | #7 |
| cii apc | #7 |
| cognate activation | #7 |
| strains disease | #7 |
| congenic mouse | #7 |
| mouse collagen | #7 |
| cia5 | #7 |
| chronic experimental | #7 |
| rheumatoid arthritis role | #7 |
| g6pi | #7 |
| oestrogen rats | #7 |
| autoimmunity collagen | #7 |
| type collagen | #7 |
| congenic strains | #7 |
| impaired induction | #7 |
| rats phases | #7 |
| periodontitis arthritis | #7 |
| glycosylated collagen | #7 |
| antibodies citrullinated antigens | #7 |
| autoantibodies lymphocytes | #7 |
| antibodyinduced arthritis | #7 |
| nonarthritogenic | #7 |
| region syntenic | #7 |
| arthritis type collagen | #7 |
| conventional environment | #7 |
| regulatory cells macrophages | #7 |
| impact cia | #7 |
| castrated females | #7 |
| cia mice | #7 |
| protective influences | #7 |
| ean animals | #7 |
| raassociated molecules | #7 |
| autoantibodies citrullinated peptides | #7 |
| chronic phase arthritis | #7 |
| yaa gene | #7 |
| cii anti | #7 |
| 3xi | #7 |
| arthritis genes | #7 |
| induction arthritis | #7 |
| analysis crosses | #7 |
| responses cii | #7 |
| response immunization | #7 |
| acpa titres | #7 |
| cryogel column | #7 |
| autoimmune human | #7 |
| aplec | #7 |
| collagen arthritis cia | #7 |
| collagen arthritis rats | #7 |
| polychondritis relapsing | #7 |
| macrophages alternative activation | #7 |
| hydrolases polymorphism | #7 |
| symptoms disease onset | #7 |
| ciireactive cells | #7 |
| antibody vivo | #8 |
| treatment monoclonal | #8 |
| fcγr2b | #8 |
| haematogenously | #8 |
| 42 rats | #8 |
| oia2 | #8 |
| rheumatoid autoimmunity | #8 |
| arthritis lymphocytes | #8 |
| ifa cii | #8 |
| patients type collagen | #8 |
| medium mem | #8 |
| rheumatoid chromosome | #8 |
| t‐cell priming | #8 |
| heterologous peptide | #8 |
| autoantibodies collagen type | #8 |
| parathyroid glands receptors | #8 |
| neutrophil cytosolic | #8 |
| expression hdac3 | #8 |
| hlase alleles | #8 |
| autoantibodies subset | #8 |
| polymeric cryogels | #8 |
| 297 cases | #8 |
| autoimmune congenic mice | #8 |
| chronic autoimmune arthritis | #8 |
| rt1f | #8 |
| ros interplay | #8 |
| destructive effects | #8 |
| α1‐microglobulin | #8 |
| sialadenitis mrl | #8 |
| mbp mog | #8 |
| hybridomas antibodies | #8 |
| clinical signs ean | #8 |
| mice ifnbeta | #8 |
| onset day day | #8 |
| diseases loci | #8 |
| hladrb11001 | #8 |
| cia animal model | #8 |
| murinised | #8 |
| experimental binding | #8 |
| inflamed synovia | #8 |
| rats mhc | #8 |
| dominant cell epitope | #8 |
| antibodies acpas | #8 |
| chromosomes loci | #8 |
| b10 background | #8 |
| eae genetic encephalomyelitis | #8 |
| humans experimental arthritis | #8 |
| persistent joint pain | #8 |
| mumt mice | #8 |
| antigenspecific priming | #8 |
| cia2 | #8 |
| illness igg | #8 |
| supermacroporous cryogel | #8 |
| cosphox | #8 |
| mice techniques | #8 |
| oxidized peptides | #8 |
| ptpn22620w | #8 |
| underlying genes | #8 |
| non‐mhc | #8 |
| lyme arthritis severity | #8 |
| murine locus | #8 |
| eae3 | #8 |
| typeii collagen | #8 |
| hdac3 expression | #8 |
| induced neuropathology | #8 |
| onset incidence | #8 |
| experimental autoimmune disease | #8 |
| incidence cia | #8 |
| autologous peptide | #8 |
| oligomeric matrix | #9 |
| posttranslational glycosylation | #9 |
| class allele | #9 |
| hgpi325 | #9 |
| bovine cii | #9 |
| development autoimmune arthritis | #9 |
| b10riii mice | #9 |
| reduced arthritis | #9 |
| variants acpa | #9 |
| human immunopeptidome | #9 |
| experimental genes | #9 |
| acpas | #9 |
| 2 nadph | #9 |
| psychological tyrosine | #9 |
| ox19 | #9 |
| autoimmunogenic | #9 |
| antibodies vivo | #9 |
| arthritis cross | #9 |
| hitr | #9 |
| specific nox2 | #9 |
| inbred dba mice | #9 |
| arthritis skg mice | #9 |
| alpha1inhibitor3 | #9 |
| idiotype‐specific | #9 |
| postmenopausal arthritis | #9 |
| eae immunization | #9 |
| response mouse | #9 |
| rt1u | #9 |
| mammalian disease models | #9 |
| ean myelin | #9 |
| inbred lew tlymphocytes | #9 |
| cia transgenic mice | #9 |
| oil adjuvants | #9 |
| patients acpas | #9 |
| early joint erosions | #9 |
| adaptive inflammation | #9 |
| rheumatoid joints | #9 |
| disease strains | #9 |
| illness receptor | #9 |
| serum interferon | #9 |
| acpas patients | #9 |
| antibody alpha | #9 |
| collagen complement | #9 |
| differentiation autoimmune | #9 |
| pristane | #9 |
| il10 role | #9 |
| histone 1 hdac1 | #9 |
| effects mabs | #9 |
| bound carbohydrates | #9 |
| animal models urgent | #9 |
| rheumatoid autoantibodies | #9 |
| murine collagen | #9 |
| nodp | #9 |
| avridine | #9 |
| experimental arthritis rats | #9 |
| intranasal animals arthritis | #9 |
| collagen female | #9 |
| loci rats | #9 |
| specific sets | #9 |
| induced metabolic syndrome | #9 |
| mouse peptide | #9 |
| rats rat | #9 |
| monoclonal antigens rats | #10 |
| immunization rats | #10 |
| beta 11 | #10 |
| severe erosive | #10 |
| dense fractions | #10 |
| acutephase response rats | #10 |
| rats lewis rats | #10 |
| knockout nadph | #10 |
| cartilage arthritis | #10 |
| collagen autoimmunity | #10 |
| hlase smoking | #10 |
| mice genistein | #10 |
| monoclonal arthritis | #10 |
| mutated mice | #10 |
| citrullinated antigen | #10 |
| mbp peptides | #10 |
| native collagen type | #10 |
| ifnbeta mice | #10 |
| cells development | #10 |
| tertbutylacrylamide | #10 |
| reactivity acpas | #10 |
| extracellular cartilage | #10 |
| cells increased production | #10 |
| cd4 cells spleen | #10 |
| mice cii | #10 |
| inbred dba | #10 |
| autoimmune disease humans | #10 |
| abp gene | #10 |
| nih heterogeneous stock | #10 |
| experimental cartilage | #10 |
| axotomized motor neurons | #10 |
| o2• h2o2 | #10 |
| endogenous collagen | #10 |
| antibodies specific | #10 |
| pain animal models | #10 |
| oestrogen | #10 |
| mice nadph | #10 |
| prl effects | #10 |
| genetic experiments | #10 |
| alpha collagen chains | #10 |
| cii mice | #10 |
| animal models | #10 |
| cell‐deficient | #10 |
| cartilage oligomeric | #10 |
| acpa diagnosis | #10 |
| cartilage collagen fibrils | #10 |
| onset chromosome | #10 |
| stock mice | #10 |
| activation male | #10 |
| h2ap | #10 |
| passive transfer experiments | #10 |
| rheumatoid arthritis dr4 | #10 |
| presence acpa | #10 |
| antibody collagen | #10 |
| development severity | #10 |
| tailbase | #11 |
| cells pia | #11 |
| nodb10h2b mice | #11 |
| antibody type collagen | #11 |
| arthritis absence | #11 |
| rat arthritis | #11 |
| rat liver rats | #11 |
| mhc control | #11 |
| naïve cells cells | #11 |
| inflammatory arthritis role | #11 |
| chronic arthritis | #11 |
| antigen variability | #11 |
| 2xi | #11 |
| cia7 | #11 |
| gad6 | #11 |
| stromal cells macrophages | #11 |
| individuals onset | #11 |
| cia30 | #11 |
| dss wt | #11 |
| lentiviral vector expression | #11 |
| monoclonal rheumatoid factors | #11 |
| rat collagen | #11 |
| mice mhc | #11 |
| loci regulating | #11 |
| development rheumatoid | #11 |
| 84–102 | #11 |
| ptpn22 smoking | #11 |
| fragments anti | #11 |
| liver receptor lxrα | #11 |
| potential autoantigens | #11 |
| antibodies association | #11 |
| chondrocytes ecm | #11 |
| mice cd1 | #11 |
| isotypes | #11 |
| species respiratory | #11 |
| icmediated | #12 |
| stages pathogenesis | #12 |
| associations antibodies | #12 |
| cross rats | #12 |
| natural loss | #12 |
| mbp response | #12 |
| antibodies structures | #12 |
| genetic contamination | #12 |
| illness sex characteristics | #12 |
| cii patients | #12 |
| natural polymorphism | #12 |
| α1ii | #12 |
| myelin ean | #12 |
| immunodominant | #12 |
| riiis | #12 |
| onset symptoms | #12 |
| study arthritis | #12 |
| rats cia | #12 |
| chronic erosive arthritis | #12 |
| autoimmune monoclonal antigens | #12 |
| peptide study | #12 |
| loci disease | #12 |
| psoriasis arthritis | #12 |
| encephalomyelitis induced | #12 |
| backgroundantibodies | #12 |
| major haplotype | #12 |
| increased litter size | #12 |
| type collagen immunization | #12 |
| qa2 | #12 |
| psoriasis mouse model | #12 |
| hydroxylysines | #12 |
| reduces severity | #12 |
| cell responses cii | #12 |
| role arthritis | #12 |
| mutation nadph | #12 |
| lymphoid cells development | #12 |
| animal immunohistochemistry | #12 |
| treatment experimental arthritis | #12 |
| fpr2 agonists | #12 |
| bovine type collagen | #12 |
| mice comp | #12 |
| structure antibodies | #12 |
| stage cia | #12 |
| rats expression | #12 |
| matrilin | #12 |
| lung macrophages mice | #12 |
| nonselfdiscrimination | #12 |
| serum concentrations comp | #12 |
| frequencies antibodies | #12 |
| mutated mouse | #12 |
| pia1 | #12 |
| t‐cell epitope | #13 |
| macroscopic scoring | #13 |
| sequence collagen | #13 |
| development type collagen | #13 |
| lew1w | #13 |
| cells salivary glands | #13 |
| arthritis knowledge | #13 |
| joints blood | #13 |
| strains incidence | #13 |
| epitope immunization | #13 |
| mtec aire | #13 |
| native type collagen | #13 |
| cyclic citrullinated | #13 |
| multispecific | #13 |
| oxidative regulation | #13 |
| l012 | #13 |
| citrullinated | #13 |
| bcelldeficient mice | #13 |
| genes mouse chromosome | #13 |
| b10p | #13 |
| dba molecular | #13 |
| expression egfp | #13 |
| rfigg | #13 |
| antibodies citrullinated proteins | #13 |
| nonobese diabetic mouse | #13 |
| advanced intercross | #13 |
| hladrb1 ptpn22 | #13 |
| mannan | #13 |
| behavioral alterations rats | #13 |
| major loci | #13 |
| 24dinitro1fluorobenzene | #13 |
| doses ici | #13 |
| ho4 | #13 |
| species deficiency | #13 |
| complement complement activation | #13 |
| levels nabs | #13 |
| oxidase nox2 | #13 |
| idd5 | #13 |
| immunohistochemistry interferon | #13 |
| mouse strains | #13 |
| cell epitope | #13 |
| μ chain | #13 |
| nos2derived | #13 |
| anticii | #13 |
| dr1 transgenic | #13 |
| ccp2 antibodies | #13 |
| factor isotypes | #13 |
| collagen disease | #14 |
| autoimmune arthritis | #14 |
| loci rheumatoid | #14 |
| blymphocyte female humans | #14 |
| specific inflammation | #14 |
| efficient promotion | #14 |
| autoimmunity animals | #14 |
| smallmolecule compound | #14 |
| murine collageninduced arthritis | #14 |
| b6n mice | #14 |
| peptides anti | #14 |
| mhc class region | #14 |
| aggregated nets | #14 |
| immunized rat | #14 |
| presence mcv | #14 |
| molecular disease models | #14 |
| loci interaction | #14 |
| cia expression | #14 |
| collagen comp | #14 |
| arlacel | #14 |
| humans nadph | #14 |
| macrophages immune response | #14 |
| protein collagen | #14 |
| experimental interferon | #14 |
| immune regulators | #14 |
| osteoclasts vivo | #14 |
| gut protection | #14 |
| arthritic paws | #14 |
| thr233 | #14 |
| antifilaggrin antibodies | #14 |
| nasal inhalation | #14 |
| involvement cells | #14 |
| candidate autoantigens | #14 |
| sirt1 mmp9 | #14 |
| deficient production | #14 |
| citrullinated peptides patients | #15 |
| treatment cia | #15 |
| raloxifene estradiol | #15 |
| osteoporosis development | #15 |
| rheumatoid arthritis presence | #15 |
| ros cii | #15 |
| exaggerates | #15 |
| antigenic epitope | #15 |
| tflask | #15 |
| congenic rats | #15 |
| antibodies arthritis | #15 |
| involvement pathogenesis | #15 |
| murine cia | #15 |
| regulation adaptive immunity | #15 |
| cdr regions | #15 |
| rat genetics | #15 |
| neuritis rats | #15 |
| mice type collagen | #15 |
| rt1a | #15 |
| 2 weight | #15 |
| monolithic cryogel | #15 |
| amps development | #15 |
| mice immunization | #15 |
| arthritis role | #15 |
| translationally modified | #15 |
| aire mtec | #15 |
| lentiviral gene delivery | #15 |
| integrated bioprocess | #15 |
| cultured human chondrocytes | #15 |
| anticollagen | #15 |
| dcii | #15 |
| monoclonal arthritis rats | #15 |
| nodb10h2b | #15 |
| presence anticarp antibodies | #15 |
| experimental allergic neuritis | #15 |
| polychondritis | #15 |
| arthritis development | #15 |
| mhc class molecule | #15 |
| apcs macrophages | #15 |
| immune complex formation | #15 |
| rats monoclonal antigens | #15 |
| type collagen development | #15 |
| levels natural antibodies | #16 |
| oligomeric matrix protein | #16 |
| pparγ lxrα | #16 |
| disease mice mice | #16 |
| autologous collagen | #16 |
| n305 | #16 |
| acute inflammation mice | #16 |
| mumt | #16 |
| subspecificities | #16 |
| class transplantation | #16 |
| development rheumatoid arthritis | #16 |
| anti‐t | #16 |
| epitopes mice mice | #16 |
| antinuclear autoimmunity | #16 |
| lew1 | #16 |
| hla–drb1 shared epitope | #16 |
| nonglycosylated form | #16 |
| congenic mice mice | #16 |
| rheumatoid arthritis genes | #16 |
| rats experimental arthritis | #16 |
| matrilin proteins | #16 |
| rheumatoid factor production | #16 |
| cep1 | #16 |
| lethal inflammatory | #16 |
| indirect genetic predisposition | #16 |
| fewer osteoclasts | #16 |
| males onset | #16 |
| genes animals | #16 |
| arthritis cii | #16 |
| mhc genes | #16 |
| rno10 | #16 |
| mhcii ciita | #16 |
| staphylococcal arthritis | #16 |
| rt1 | #16 |
| h2p | #16 |
| arthritis severity mice | #16 |
| human fcγriia | #17 |
| cab4 | #17 |
| nox2 derived | #17 |
| leuphe | #17 |
| genistein mice | #17 |
| animals congenic | #17 |
| arthritis rheumatoid autoantibodies | #17 |
| mice rheumatoid arthritis | #17 |
| allergic neuritis | #17 |
| native denatured | #17 |
| collagen induced arthritis | #17 |
| triplehelical conformation | #17 |
| cartilage collagen | #17 |
| collagen specific | #17 |
| strains lymphocytes | #17 |
| polyphosphate4 | #17 |
| cells collagen | #17 |
| inbred lew | #17 |
| periodontitis antibodies | #17 |
| clever1 | #17 |
| cells female mice | #17 |
| rt1av1 | #17 |
| progesterone development | #17 |
| skg | #17 |
| ethanol development | #17 |
| rats lewis | #17 |
| rheumatoid arthritis subsets | #17 |
| cells presenting cells | #17 |
| onset rheumatoid arthritis | #17 |
| spleen peyers patches | #17 |
| autoimmune illness | #18 |
| day arthritis | #18 |
| addition ros | #18 |
| disease duration onset | #18 |
| day immunization | #18 |
| anti cd44 | #18 |
| salivary glands mice | #18 |
| purified anti | #18 |
| moginduced eae | #18 |
| keratinocytes induction | #18 |
| galactose moiety | #18 |
| cuiiida | #18 |
| short‐term administration | #18 |
| arthritis anti | #18 |
| hybridomas mice mice | #18 |
| ealkene | #18 |
| collagen autoantibodies | #18 |
| joint inflammatory | #18 |
| langerhans cells cells | #18 |
| dra0101 | #18 |
| h2z | #18 |
| ros data | #18 |
| adjuvant arthritis rats | #18 |
| genes spleen | #18 |
| humanized transgenic mice | #18 |
| expression lxrα | #18 |
| phenotypic feature | #18 |
| cartilage type collagen | #18 |
| defined epitope | #18 |
| future utility | #19 |
| supermacroporous | #19 |
| cia eae | #19 |
| inflammatory attack | #19 |
| protein comp | #19 |
| new avenues | #19 |
| elisa cia | #19 |
| mrl mp mice | #19 |
| three‐dimensional culture | #19 |
| suppression dth | #19 |
| collagen response | #19 |
| castrated female rats | #19 |
| vivo elimination | #19 |
| cd4 transgenic | #19 |
| trimolecular complex | #19 |
| rats snp | #19 |
| protective alleles | #19 |
| citrullinated proteins acpa | #19 |
| tbetarii gene | #19 |
| blood monocytes neutrophils | #19 |
| gly262 | #19 |
| mice develop | #19 |
| peyers patches spleen | #19 |
| mice congenic mice | #19 |
| beta oestradiol | #19 |
| single intradermal injection | #19 |
| patients polychondritis | #19 |
| response mbp | #20 |
| 5p14 | #20 |
| nox1deficient mice | #20 |
| matrilin1 | #20 |
| fls tnfα | #20 |
| antibody treatment | #20 |
| mbp rats | #20 |
| knockout mice transgenic | #20 |
| loci chromosomes | #20 |
| mice cia | #20 |
| stress phospholipids | #20 |
| enhanced tcr | #20 |
| littermate | #20 |
| inflammation mice | #20 |
| ciita mhcii | #20 |
| role nox | #20 |
| experimental autoimmunity | #20 |
| rt1d | #20 |
| 5r5 | #20 |
| development disease | #20 |
| ncr3 | #20 |
| monkeys rodents | #20 |
| imaging reactive | #20 |
| highly susceptible | #20 |
| underlying gene | #20 |
| mhc class alleles | #20 |
| prominent infiltration | #20 |
| progesterone oestrogen | #20 |
| pvg1av1 | #20 |
| glycosylated | #20 |
| serm raloxifene | #20 |
| human rheumatoid arthritis | #20 |
| cells adaptive immune | #21 |
| chronic relapsing | #21 |
| triplehelical peptides | #21 |
| igg fcgammar | #21 |
| onset severity | #21 |
| genes controlling | #21 |
| cia treatment | #21 |
| linomide treatment | #21 |
| arthritis pregnancy | #21 |
| muscle ros | #21 |
| diseases lymphocytes | #21 |
| rats development | #21 |
| supermacroporous cryogels | #21 |
| suppressor cytotoxic cells | #21 |
| nox2 activity | #21 |
| α1acidglycoprotein | #21 |
| positional cloning | #21 |
| granule mobilization | #21 |
| nox2 mice | #21 |
| drb11001 | #21 |
| pathogenesis rheumatoid | #21 |
| illness autoimmune | #21 |
| mice mutant strains | #21 |
| nitratenitriteno pathway | #21 |
| n286 | #21 |
| olahsd | #21 |
| n141 | #21 |
| experimental rheumatoid | #21 |
| ean rats | #21 |
| individual acpa | #21 |
| conserved haplotype | #21 |
| serum levels comp | #21 |
| rats nonalcoholic steatohepatitis | #22 |
| 270 | #22 |
| experimental phenotype | #22 |
| antiidiotypic antibody | #22 |
| vh j558 | #22 |
| semiallogenic | #22 |
| ul1 | #22 |
| cultured hepatic cells | #22 |
| induced eae | #22 |
| animal epitopes humans | #22 |
| c57bl mice subfamily | #22 |
| identification susceptibility genes | #22 |
| ccp negative | #22 |
| samples onset | #22 |
| association pv | #22 |
| 81a | #22 |
| mice independent | #22 |
| determinant selection | #22 |
| rats loss | #22 |
| response myelin | #22 |
| loss collagen | #23 |
| comp | #23 |
| rats inbred lew | #23 |
| mace association | #23 |
| monoclonal antigens autoimmune | #23 |
| 4npa | #23 |
| cryogel beads | #23 |
| citrullinated antigens | #23 |
| citrullinated protein | #23 |
| experimental chromatography | #23 |
| phage clones | #23 |
| 17 betaoestradiol | #23 |
| immunopeptides | #23 |
| onset cia | #23 |
| complex influences | #23 |
| peptide activation | #23 |
| antibodies acpa | #23 |
| arthritis type | #23 |
| lymphocytes amino | #23 |
| cells presentation | #23 |
| cells b10 | #23 |
| inflammation absence | #23 |
| mbp eae | #23 |
| animal genes | #23 |
| anti‐cd5 | #23 |
| citrullinated epitopes | #23 |
| b10r | #23 |
| castration rats | #23 |
| experimental autoimmune diseases | #23 |
| diseases autoimmunity | #23 |
| tgfbeta resistance | #23 |
| levels comp | #24 |
| ftirm | #24 |
| subloci | #24 |
| mouse models development | #24 |
| experimental lupus | #24 |
| postpartum flare | #24 |
| new mouse | #24 |
| inflammation arthritis | #24 |
| animal epistasis | #24 |
| secondary immune response | #24 |
| antinuclear apoptosis | #24 |
| severity ali | #24 |
| cells c3h | #24 |
| controls anti | #24 |
| mediated arthritis | #24 |
| loci chromosome | #24 |
| autoantibodies rheumatoid | #24 |
| chronic autoimmune diseases | #24 |
| 339 | #24 |
| monoclonal anti | #24 |
| experimental cells | #24 |
| y35 | #24 |
| rat induction | #24 |
| severity chronicity | #24 |
| flss patients | #24 |
| mice nox2 | #24 |
| c57bl 10 mice | #24 |
| immunization development | #25 |
| specific epitopes | #25 |
| relapsing polychondritis | #25 |
| production monoclonal | #25 |
| monocytes nadph | #25 |
| tolerized rats | #25 |
| ros | #25 |
| common autoimmune disease | #25 |
| complex male | #25 |
| autoimmune messenger | #25 |
| cix | #25 |
| beta lymphocytes | #25 |
| cell hybridomas | #25 |
| bnda | #25 |
| inbred lew rats | #25 |
| massive infiltration | #25 |
| immunodominant epitope | #25 |
| arthritis experimental arthritis | #25 |
| murine lyme arthritis | #25 |
| rat mhc | #25 |
| proteinarginine deiminase type | #25 |
| congenic animals | #25 |
| autoimmune diseases humans | #25 |
| arginine arthritis | #25 |
| 8 antibodies | #25 |
| parasitemia survival | #25 |
| collagen cartilage | #25 |
| b6 balb | #25 |
| interleukin2 mice receptors | #25 |
| cells immunization | #25 |
| rno4 | #25 |
| autoantibody response | #25 |
| nitrophenylalanine | #26 |
| eae development | #26 |
| cells joints | #26 |
| polychondritis rp | #26 |
| igg2a mice | #26 |
| gene regions | #26 |
| glutamax | #26 |
| local exposure | #26 |
| hydrocarbon oil | #26 |
| cb11 | #26 |
| autoantibodies citrullinated proteins | #26 |
| viable chondrocytes | #26 |
| anti citrullinated | #26 |
| granulocytes cells | #26 |
| mice gammadelta cells | #26 |
| helperinducer animals antibodies | #26 |
| post translationally | #26 |
| pointmutation | #27 |
| perforin deficiency | #27 |
| hladrb1 shared epitope | #27 |
| nonmhc genes | #27 |
| immunodominant response | #27 |
| antibodies type | #27 |
| individuals antibodies | #27 |
| disease immunoglobulin | #27 |
| trypsination | #27 |
| ccp2 | #27 |
| interleukin21 tlymphocytes | #27 |
| intercrossed | #27 |
| innate interleukin10 | #27 |
| rheumatoid factor isotypes | #27 |
| physiological level | #27 |
| c1i | #27 |
| immunospecific | #27 |
| pannus tissue | #27 |
| lysine position | #28 |
| protein peptides | #28 |
| severity day | #28 |
| w3 25 | #28 |
| antibodies mab | #28 |
| nr8383 | #28 |
| rat strain | #28 |
| upregulation cytokines | #28 |
| mediated effects | #28 |
| anti rat | #28 |
| eae susceptibility | #28 |
| onset day | #28 |
| antigenspecific tolerance | #28 |
| mrna ifngamma | #28 |
| animal models neurodegeneration | #28 |
| chronicity | #28 |
| ros induction | #28 |
| antily6g | #28 |
| autoimmune inflammatory | #28 |
| cartilage vivo | #28 |
| cia3 | #28 |
| hiit exercise | #29 |
| rfigm | #29 |
| chronic dss | #29 |
| suboptimal doses | #29 |
| peptide anti | #29 |
| cfa cia | #29 |
| parotid secretory protein | #29 |
| ls2616 | #29 |
| absence inflammation | #29 |
| antibody producing cells | #29 |
| ros production macrophages | #29 |
| presence synovial fluid | #29 |
| 246trinitrophenyl | #29 |
| phenomes | #29 |
| acpa | #29 |
| membrane lymphocytes | #29 |
| glucose transport capacity | #29 |
| immunopathogenicity | #29 |
| smoking presence | #29 |
| mice mab | #29 |
| chain collagen | #30 |
| hlase | #30 |
| increased salt | #30 |
| paws | #30 |
| vpba | #30 |
| treatment raloxifene | #30 |
| disease immunity | #30 |
| dba mice | #30 |
| linkage disease | #30 |
| plasminogendeficient mice | #30 |
| synovial cells patients | #30 |
| variable heavy chain | #30 |
| chronic autoimmune | #30 |
| ctla4 mice | #30 |
| development experimental | #30 |
| translational rats | #30 |
| cultivation cells | #30 |
| acpa fine | #30 |
| vivo exercise | #30 |
| 11 cells | #30 |
| adult thymectomy | #30 |
| alphabetat | #30 |
| metabolic syndrome rats | #30 |
| vgenes | #30 |
| nox2 nox1 | #31 |
| synovial fluid blood | #31 |
| human type collagen | #31 |
| acute‐phase response | #31 |
| ige cd23 | #31 |
| expressing cells | #31 |
| drugs addition | #31 |
| perpetuated | #31 |
| comparative genetic analysis | #31 |
| pristaneinduced lupus | #31 |
| littermate controls | #31 |
| monoclonal antibody production | #31 |
| psoriasis model | #31 |
| trimolecular | #31 |
| selfprotein | #31 |
| apc development | #31 |
| immunization | #31 |
| phytol | #31 |
| hiit training | #31 |
| common chain | #31 |
| disease development | #31 |
| rats autoimmune | #31 |
| receptor preference | #32 |
| nonb cells | #32 |
| cells uterus | #32 |
| congenic mice | #32 |
| polymorphic genes | #32 |
| presence acpas | #32 |
| nadph oxidases nox | #32 |
| mucosal tolerance | #32 |
| nodes mice | #32 |
| role osteoclastogenesis | #32 |
| type antibody | #32 |
| methods serum samples | #32 |
| genomewide genotyping | #32 |
| hladrb104 | #32 |
| 11 cell | #32 |
| epitope antibodies | #32 |
| rt11 | #32 |
| beta mice | #32 |
| ra33 | #32 |
| caia mice | #32 |
| h2aq | #32 |
| influence genes | #32 |
| differentiation arthritis | #32 |
| steen | #32 |
| cell ratio | #32 |
| arthritis therapy | #32 |
| ros rns | #32 |
| specificity function | #32 |
| acpa rheumatoid arthritis | #32 |
| bound peptides | #32 |
| tolerance immunization | #33 |
| modified collagen | #33 |
| arthritic mice | #33 |
| tcell receptor | #33 |
| antigenpresenting cells cells | #33 |
| role vav1 | #33 |
| autoantibody activity | #33 |
| multiplex analysis | #33 |
| type cross | #33 |
| epitopes antibodies | #33 |
| induced immunization | #33 |
| skews | #33 |
| autoimmune demyelinating disease | #33 |
| rheumatoid joint | #33 |
| cytosolic factor | #33 |
| delayed type | #33 |
| fpr1 | #34 |
| chronic polyarthritis | #34 |
| interferon activity | #34 |
| promiscuous expression | #34 |
| neurodegeneration role | #34 |
| nox2 deficiency | #34 |
| patients animal models | #34 |
| c4bp | #34 |
| cells dendritic cells | #34 |
| joint pathology | #34 |
| natural antibodies nabs | #34 |
| heterogeneous stock | #34 |
| monoclonal rheumatoid | #35 |
| accessible sites | #35 |
| autoreactive | #35 |
| plasminogen deficiency | #35 |
| acs stroke | #35 |
| nets neutrophils | #35 |
| patients populations | #35 |
| 1xi | #35 |
| antirat | #35 |
| vdr cells | #35 |
| psoriasiform skin | #35 |
| phagotope | #35 |
| hybridomas | #35 |
| triple helical | #35 |
| arthritis disease | #35 |
| major regulators | #35 |
| infectious disease models | #35 |
| antiarthritis | #35 |
| complex arthritis | #35 |
| development chronic | #35 |
| destructive arthritis | #35 |
| phagocyte | #36 |
| flow cytometry expression | #36 |
| specificity sera | #36 |
| female histocompatibility | #36 |
| nk cells recognition | #36 |
| dth | #36 |
| induction tregs | #36 |
| h2r | #36 |
| variance animals antibodies | #36 |
| comparative genetics | #36 |
| protein specific | #36 |
| animals antigen | #36 |
| arthritis cartilage | #36 |
| cii cfa | #36 |
| dinitro1 | #36 |
| tolerance tlymphocytes | #36 |
| cartilage joints | #36 |
| oxidases rna | #36 |
| techniques mice | #36 |
| h2g7 | #36 |
| synthetic glycopeptides | #37 |
| immunopathological features | #37 |
| c129 | #37 |
| mif pathogenesis | #37 |
| oxidases oxidation | #37 |
| recombinant vaccine | #37 |
| rich lipid | #37 |
| cii protein | #37 |
| encephalomyelitis | #37 |
| peptides binding | #37 |
| dba1 | #37 |
| lymphocytes disease | #37 |
| joint cartilage | #37 |
| spontaneous arthritis | #37 |
| susceptibility autoimmune diseases | #37 |
| genetic control | #37 |
| acpa positive | #37 |
| role gamma interferon | #37 |
| cldn4 | #38 |
| nitrogen species | #38 |
| animal models pain | #38 |
| snat | #38 |
| antibodies animals | #38 |
| innovative tools | #38 |
| human blood neutrophils | #38 |
| sialophorin | #38 |
| cochranmantelhaenszel test | #38 |
| target autoantigens | #38 |
| ym1 | #39 |
| clonal expansion cells | #39 |
| cell tolerance | #39 |
| autoreactive cells | #39 |
| allogeneically | #39 |
| acpa response | #39 |
| nzw | #39 |
| ccia | #39 |
| wasting syndrome | #39 |
| b6n | #39 |
| benoist | #39 |
| resultsrats | #39 |
| data myelin | #39 |
| nfr | #39 |
| measurement activity | #39 |
| endoβnacetylglucosaminidase | #39 |
| oestrogen treatment | #39 |
| adjuvant induced | #40 |
| isostere | #40 |
| genetic complexity | #40 |
| peptide cell | #40 |
| positive rheumatoid | #40 |
| addition impact | #40 |
| disease animal models | #40 |
| rt1c | #40 |
| antigens arthritis | #40 |
| polyclonal cell activation | #40 |
| immunocap isac | #41 |
| priming phase | #41 |
| congenic mapping | #41 |
| aq | #41 |
| mhc haplotype | #41 |
| genes loci | #41 |
| autoimmune inflammatory diseases | #41 |
| severity incidence | #41 |
| ncii | #41 |
| rat myelin | #41 |
| autoimmune | #41 |
| rats anti | #41 |
| effects experiments | #41 |
| expected onset | #42 |
| th17 axis | #42 |
| cartilage bone destruction | #42 |
| species receptors | #42 |
| fibroblasts mice | #42 |
| mhc class class | #42 |
| spleen weight | #42 |
| antibody isotypes | #42 |
| p38 mapk nfκb | #42 |
| ptpn22 locus | #42 |
| pineal gland melatonin | #42 |
| articular collagen | #42 |
| drb1 shared | #42 |
| mice autoimmune | #43 |
| cd11bly6g | #43 |
| crosses genetic | #43 |
| spinal glia | #43 |
| pc8 | #43 |
| congeneic | #43 |
| rats sex | #43 |
| kgf treatment | #43 |
| collagen | #43 |
| anticyclic | #43 |
| arthritis data | #43 |
| type‐ii | #43 |
| lew lymphocytes | #43 |
| lew rats | #43 |
| anticitrullinated | #43 |
| immunodominant epitopes | #43 |
| autoreactive cell | #43 |
| treatment autoimmune diseases | #43 |
| c4bbinding protein c4bp | #44 |
| chloro23 | #44 |
| mathis | #44 |
| inflammation animals | #44 |
| homozygous form | #44 |
| neuritis ean | #44 |
| epitopes lymphocyte | #44 |
| genetic linkage analysis | #44 |
| mice mice autoimmune | #44 |
| mice adulthood | #44 |
| peptide induced | #44 |
| provocations | #44 |
| defensins humans | #44 |
| addition order | #44 |
| phagotopes | #45 |
| relapsing disease | #45 |
| outbred rats | #45 |
| nzb | #45 |
| disease histocompatibility | #45 |
| susceptibility arthritis | #45 |
| chromosome development | #45 |
| genetic encoding | #45 |
| potent suppression | #45 |
| lower severity | #46 |
| rat2 | #46 |
| isosteres | #46 |
| neuritis autoimmune | #46 |
| affinity purified | #46 |
| c227 | #46 |
| mhc class humans | #46 |
| alphachains | #46 |
| disease induction | #46 |
| posttranslationally | #46 |
| carp antibodies | #46 |
| locus controlling | #46 |
| specific tolerance | #46 |
| eae mbp | #46 |
| cocrystallisation | #46 |
| protective allele | #47 |
| idiotypic antibody | #47 |
| antibody reactivities | #47 |
| posttranslational rats receptors | #47 |
| rheumatoid factors | #47 |
| f1 hybrid mice | #47 |
| association hladrb1 alleles | #47 |
| complex mediated | #47 |
| diagnostic accuracy diagnosis | #47 |
| intercrosses | #47 |
| mice carrying | #48 |
| mice nzb | #48 |
| lupus disease | #48 |
| experimental arthritis mice | #48 |
| collagen glycosylation | #48 |
| tlr12 | #48 |
| cia rats | #48 |
| humanized model | #48 |
| f1 crosses | #48 |
| peptide recognized | #48 |
| synovial lining layer | #48 |
| antibody specificity | #48 |
| collagen peptide | #48 |
| γchains | #48 |
| acetylchitobiose | #48 |
| monoclonal autoimmune diseases | #49 |
| polyvinylcaprolactam | #49 |
| immune nervous | #49 |
| class major | #49 |
| comp levels | #49 |
| tcell stimulation | #49 |
| sex genes | #49 |
| bystander activation | #49 |
| mice caia | #49 |
| experimental crosses | #49 |
| mouse cartilage | #49 |
| histone hdacs | #49 |
| glutamine uptake | #50 |
| parathyroid cells | #50 |
| dependent chronic | #50 |
| loci animals | #50 |
| cytometry analyses | #50 |
| anticarbamylated protein | #50 |
| mice tolerance | #50 |
| animal cell culture | #50 |
| complex region | #50 |
| disease rats | #50 |
| alagly | #50 |
| ciiia | #50 |
| inflammation kynurenine | #50 |
| glycosylated form | #50 |
| monoclonal epitopes | #50 |
| antigenantibody | #50 |
| lentiviral particles | #51 |
| antibodies cells | #51 |
| autoantibodies rheumatoid arthritis | #51 |
| runting | #51 |
| c57bl 6j background | #51 |
| rheumatoid factor activity | #51 |
| inbred c57bl autoimmune | #51 |
| derived type | #51 |
| aire mice | #51 |
| tracheal cartilage | #51 |
| tolerized | #51 |
| cells ova | #51 |
| delayed immunization | #51 |
| evidence animal models | #51 |
| fewer cells | #51 |
| antigenpresenting cells | #52 |
| macrophages skin | #52 |
| xor activity | #52 |
| model collagen | #52 |
| matrix protein | #52 |
| ptpn22 | #52 |
| cartilage erosion | #53 |
| carbamylated proteins | #53 |
| lysosomal compartments | #53 |
| arthritis induction | #53 |
| physiological doses | #53 |
| melatonin day | #53 |
| antibodies epitopes | #53 |
| protein antibodies | #53 |
| induced autoimmunity | #53 |
| production reactive | #53 |
| patients rheumatic conditions | #53 |
| aged peptides | #53 |
| gastric parietal cell | #53 |
| triple helical structure | #53 |
| nodes lymphocyte | #54 |
| predating | #54 |
| animals autoimmune | #54 |
| major epitope | #54 |
| rats social isolation | #54 |
| carbamylated protein | #54 |
| crossbreeding | #54 |
| development individuals | #54 |
| melatonin animals | #54 |
| antigens myelomonocytic arthritis | #54 |
| strain rats | #54 |
| imitating | #54 |
| yaa | #54 |
| arthritis genetic | #55 |
| autoimmune nzb | #55 |
| complex genetic disease | #55 |
| autoimmune reactions | #55 |
| susceptibility autoimmune disease | #55 |
| macrophage mannose receptor | #55 |
| inflammatory manifestations | #55 |
| mhc | #56 |
| animals antibody | #56 |
| labels superoxide | #56 |
| alpha1microglobulin | #56 |
| cells salivary | #56 |
| selfreactive cells | #56 |
| new animal | #56 |
| antibodies | #57 |
| arthritis pathogenesis | #57 |
| igg abs | #57 |
| development autoimmune | #57 |
| vivo depletion | #57 |
| animals antirheumatic | #57 |
| cd1 mice | #57 |
| antibodies bind | #57 |
| collagen sequence | #57 |
| schafer | #58 |
| rat type | #58 |
| urokinase activity | #58 |
| oestrogen progesterone | #58 |
| peptide response | #58 |
| chronic eae | #58 |
| anticarp antibodies | #59 |
| genes mhc | #59 |
| encephalitogenicity | #59 |
| anti cd8 | #59 |
| hydroxylase diet | #59 |
| resistance eae | #59 |
| cartilage matrix protein | #59 |
| oligoclonal igg bands | #59 |
| articular joints | #59 |
| anti cell | #59 |
| macrophage mannose | #60 |
| alternative activation macrophages | #60 |
| hpaaxis | #60 |
| inflammatory cells macrophages | #60 |
| dichotomous effects | #60 |
| joint erosions | #60 |
| protein peptide | #60 |
| assay epitopes | #60 |
| immunohistopathology | #60 |
| epitope spreading | #61 |
| incidence severity | #61 |
| alpha1m | #61 |
| cells innate immune | #61 |
| major histocompatibility | #61 |
| serum comp | #61 |
| experimental evoked potentials | #61 |
| species reactive | #61 |
| experimental rats rats | #61 |
| differentiation myelomonocytic arthritis | #61 |
| syngeneically | #62 |
| interferon‐β | #62 |
| toxin1 | #62 |
| adaptive immune | #62 |
| mice susceptibility | #62 |
| reduced oxidative | #62 |
| cyclic sensitivity | #62 |
| autoantibody formation | #62 |
| antigens class histocompatibility | #62 |
| basic characterization | #62 |
| placenta uterus | #62 |
| fpr2 | #62 |
| hypersensitivity dth | #63 |
| constant darkness | #63 |
| mice polyi | #63 |
| transfer animals | #63 |
| duval | #63 |
| collagen cell | #63 |
| specific stages | #63 |
| protein disease | #63 |
| glycoprotein myelin | #63 |
| peptide specific | #63 |
| delayed interferon | #63 |
| mog1 | #63 |
| nadph oxidases | #63 |
| induced experimental | #63 |
| post‐partum | #63 |
| specificity tumor | #63 |
| rats strain | #63 |
| igaproducing cells | #63 |
| tolerance model | #64 |
| maternal origin | #64 |
| secondary immune | #64 |
| role apc | #64 |
| lower capacity | #64 |
| freund adjuvant | #64 |
| flss | #65 |
| major subset | #65 |
| induced suppression | #65 |
| weight variation | #65 |
| hindpaws | #65 |
| model chronic | #65 |
| histocompatibility complex | #65 |
| autoimmunity humans | #65 |
| spontaneous disease | #66 |
| hladr2 | #66 |
| phagocytosis oxidative burst | #66 |
| resemblances | #66 |
| experimental lymphocytes | #66 |
| chromosomes mammalian | #66 |
| thy1 antigen | #66 |
| peripheral joints | #66 |
| acute arthritis | #66 |
| negative rheumatoid | #66 |
| multispecificity | #66 |
| rheumatoid synovial cells | #66 |
| experimental allergic | #67 |
| fibrinogen genotype | #67 |
| experimental encephalomyelitis | #67 |
| strains susceptible | #67 |
| myelomonocytic arthritis | #67 |
| development cell | #67 |
| mice cell | #67 |
| dendritic cells epitopes | #67 |
| endos | #67 |
| key interactions | #67 |
| rheumatoid arthritis susceptibility | #67 |
| mice induced | #67 |
| severity periodontitis | #68 |
| individuals positive | #68 |
| anti carp | #68 |
| sodium diethyldithiocarbamate | #68 |
| class region | #68 |
| tolerized mice | #68 |
| cells mhc class | #68 |
| frequent infections | #68 |
| complex class | #68 |
| helper phenotype | #68 |
| iggrf | #68 |
| female sex hormones | #68 |
| rheumatoid chromosomes | #68 |
| direct damage | #69 |
| vertebrate immune | #69 |
| cells mouse | #69 |
| relapsing | #69 |
| zap‐70 | #69 |
| rheumatoid disease | #69 |
| lymphocytes chronic | #69 |
| frequency antibodies | #69 |
| role cells | #70 |
| translationally | #70 |
| response type | #70 |
| mrl mice | #70 |
| prolonged graft survival | #70 |
| presence rheumatoid factor | #70 |
| immunoglobulin interferon | #70 |
| cb10 | #71 |
| isolated rats | #71 |
| swr | #71 |
| human psoriasis | #71 |
| expression pparγ | #71 |
| cartilage mice | #71 |
| susceptibility female | #71 |
| ztm | #71 |
| napdh | #72 |
| autoimmunity lymphocytes | #72 |
| interphalangeal joints | #72 |
| naïve mice | #72 |
| dark agouti rats | #72 |
| antibodies binding | #72 |
| lathyritic | #72 |
| delayedtype hypersensitivity dth | #72 |
| study antibodies | #72 |
| type ifn signature | #73 |
| mrl lpr | #73 |
| treatment stages | #73 |
| knockout protein processing | #73 |
| environmental lighting | #73 |
| bovine type | #73 |
| oxidase complex | #73 |
| membrane animals | #73 |
| species ros | #73 |
| pregnancyinduced | #74 |
| peptides sequences | #74 |
| igarf | #74 |
| hypersensitivity delayed | #74 |
| antigens class | #74 |
| cartilage explants | #74 |
| genetic disease models | #75 |
| inbred dba receptors | #75 |
| diabetes arthritis | #75 |
| effects development | #75 |
| oestradiol | #75 |
| cell reactivity | #75 |
| acpapositive | #75 |
| dth mice | #75 |
| type collagens | #76 |
| rat splenocytes | #76 |
| peptide mhc | #76 |
| anti carbamylated | #76 |
| disease rheumatoid arthritis | #76 |
| pain inflammation | #77 |
| cyp7a1 | #77 |
| lpr mrl | #77 |
| inbred mouse strains | #77 |
| new animal model | #77 |
| collagen chains | #77 |
| cell deficient | #77 |
| rt1n | #77 |
| regulatory vaccines | #77 |
| rats eae | #77 |
| oligomeric | #77 |
| eae induced | #77 |
| development insulitis | #77 |
| nerve conduction velocity | #77 |
| autoantigenic | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| clinical arthritis | #78 |
| rats respiratory | #78 |
| mhc expression | #78 |
| cartilage integrity | #78 |
| pythons | #78 |
| 1ii | #79 |
| mononuclear lung | #79 |
| susceptibility disease | #79 |
| inflammatory autoimmune | #79 |
| autoimmune experimental epitopes | #79 |
| shared epitope | #79 |
| erosive arthritis | #80 |
| chromosome study | #80 |
| oxidases | #80 |
| detection autoantibodies | #80 |
| hnrnpa2 | #81 |
| class antigen expression | #81 |
| mhcii expression | #81 |
| mog mbp | #81 |
| sex linkage | #81 |
| dr1 antigen | #81 |
| inflammatory phase | #81 |
| aspartic acid position | #81 |
| spleen study | #81 |
| induced leukocyte | #81 |
| estrogen suppression | #81 |
| mrl mp | #81 |
| arthritis cells | #81 |
| expression ll37 | #81 |
| type macrophages | #81 |
| 14weeks | #82 |
| pannus formation | #82 |
| nadphoxidase | #82 |
| drug encephalomyelitis | #83 |
| bcg infection | #83 |
| mice igg | #83 |
| tlymphocyte genes | #83 |
| cell independent | #83 |
| expression mhc | #83 |
| multiple sclerosis evidence | #84 |
| naïve cells | #84 |
| arthritis day | #84 |
| strains animals | #84 |
| reactive cells | #84 |
| epidermal cells | #84 |
| rat cardiac allografts | #84 |
| spontaneous development | #84 |
| inflammation joints | #85 |
| knockout receptors | #85 |
| cells recognize | #85 |
| inflammation joint | #85 |
| class molecule | #85 |
| homopentamer | #85 |
| antiifngamma | #85 |
| anti cd4 | #86 |
| animal humans | #86 |
| severe eae | #86 |
| classical humans | #86 |
| mutant strains | #86 |
| monoclonal antibodies mab | #86 |
| gfoger | #86 |
| phagocyte nadph | #86 |
| preclinical stage | #86 |
| contribution genes | #86 |
| mhc class gene | #87 |
| inbred rat strains | #87 |
| alpha1acid glycoprotein | #87 |
| estrogen induced | #87 |
| smash | #87 |
| thps | #88 |
| fine specificities | #88 |
| narac | #88 |
| levels anti | #88 |
| copy variation | #88 |
| inguinal lymph nodes | #88 |
| experimental autoimmune | #89 |
| peptide immunization | #89 |
| arthritic | #89 |
| mice antibodies | #89 |
| depletion cd8 cells | #89 |
| genetic quantitative | #89 |
| mabs mab | #89 |
| mediated mechanisms | #90 |
| adjuvant arthritis | #90 |
| rheumatoid arthritis cells | #90 |
| ilc2 activation | #90 |
| autoimmune inbred c57bl | #90 |
| susceptible | #90 |
| genistein treatment | #90 |
| pineal hormone melatonin | #90 |
| arthritis compared | #90 |
| monkeys mice | #90 |
| histological sections | #91 |
| synovial fluid serum | #91 |
| cells apc | #91 |
| activation cd4 cells | #91 |
| protein induced | #91 |
| cattle collagen | #91 |
| backgroundan | #91 |
| experimental mouse models | #92 |
| abdominal region | #92 |
| nod mhc | #92 |
| anticitrullinated protein | #92 |
| humans immunodominant | #92 |
| difco | #92 |
| mice melatonin | #93 |
| xor | #93 |
| animals autoantibodies | #93 |
| natural polymorphisms | #93 |
| 290 patients | #93 |
| cellspecific | #93 |
| knockout myelin | #93 |
| activated cells cells | #94 |
| fcγrs | #94 |
| macrophages development | #94 |
| galactosylated | #94 |
| autosomal genes | #94 |
| endosomal acidification | #94 |
| moderateintensity exercise | #95 |
| induced sarcoma | #95 |
| binding integrins | #95 |
| chronic phase disease | #95 |
| data rats | #96 |
| cell alpha | #96 |
| pregnancy disease | #96 |
| macrophages stimulation | #96 |
| nonglycosylated | #96 |
| ifnbeta | #96 |
| romani | #96 |
| lung emphysema | #96 |
| messenger tolllike receptor | #96 |
| fetal rejection | #96 |
| antiimmunoglobulin | #97 |
| rheumatoid lymphocytes | #97 |
| macrophages fibroblasts | #97 |
| cathelicidins | #97 |
| genetic female genes | #97 |
| il33r | #97 |
| hydroxylysine | #97 |
| citrullinated fibrinogen | #97 |
| complex mice | #97 |
| acpa igg | #98 |
| autoimmune experimental | #98 |
| rheumatoid cartilage | #98 |
| autoimmune rats | #98 |
| ean | #98 |
| swr mice | #98 |
| collagen cytokines | #99 |
| alternative pathways | #99 |
| interleukin‐4 | #99 |
| rat chromosomes | #99 |
| tap2 | #100 |
| ccp anti | #100 |
| cultured crosses | #100 |
| rats monoclonal antibodies | #100 |
| protein antibody | #100 |
| invading pathogens | #100 |
| peptides cells | #100 |
| thy1 antigens | #100 |
| inducer animals | #100 |
| tlymphocyte immunity | #100 |
| eira | #101 |
| diarthrodial | #101 |
| cell determinants | #101 |
| singlenucleotide polymorphism | #101 |
| susceptible strain | #101 |
| fprs | #101 |
| safety drugs | #101 |
| bone degradation | #101 |
| findings treatment | #102 |
| mouse monoclonal antibodies | #102 |
| eae animal encephalomyelitis | #102 |
| candidate autoantigen | #102 |
| brucei infection | #102 |
| oxidative burst | #103 |
| agalactosyl | #103 |
| ros homeostasis | #103 |
| pathogenesis emphysema | #103 |
| hla dr1 | #103 |
| drb10401 | #103 |
| mhcii | #104 |
| male mice mice | #104 |
| arthritic disease | #104 |
| haplotypes histocompatibility | #104 |
| synchrotron infrared | #104 |
| f1 males | #104 |
| skg mice | #104 |
| nonarthritic | #104 |
| mutation mice | #104 |
| thelper cells | #104 |
| fcγr | #105 |
| osteoclasts mice | #105 |
| type 22 | #105 |
| vivo macrophages | #105 |
| development antibodies | #105 |
| autoreactivity | #105 |
| hybridoma cell | #105 |
| dmaam | #105 |
| limited cross | #106 |
| primed cells | #106 |
| arthritis hla | #106 |
| tcell immunity | #106 |
| 273 | #106 |
| disease dose | #106 |
| proteoglycan loss | #106 |
| c3h mice | #107 |
| cells synovial | #107 |
| nzb mice | #107 |
| development autoimmune disease | #108 |
| fpr | #108 |
| study tolerance | #108 |
| littermates | #108 |
| type hypersensitivity | #109 |
| monoclonal igg | #109 |
| delayedtype hypersensitivity | #109 |
| enthesophytes | #109 |
| reactive cell | #109 |
| citrullinated proteins | #109 |
| autoantibodies autoantigens | #109 |
| presentation cells | #109 |
| structural polymorphism | #109 |
| carcinoma tumors | #110 |
| autoimmune encephalomyelitis | #110 |
| toxic shock syndrome | #111 |
| experimental female | #111 |
| cartilage | #111 |
| inbred dba microscopy | #111 |
| dba 1j mice | #111 |
| backcross | #111 |
| mog eae | #111 |
| streptococcal cell wall | #111 |
| female hypersensitivity | #111 |
| humoral autoimmunity | #112 |
| alphabeta receptors antigen | #112 |
| presymptomatic individuals | #112 |
| anti idiotypic antibodies | #112 |
| extensive literature search | #112 |
| amide bond | #112 |
| trait loci | #113 |
| tcra | #113 |
| db1 | #113 |
| mice collageninduced arthritis | #113 |
| restricted cell | #113 |
| adjuvant properties | #113 |
| xid mice | #113 |
| autoimmune c57bl mice | #113 |
| oligoclonality | #113 |
| ifngammaproducing cells | #114 |
| adjuvantinduced arthritis | #114 |
| rats collagen | #115 |
| anti mcv | #115 |
| mice disease | #115 |
| drb10402 | #115 |
| autoantigens autoimmunity | #115 |
| proinflammatory cytokine | #115 |
| susceptibility eae | #116 |
| experimental epitopes | #116 |
| pathogenesis autoimmune diseases | #116 |
| lutz | #116 |
| immunosorbents | #116 |
| glycopeptides | #116 |
| lymphocyte female | #116 |
| ccp patients | #116 |
| transgenic peptides receptors | #116 |
| glyco | #116 |
| antiarthritic | #117 |
| congenic lines | #117 |
| mice type | #117 |
| tolerance induced | #117 |
| encephalomyelitis autoimmune | #117 |
| fluorescence nf | #117 |
| antibodies reactive | #117 |
| class expression | #118 |
| samples individuals | #118 |
| α enolase | #118 |
| psoriasiform dermatitis | #118 |
| myelin oligodendrocyte | #118 |
| rats immunized | #118 |
| alpha1acid | #118 |
| pineal hormone | #118 |
| 05m | #119 |
| rheumatoid arthritis review | #119 |
| cd4 tcells | #119 |
| radiological damage | #119 |
| psa rheumatoid arthritis | #119 |
| response cells | #119 |
| neutrophils nets | #120 |
| protein mbp | #120 |
| experimental animal models | #121 |
| chondrocyte cultures | #121 |
| vivo animal models | #121 |
| acpa negative | #122 |
| treatment progesterone | #122 |
| immune complex deposition | #122 |
| genes age | #122 |
| t‐lymphocyte | #122 |
| transgenic neurons receptors | #122 |
| pharmacological potential | #122 |
| transfer arthritis | #122 |
| patients acpa | #122 |
| alphabeta cells | #123 |
| c5b | #123 |
| cell monoclonal | #123 |
| symptoms associations | #123 |
| nox2 activation | #123 |
| type cytokines | #123 |
| cartilage surface | #124 |
| inbred mouse | #124 |
| tlr4 stimulation | #124 |
| oxidases neutrophils | #125 |
| genetic rats | #125 |
| blocking antigens | #125 |
| allelic variations | #125 |
| preimmunized | #125 |
| immunodominant peptide | #125 |
| cryogel | #125 |
| general mechanisms | #125 |
| disease mechanisms | #125 |
| helperinducer | #125 |
| qtl genes | #125 |
| nzb nzw | #126 |
| pnipaam | #126 |
| nonobese diabetic | #126 |
| female immunization | #126 |
| cyclic polymorphism | #126 |
| animal enzyme | #127 |
| knockout murine | #127 |
| atp8 | #127 |
| absence cells | #127 |
| microarray detection | #127 |
| chronic inflammatory disease | #128 |
| deiminases | #128 |
| anticitrullinated peptide | #128 |
| lining layer | #128 |
| dominant epitope | #128 |
| rats patients | #129 |
| spleen rats | #129 |
| bxsb | #129 |
| multiple epitopes | #129 |
| nos2 | #130 |
| cells eae | #130 |
| psd1 | #130 |
| disease induced | #130 |
| oestradiol testosterone | #130 |
| vivo absence | #130 |
| onset arthritis | #131 |
| lipomannan | #131 |
| epitope specific | #131 |
| pronociceptive | #132 |
| linomide | #132 |
| intercross | #132 |
| mineral oils | #132 |
| kgf | #132 |
| induction regulatory cells | #132 |
| disease cgd | #132 |
| leukosialin | #133 |
| reduced severity | #133 |
| ggaa | #133 |
| rat chromosome | #133 |
| myocellular | #134 |
| knockout receptors antigen | #134 |
| species animals | #134 |
| mice estrogen | #134 |
| patients cytokines | #134 |
| accentuate | #134 |
| interstitial collagens | #134 |
| plasma synovial fluid | #134 |
| eae | #134 |
| peptides cyclic | #135 |
| igg immune complexes | #135 |
| spinal glial | #135 |
| macrophages dendritic | #136 |
| intracellular reactive | #136 |
| chronic autoimmune disease | #136 |
| immunizing | #136 |
| receptor upregulation | #137 |
| innate lymphocytes | #137 |
| stimulated muscle | #137 |
| immunopathological | #137 |
| mice deficient | #138 |
| ditiocarb | #138 |
| immunomodulatory drug | #139 |
| autoimmune mice | #139 |
| control development | #139 |
| dmannitol | #139 |
| tcrdelta | #140 |
| oligoclonal expansion | #141 |
| thermoresponsive polymer | #141 |
| producing cell | #141 |
| gamma lymphocyte | #142 |
| interferon‐γ | #142 |
| or113 | #142 |
| single subcutaneous injection | #142 |
| genetic factors development | #142 |
| phadia | #142 |
| smfish | #142 |
| rejection tolerance | #142 |
| phosphate isomerase | #143 |
| class haplotypes | #143 |
| mice beta | #143 |
| tcell alphabeta receptors | #143 |
| cell hybridoma | #143 |
| mhc haplotypes | #144 |
| rheumatoid arthritis | #144 |
| rat strains | #144 |
| synovial hyperplasia | #144 |
| syngenic | #145 |
| severe chronic | #145 |
| lyme arthritis | #145 |
| tnf production | #145 |
| tcr gamma delta | #145 |
| treatment ici | #145 |
| inbred buf rats | #145 |
| rats induced | #146 |
| neonatal growth | #146 |
| function cells | #147 |
| cellular heterogeneity | #147 |
| ccp antibodies | #147 |
| pregnancy levels | #147 |
| systemic challenge | #147 |
| gammainterferon | #147 |
| phagocyte nadph oxidase | #148 |
| α2i | #148 |
| autoimmune disease | #148 |
| cell surface antigen | #148 |
| interestingly | #148 |
| redox regulation | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| drb104 | #150 |
| mhc binding | #150 |
| larsen score | #150 |
| humans hybridomas | #151 |
| levels antibodies | #151 |
| receptor rats | #151 |
| differential gene expression | #151 |
| mice animals | #151 |
| epicutaneously | #151 |
| alphabeta receptors | #152 |
| arthritic animals | #153 |
| levels pregnancy | #153 |
| key player | #153 |
| pepsin | #153 |
| mononuclear cells | #153 |
| selfpeptides | #154 |
| joint inflammation | #154 |
| male rats rats | #154 |
| daf1 | #154 |
| fcgammar | #154 |
| immune priming | #154 |
| expression class | #154 |
| critical event | #154 |
| c4bbinding protein | #154 |
| arthritis rheumatoid | #155 |
| f1 mice | #155 |
| autoantibodies autoimmune | #155 |
| mace acs | #155 |
| padi4 | #155 |
| infiltrating cells | #155 |
| serum synovial fluid | #155 |
| specificities | #156 |
| suppressive role | #156 |
| mhc region | #156 |
| stabilin1 | #156 |
| murine keratinocytes | #157 |
| adjuvanticity | #157 |
| downstream signals | #157 |
| genetic diabetes mellitus | #158 |
| parentals | #158 |
| analysis structure | #158 |
| hypersensitivity reaction | #158 |
| consensus motif | #159 |
| meaib | #159 |
| animals autoimmunity | #159 |
| inbred c3h mice | #159 |
| arthritis infectious | #159 |
| systemic mice mice | #159 |
| nursed | #161 |
| day onset | #161 |
| gamma interferon | #161 |
| specific autoimmunity | #161 |
| factors anti | #161 |
| knockout severity | #161 |
| benzylated | #161 |
| anti ccp | #162 |
| rheumatoid autoantigens | #162 |
| βarrestin recruitment | #162 |
| psors1 | #162 |
| epitope | #162 |
| arthritis inflammation | #162 |
| binding collagen | #162 |
| cd152 | #162 |
| laboratory rats | #163 |
| chains humans | #163 |
| mouse type | #163 |
| onset disease | #163 |
| agalactosyl igg | #164 |
| mrl | #164 |
| striking similarities | #164 |
| rats induction | #164 |
| progesterone effects | #164 |
| genes qtl | #164 |
| autoantibody responses | #164 |
| endobetanacetylglucosaminidase | #164 |
| cells macrophages | #165 |
| animal humans immunity | #165 |
| nonimmunized | #166 |
| tolerance induction | #166 |
| pathogenic pathways | #166 |
| melatonin mice mice | #166 |
| epitope alleles | #166 |
| class mice | #167 |
| human autoimmunity | #167 |
| ag7 | #167 |
| tlymphocyte humans | #167 |
| nox2 | #167 |
| seronegative | #167 |
| phase disease | #168 |
| genetic backgrounds | #168 |
| cd1 | #168 |
| mice cd4 cells | #168 |
| acpa levels | #169 |
| p12 | #169 |
| oxazole | #169 |
| denoted | #169 |
| pathogenesis arthritis | #170 |
| cryogels | #170 |
| joints male | #170 |
| lymph node cells | #170 |
| mirp | #170 |
| inherited disorder | #170 |
| experimental animal | #170 |
| ros nitric oxide | #171 |
| encephalomyelitis eae | #171 |
| oxazolone | #171 |
| peripheral lymphoid organs | #172 |
| rat placenta | #172 |
| single nucleotide polymorphism | #172 |
| lst1 | #172 |
| autoimmune eae | #172 |
| rheumatoid | #172 |
| autoimmunity cell | #172 |
| monoclonal autoantibodies | #173 |
| inbred dba models | #173 |
| sod3 | #173 |
| resistant rats | #174 |
| nasal cartilage | #174 |
| studies pain | #174 |
| presence autoantibodies | #174 |
| class gene | #174 |
| mice mutation | #175 |
| ifn signature | #175 |
| understanding pathogenesis | #175 |
| maternal decidua | #175 |
| new mouse model | #176 |
| skin disease | #176 |
| mammalian crosses | #176 |
| tryptophan catabolism | #176 |
| secondary challenge | #176 |
| moab | #176 |
| strains molecular | #176 |
| lymphotoxinα | #177 |
| ctla‐4 | #178 |
| hladrb1 alleles | #178 |
| histocompatibility | #178 |
| alternative pathway complement | #179 |
| immunized | #179 |
| protein anti | #179 |
| dextran sulphate sodium | #179 |
| nod genes | #179 |
| mice role | #179 |
| epitopes female | #180 |
| complex disease | #180 |
| arthritis methods | #180 |
| cgd patients | #180 |
| alleles arthritis | #181 |
| molecular adaptations | #181 |
| genetic influence | #181 |
| autoimmunity disease | #181 |
| arginine deiminases | #182 |
| hormone melatonin | #182 |
| immunoglobulin mice mice | #185 |
| multistep process | #186 |
| rats reactive | #186 |
| cells lymph nodes | #186 |
| antigen processing presentation | #186 |
| drb1 chains | #187 |
| dba | #187 |
| b10 | #187 |
| tcell recognition | #187 |
| chondritis | #188 |
| substrains | #188 |
| molecular peptide | #188 |
| mtec | #189 |
| cells disease | #189 |
| synovial membranes | #190 |
| inflamed joint | #190 |
| positionally | #190 |
| hnrnpa2b1 | #190 |
| oligodendrocyte glycoprotein | #191 |
| ly1 | #192 |
| autoantibody profiles | #192 |
| cross‐reactivity | #192 |
| fmlf | #193 |
| passive mice mice | #193 |
| cyclic predictive | #194 |
| glycoprotein peptide | #194 |
| proteins myelin | #194 |
| chapter 16 | #195 |
| mice mutant | #195 |
| mhv | #195 |
| perpetuate | #195 |
| oophorectomized | #196 |
| lewis rat | #196 |
| mhc class expression | #196 |
| tcell response | #196 |
| myelin glycoprotein | #196 |
| acutephase response | #197 |
| pannus | #197 |
| evidence development | #197 |
| multiplex assay | #197 |
| early appearance | #198 |
| swedish patients | #198 |
| igmrf | #198 |
| genetic links | #198 |
| dr4 antigen | #199 |
| rat genome | #199 |
| interleukin17 | #199 |
| hla association | #200 |
| citrullinated peptide | #200 |
| cell collagen | #200 |
| pathogenesis autoimmune | #201 |
| acpa status | #202 |
| myelin proteolipid protein | #202 |
| myelin proteins myelin | #202 |
| dendritic cells macrophages | #202 |
| instigation | #202 |
| complete elimination | #203 |
| mice cells | #203 |
| immunization immunoglobulin | #204 |
| 2 complex | #204 |
| spleen staining | #204 |
| class molecules | #204 |
| dth response | #205 |
| ides | #205 |
| macrophages mice | #205 |
| native collagen | #205 |
| suppresses | #205 |
| nonparametric tlymphocytes | #205 |
| defb4 | #206 |
| wild rats | #206 |
| betaestradiol | #206 |
| induced upregulation | #207 |
| mice peptide | #207 |
| insulitis diabetes | #207 |
| desmoglein 3 | #207 |
| interleukin4 mice mice | #207 |
| noxs | #207 |
| parental strains | #207 |
| alternative complement pathway | #207 |
| intranasal challenge | #207 |
| immunization mice | #208 |
| highest probability | #208 |
| severity disease | #208 |
| vivo patients | #208 |
| antigen presenting | #208 |
| naive mice | #208 |
| immunoglobulin vh | #209 |
| disease rheumatoid | #209 |
| cotwins | #209 |
| vav1 | #210 |
| valuable tools | #210 |
| specific antibodies | #210 |
| susceptible strains | #210 |
| citrullinated vimentin | #210 |
| highfatdiet | #210 |
| hla dr4 | #211 |
| purified protein derivative | #211 |
| natural antibodies | #211 |
| diseases genetic | #211 |
| glucose6 phosphate | #211 |
| association rheumatoid arthritis | #212 |
| cells immobilized | #212 |
| large numbers | #212 |
| psoriasiform | #213 |
| antibody binding | #213 |
| mice injected | #213 |
| tsst1 | #214 |
| triethylsilane | #215 |
| inbred rat | #215 |
| cytofluorometric | #215 |
| antigen induced | #215 |
| central tolerance | #215 |
| mhc class antigens | #215 |
| dissect | #216 |
| training hiit | #216 |
| lower level | #216 |
| rats immunization | #217 |
| lentiviral vector | #217 |
| cd23 | #217 |
| induced autoimmune | #217 |
| inflammatory infiltrates | #217 |
| joints mice | #217 |
| resistant strain | #217 |
| treatment onset | #218 |
| antigen tcell | #218 |
| peptide antibodies | #219 |
| k8 | #219 |
| granuloma formation | #219 |
| fcrγ | #219 |
| autoimmunity | #219 |
| cells autoimmune | #220 |
| bone erosions | #220 |
| hyl | #220 |
| peptidylarginine deiminases | #220 |
| cyclosporin treatment | #221 |
| redox signaling | #221 |
| fine specificity | #221 |
| cells dendritic | #221 |
| rheumatoid factor | #221 |
| agouti rats | #221 |
| targeted deletion | #221 |
| pinealectomy | #221 |
| wkymvm | #222 |
| cybb | #222 |
| monoclonal antigens differentiation | #222 |
| cartilage damage | #222 |
| thymectomized | #222 |
| multiplex | #223 |
| igg2a | #223 |
| experimental autoimmune neuritis | #223 |
| carbamylated | #223 |
| inflammation vivo | #224 |
| expressing | #224 |
| cells antigen | #225 |
| clinical scoring | #225 |
| established disease | #225 |
| interleukin‐10 | #225 |
| lew | #225 |
| pathogenic antibodies | #226 |
| disease locus | #226 |
| j1 | #227 |
| macrophagelike cells | #227 |
| arthritis objective | #228 |
| presenting cells | #228 |
| delayed type hypersensitivity | #228 |
| presence anti | #229 |
| cell selection | #229 |
| site inflammation | #230 |
| eae rats | #230 |
| ls1 | #231 |
| human rheumatoid | #231 |
| reactive oxygen | #232 |
| monoclonal immunohistochemistry | #232 |
| ameliorated | #233 |
| role eosinophils | #233 |
| synovial joints | #233 |
| lack expression | #233 |
| production ros | #233 |
| centimorgan | #234 |
| lower numbers | #234 |
| mhc gene | #235 |
| chromosome 14 | #235 |
| chronic psychosocial stress | #235 |
| staphylococcal infection | #235 |
| immune complex | #236 |
| specificity animals | #236 |
| pathological mechanisms | #237 |
| control strain | #237 |
| autoimmune chronic | #238 |
| progression arthritis | #238 |
| c5 | #239 |
| trait locus | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| strong influence | #242 |
| joint pain | #242 |
| class genetic | #243 |
| monoclonal antigen | #243 |
| hla drb1 | #243 |
| multicomponent | #243 |
| positive anti | #243 |
| protected | #243 |
| treatment autoimmune | #244 |
| crosses | #244 |
| common denominator | #244 |
| cutaneous infection | #244 |
| estrus cycle | #244 |
| inflammation cartilage | #244 |
| binding antibodies | #245 |
| allelic differences | #246 |
| development emphysema | #246 |
| rt1l | #246 |
| antibodies anti | #247 |
| new model | #247 |
| florescence | #247 |
| normal cartilage | #247 |
| antibody response | #247 |
| inbred strain | #247 |
| efficient expression | #248 |
| activity assays | #248 |
| induced chronic | #249 |
| oxygen species | #249 |
| picryl | #250 |
| mouse rat | #250 |
| arthritic joints | #250 |
| fragments rats | #250 |
| node cells | #250 |
| inflammation score | #250 |
| hyperinflammation | #251 |
| conditional knockout mice | #251 |
| develops | #251 |
| nadph oxidase | #251 |
| treatment rats | #251 |
| mice lack | #252 |
| dark agouti | #252 |
| mice lymphocytes | #252 |
| response disease | #252 |
| role model | #252 |
| lpr mice | #254 |
| cartilage matrix | #254 |
| onset clinical | #254 |
| lacking | #254 |
| proteins glycoproteins | #254 |
| dinitrofluorobenzene | #254 |
| class mhc | #254 |
| inbred c3h | #255 |
| autoimmune response | #255 |
| anti arthritic | #256 |
| specific subgroups | #256 |
| postmenopausal bone | #256 |
| specific neutralizing | #256 |
| inflammatory disorder | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| mir144 | #260 |
| relationship immunologic | #260 |
| chronic granulomatous | #260 |
| mediated suppression | #261 |
| secondary osteoporosis | #261 |
| denatured | #261 |
| lymphocytes helper | #261 |
| autoimmune neuritis | #261 |
| mice expressing | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| tolerance mice | #265 |
| genetic techniques | #265 |
| primary immunization | #265 |
| pregnancy mice | #265 |
| mouse strain | #265 |
| crossreactive | #265 |
| cysteine proteases | #267 |
| rats animals | #267 |
| antigen specific | #267 |
| vim2 | #267 |
| posttranslational modifications | #268 |
| xid | #268 |
| lentiviral gene | #268 |
| pathogenic roles | #269 |
| mann whitney | #269 |
| complement c5 | #270 |
| oxpl | #270 |
| monosodium urate crystals | #271 |
| selfantigens | #271 |
| melatonin effects | #271 |
| castrated | #271 |
| amino acid transporters | #273 |
| experimental model | #273 |
| lewis rats | #274 |
| hdac1 | #275 |
| tcells | #275 |
| inhibitory peptide | #275 |
| synovial lining | #275 |
| nasally | #275 |
| macrophages dendritic cells | #276 |
| fcgr3b | #276 |
| viral female hepatitis | #277 |
| deiminase type | #277 |
| rheumatoid arthritis association | #277 |
| producing cells | #277 |
| metabolic properties | #278 |
| recognize | #278 |
| gp70 | #279 |
| colon length | #279 |
| interferongamma | #279 |
| induced tolerance | #280 |
| dinucleotide phosphate | #280 |
| immunological receptors antigen | #281 |
| neonatal mice | #281 |
| recipient mice | #281 |
| inflammatory conditions | #281 |
| passive transfer | #281 |
| hemiacetal | #282 |
| isoflavone genistein | #283 |
| factor production | #283 |
| inbred nod | #283 |
| disease susceptibility | #283 |
| igg2b | #283 |
| increased serum levels | #284 |
| helper inducer | #284 |
| aire | #284 |
| severe colitis | #284 |
| idiotope | #285 |
| aureus strain | #285 |
| complete protection | #285 |
| maintained | #285 |
| publication animals antibodies | #285 |
| endophilin | #285 |
| theilovirus | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| antibody production | #288 |
| melatonin mice | #288 |
| tlr9 mice | #288 |
| melatonin release | #288 |
| myelin basic protein | #288 |
| mice immunized | #289 |
| cells autoimmunity | #289 |
| synovial cells | #291 |
| ctla4 expression | #291 |
| disease cells | #291 |
| autoimmune mechanisms | #292 |
| rheumatic conditions | #292 |
| cytokines disease | #293 |
| induced ros | #293 |
| collagen receptors | #293 |
| increased copy | #293 |
| mouse genes | #294 |
| unique model | #294 |
| antigen processing | #295 |
| gastric parietal | #295 |
| c3h | #295 |
| c57bl 6 mice | #295 |
| nerve conduction | #296 |
| 6week | #296 |
| immunological receptors | #296 |
| tissue‐specific | #296 |
| dnfb | #297 |
| phosphopyruvate | #297 |
| murine dendritic cells | #297 |
| helical peptides | #297 |
| vivo imaging | #298 |
| ppad | #298 |
| cd19 cells | #298 |
| gene selection | #298 |
| transplantation antigens | #299 |
| citrullination | #299 |
| solidphase synthesis | #299 |
| tcr beta | #300 |
| posttranslational rats | #301 |
| neutrophil extracellular traps | #301 |
| alphabeta | #302 |
| peptide antibody | #302 |
| draining lymph | #302 |
| extraembryonic tissues | #302 |
| animals antibodies | #303 |
| epidemiological investigation | #303 |
| 1 interferon | #303 |
| pathogeneses | #303 |
| strains mice | #303 |
| autoimmune diseases | #304 |
| igg glycosylation | #304 |
| cgd | #304 |
| conditioned disease models | #304 |
| mutant strains mice | #305 |
| cells tcr | #305 |
| cartilage development | #305 |
| immunological function | #305 |
| immunological studies | #306 |
| murine colitis | #306 |
| αgalcer | #306 |
| gammaifn | #306 |
| hcdr3 | #306 |
| class histocompatibility | #307 |
| inpp4b | #307 |
| immunisation | #307 |
| basal metabolic rate | #308 |
| basal metabolic | #309 |
| chromosome 10 | #309 |
| articular cattle cells | #310 |
| arthritis study | #310 |
| perpetuation | #311 |
| multiple sclerosis eae | #311 |
| synthetic peptide | #312 |
| alleles animals | #312 |
| disease symptoms | #312 |
| inflamed joints | #312 |
| c3bi | #313 |
| exuberant | #313 |
| epitopes | #313 |
| induced colitis | #314 |
| activatory | #314 |
| r620w | #315 |
| mice genes | #315 |
| intradermally | #315 |
| trypanosoma brucei brucei | #316 |
| onset rheumatoid | #318 |
| classical risk factors | #318 |
| tubule cells | #319 |
| genetic interactions | #319 |
| galactosyl | #319 |
| genomewide linkage analysis | #320 |
| deiminase | #320 |
| mice subjected | #320 |
| spleen bone marrow | #320 |
| cells specific | #323 |
| il21r | #323 |
| impact disease | #324 |
| daf2 | #324 |
| ccp1 | #324 |
| expressing human | #324 |
| expression cells | #325 |
| specific cell | #325 |
| rat gene | #325 |
| surprisingly | #326 |
| resembles | #327 |
| mgps | #327 |
| c57bl mice | #328 |
| allelic variant | #328 |
| immunoenzyme | #329 |
| publication adjuvants | #329 |
| constant light | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| glycoprotein mog | #332 |
| fcgammariia | #332 |
| rheumatoid synovial | #332 |
| nucleotide polymorphism | #332 |
| anticcp | #333 |
| mouse hepatitis virus | #333 |
| 35ssulfate | #334 |
| joint tissues | #335 |
| mrl lpr mice | #335 |
| susceptibility genes | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| epitope specificity | #340 |
| cells spleen | #340 |
| delayed onset | #340 |
| ros oxygen species | #341 |
| activation macrophages | #341 |
| adjuvants immunologic | #341 |
| rat | #341 |
| erosive | #341 |
| specific autoimmune | #342 |
| 6weeks | #342 |
| animal enzyme inhibitors | #342 |
| incident cardiovascular events | #342 |
| drb1 alleles | #343 |
| diabetic mouse | #343 |
| sequence animals | #343 |
| rats injection | #343 |
| rapid spread | #343 |
| 182780 | #344 |
| monoclonals | #344 |
| favor | #345 |
| acpa positivity | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| complement activity | #349 |
| reduced capacity | #349 |
| neuritis | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| methylcholanthrene | #352 |
| thymic selection | #352 |
| mice induction | #353 |
| anti cyclic | #353 |
| immunoregulation | #353 |
| c3h hej | #353 |
| mice cd4 | #354 |
| arthritis synovial | #354 |
| autoantigens autoimmune | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| cells autoantibodies | #358 |
| adjuvant activity | #358 |
| tbetarii | #358 |
| injected | #359 |
| neuritogenic | #359 |
| enos | #359 |
| tcrbeta | #360 |
| tlr3 | #361 |
| pvg | #361 |
| freund | #361 |
| murine lupus | #362 |
| hla transgenic | #362 |
| allergic encephalomyelitis | #363 |
| determines | #363 |
| identification genes | #363 |
| mouse chromosome | #363 |
| generation ros | #363 |
| hladr4 | #364 |
| cells anti | #364 |
| recognized | #364 |
| immune deviation | #366 |
| glycoproteins mice | #366 |
| sex chromosomes | #366 |
| european journal | #366 |
| psychosocial stress | #367 |
| antiidiotypic antibodies | #367 |
| toxic shock | #368 |
| loci | #368 |
| 100 micrograms | #368 |
| ncf2 | #368 |
| autoimmune responses | #368 |
| affinity ligand | #368 |
| histocompatibility antigens | #369 |
| nasal administration | #369 |
| pentameric | #369 |
| increased production | #370 |
| immune pathogenesis | #370 |
| clinical onset | #371 |
| regulate | #371 |
| serum transfer | #371 |
| newborn antibodies | #372 |
| role mif | #372 |
| alternative activation | #373 |
| autoantigens | #375 |
| rheumatoid cell | #375 |
| acutephase proteins | #376 |
| undifferentiated arthritis | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| mouse monoclonal antibody | #381 |
| induced lupus | #381 |
| oxidase deficiency | #381 |
| fia | #382 |
| fragments immunoglobulin | #382 |
| granulomatous | #383 |
| granulomatous disease | #384 |
| c1a | #384 |
| specific loci | #384 |
| naive rats | #384 |
| postmenopausal bone loss | #385 |
| shock syndrome | #385 |
| cell specificity | #386 |
| pc4 | #386 |
| ptpn22 gene | #387 |
| filaggrin | #387 |
| antioxid | #387 |
| backcrosses | #387 |
| phase response | #388 |
| inbred nod receptors | #388 |
| downregulating | #389 |
| deficient | #390 |
| ovulation rate | #390 |
| greater 50 | #390 |
| radiological progression | #391 |
| anaphylatoxin c5a | #391 |
| peptidylarginine | #391 |
| finetune | #392 |
| il4 il10 | #394 |
| rf1 | #394 |
| ameliorating | #395 |
| draining | #397 |
| autoantibody levels | #397 |
| induced metabolic | #397 |
| juvenile chronic arthritis | #398 |
| immunized mice | #399 |
| regulation animals | #399 |
| protein myelin | #399 |
| inflammatory reactions | #400 |
| reactive oxygen species | #400 |
| antibody formation | #401 |
| genes cells | #401 |
| inflammation demyelination | #403 |
| immunopeptidome | #403 |
| biacore | #403 |
| beta chain | #404 |
| fcγriib | #404 |
| experimental | #405 |
| basic protein | #405 |
| n31 | #407 |
| effects models | #407 |
| rheumatoid case | #407 |
| pam3csk4 | #408 |
| immunogenetics | #409 |
| major locus | #409 |
| 3hproline | #410 |
| diabetes loci | #410 |
| intracellular processing | #410 |
| hladrb1 | #412 |
| cd43 | #412 |
| cell phenotypes | #412 |
| titres | #413 |
| susceptibility loci | #413 |
| reproductive performance | #414 |
| characteristic feature | #414 |
| cultured collagen | #415 |
| igk | #415 |
| levels autoantibodies | #416 |
| female mice | #416 |
| synovial inflammation | #417 |
| spontaneous mutation | #417 |
| lupus mice | #417 |
| genetically modified mice | #418 |
| wtccc | #419 |
| induced pain | #419 |
| molecular interactions | #419 |
| class hdacs | #419 |
| hiit | #420 |
| ameliorate | #420 |
| tcell | #421 |
| lower affinity | #422 |
| dr4 | #422 |
| lipidomic | #423 |
| restricted | #424 |
| subsets animals | #424 |
| hyaline cartilage | #425 |
| congenic strain | #426 |
| inflammatory cells | #426 |
| regulatory animals | #426 |
| carbohydrate moiety | #429 |
| postimmunization | #430 |
| nonimmunogenic | #430 |
| epitopes humans | #430 |
| nod mouse | #430 |
| immunoregulatory | #431 |
| il10 mice | #433 |
| patients healthy individuals | #433 |
| cells antibodies | #434 |
| spontaneous autoimmune | #435 |
| factor 5 | #435 |
| cells beta | #436 |
| reactivities | #436 |
| mass spectrometric analysis | #437 |
| decalcified | #437 |
| chromosomes chromosome | #437 |
| crystallizable | #437 |
| mice effects | #438 |
| immunised | #438 |
| specific antigens | #438 |
| helperinducer tlymphocytes | #438 |
| joint swelling | #439 |
| cells | #439 |
| nod | #440 |
| wildtype mice | #440 |
| vitro techniques leukocytes | #441 |
| female immunoglobulin | #441 |
| effector functions | #441 |
| normal rats rats | #441 |
| complete adjuvant | #442 |
| mice activation | #442 |
| patients population | #442 |
| methylβcyclodextrin | #443 |
| mhc class molecules | #443 |
| tlr2 expression | #444 |
| myelin basic | #444 |
| genomewide scan | #445 |
| mouse models | #445 |
| systemic mice | #445 |
| mice humans | #445 |
| skeletal muscle function | #445 |
| ros production | #447 |
| control mice | #448 |
| induced mice | #448 |
| pain model | #448 |
| inbred strains receptors | #448 |
| synovial tissue | #449 |
| tcell responses | #449 |
| complement factor | #449 |
| innate adaptive | #450 |
| igg anti | #451 |
| apcs | #451 |
| hybridoma cells | #452 |
| reduced production | #452 |
| heterologous | #452 |
| differs | #454 |
| cells chronic | #456 |
| lglutamine | #456 |
| raloxifene | #457 |
| inbred c57bl tlymphocytes | #457 |
| rheumatoid cells | #459 |
| eae cns | #459 |
| resembling | #459 |
| lung macrophages | #459 |
| priming | #459 |
| antibodies monoclonal | #460 |
| 256 | #462 |
| autoantigen | #462 |
| neutrophil functions | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| salivary glands | #466 |
| receptor tcr | #466 |
| cells lymph | #467 |
| titers | #469 |
| earlier onset | #469 |
| anticyclic citrullinated peptide | #474 |
| arthritic rats | #474 |
| disease mice | #474 |
| antibody mediated | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| cluster genes | #477 |
| mice exhibited | #477 |
| mediated inflammation | #478 |
| therapeutic vaccination | #478 |
| female hla | #479 |
| apoptosis arthritis | #479 |
| laboratory rat | #479 |
| aggravated | #480 |
| quantitative trait loci | #480 |
| deacetylase 1 | #480 |
| polymorphonuclear cells | #482 |
| anti idiotypic | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| jca | #487 |
| tcralpha | #487 |
| oxyntic | #487 |
| controlling | #487 |
| invariant natural | #488 |
| insulitis | #488 |
| specific immune | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| early rheumatoid | #496 |
| reactive nitrogen | #496 |
| conclude | #496 |
| gammadelta cells | #496 |
| h2b | #496 |
| mbp | #498 |
| small effects | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| autoreactive cd4 | #503 |
| nadph | #503 |
| immunoenzyme techniques | #503 |
| pathogenic | #506 |
| immunofluorescence analysis | #507 |
| chondrocytes collagen | #507 |
| mab mabs | #508 |
| persistent pain | #508 |
| mineral oil | #508 |
| isopropyl | #508 |
| gingipain | #509 |
| orosomucoid | #509 |
| immunization passive | #509 |
| mhc class | #510 |
| mice knockout mice | #510 |
| c3h hej mice | #511 |
| differential gene | #511 |
| deficient mice | #511 |
| 812 | #511 |
| systemic spread | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| behavioral alterations | #517 |
| hydroxyquinolines | #517 |
| antibody complex | #518 |
| u1 | #518 |
| suggestive linkage | #519 |
| chronic granulomatous disease | #519 |
| inflammation | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| pcorr | #522 |
| ttg | #522 |
| dextran sulfate sodium | #522 |
| inflammation role | #523 |
| data peptide | #523 |
| litter size | #524 |
| p47phox | #524 |
| encephalitogenic | #524 |
| neutrophil granulocytes | #525 |
| mnc | #526 |
| tconv | #526 |
| mechanical hypersensitivity | #526 |
| maternal antibodies | #527 |
| disease acute | #527 |
| spleen cells | #527 |
| vaccinates | #528 |
| larsen | #528 |
| primed | #528 |
| tolonium | #528 |
| rat rats | #529 |
| tolllike receptor tlr4 | #529 |
| displayed | #529 |
| ifa | #529 |
| cell antibodies | #530 |
| autoantibody | #530 |
| antigen presentation | #530 |
| pathogenesis sle | #530 |
| isac | #530 |
| ratg | #531 |
| epistatic | #532 |
| bred | #532 |
| complex role | #533 |
| lyt2 | #533 |
| posttranslational receptors | #534 |
| spleen lymphocytes | #536 |
| resorptions | #536 |
| translational modification | #536 |
| urokinase | #537 |
| synovial | #537 |
| experimental rats | #538 |
| cells inflammatory | #538 |
| animals | #538 |
| joints | #540 |
| fibroblast synoviocytes | #540 |
| antigen recognition | #540 |
| suppressive | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| regulating | #545 |
| protein tyrosine phosphatase | #545 |
| hypomorphic | #546 |
| tlymphocytes | #547 |
| animal gene | #547 |
| shortcut | #547 |
| immunohistochemical methods | #548 |
| entheses | #548 |
| formyl peptide receptors | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| cell epitopes | #557 |
| stronger association | #557 |
| beta animals | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| ptdins3p | #563 |
| inbred strains | #563 |
| negative selection | #563 |
| neutrophil depletion | #564 |
| deeper layers | #565 |
| therapeutic treatment | #565 |
| earlier | #566 |
| target tissue | #566 |
| immunoglobulin heavy chains | #566 |
| darkness | #566 |
| crucial | #567 |
| interferon signature | #568 |
| disease loci | #568 |
| outbred | #568 |
| mycobacteria | #569 |
| cells pathogenesis | #569 |
| neutrophilia | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| btla | #572 |
| transgenic mouse models | #572 |
| keratin8 | #573 |
| col2 | #574 |
| presenting | #576 |
| pepstatins | #576 |
| estrogen treatment | #577 |
| terpenes | #577 |
| keratinocyte growth factor | #578 |
| prolactin prl | #578 |
| ptm | #579 |
| sera patients | #579 |
| triple helix | #580 |
| f1 hybrids | #581 |
| methotrexate mice | #581 |
| production ifngamma | #583 |
| hybridoma | #583 |
| inflammatory joint | #583 |
| exaggerated | #584 |
| time onset | #584 |
| lymphocyte antigens | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| antigen antibody | #591 |
| environmental triggers | #591 |
| immunological tolerance | #592 |
| lxrα | #592 |
| oligoclonal | #592 |
| transgenic models | #593 |
| noncollagenous | #593 |
| macrophages | #594 |
| autoimmune disorders | #594 |
| adaptive immunity | #594 |
| clonal expansion | #595 |
| multiplexing | #595 |
| th1 cytokines | #595 |
| xanthine oxidoreductase | #596 |
| tcell activation | #599 |
| cells study | #599 |
| develop | #600 |
| th2 cytokines | #602 |
| augmented | #602 |
| n85 | #602 |
| spite | #602 |
| common diseases | #603 |
| pemphigus vulgaris | #603 |
| mouse monoclonal | #603 |
| phagosomal | #604 |
| cells male | #604 |
| cells involved | #604 |
| oxa | #606 |
| mice inbred | #606 |
| animal rats | #606 |
| class humans | #607 |
| genotype hla | #608 |
| frozen sections | #608 |
| spleen animals | #609 |
| inefficiently | #610 |
| regulatory role | #610 |
| production ifn | #611 |
| naive | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| th1 type | #616 |
| acetophenones | #616 |
| mutant strains receptors | #616 |
| alpha chains | #616 |
| class antigens | #616 |
| idiotypic | #616 |
| autoantibodies | #616 |
| exponential phase | #616 |
| oral immunization | #617 |
| nonobese | #617 |
| beta type | #618 |
| day mice | #619 |
| wistar restraint | #620 |
| promiscuous | #620 |
| inflammatory role | #621 |
| consequent | #621 |
| receptor 3 | #621 |
| nicotinamide adenine | #622 |
| receptors antigen | #624 |
| fluorine18 | #624 |
| loci identified | #625 |
| chronic stage | #625 |
| cytoplasmic ca2 | #628 |
| animal mice | #628 |
| local injection | #629 |
| inflammatory disease | #630 |
| cross reactions | #630 |
| healthy rats | #632 |
| reactive antibodies | #632 |
| development eae | #633 |
| fibromodulin | #634 |
| highintensity interval training | #634 |
| vivo binding | #635 |
| langerhans cells | #635 |
| nabs | #637 |
| ifn beta | #637 |
| cells inhibition | #638 |
| class genes | #638 |
| inflammation autoimmunity | #640 |
| estrogens female | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| patients sera | #650 |
| antigen specificity | #650 |
| genetic disease | #652 |
| hexadecane | #654 |
| idiotypic antibodies | #654 |
| antibody titres | #655 |
| interphalangeal | #655 |
| new pathway | #658 |
| genetic linkage | #658 |
| axotomized | #659 |
| cyba | #660 |
| sialoprotein | #660 |
| peptide binding | #661 |
| inbred cba mice | #661 |
| acute inflammation | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| animal ear | #665 |
| delayed hypersensitivity | #665 |
| superantigens | #666 |
| 264 | #666 |
| reactive | #666 |
| lymphoid organs | #666 |
| receptors igg | #666 |
| activation mice | #669 |
| drb1 | #670 |
| apeced | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| cells induce | #674 |
| treatment protocol | #674 |
| genetic epistasis | #675 |
| pyramidal neurons | #675 |
| desmoglein | #675 |
| strikingly | #676 |
| adherent cells | #677 |
| idiotypes | #677 |
| germinal center | #677 |
| china cohort | #678 |
| major genes | #679 |
| igg response | #679 |
| il12p70 | #679 |
| thelper | #680 |
| cells role | #682 |
| lymphocytes mice | #682 |
| puzzle | #683 |
| inbred c57bl mice | #683 |
| normal animals | #683 |
| helper cell | #684 |
| specific antibody | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| foot joints | #689 |
| delayed | #689 |
| subsets | #689 |
| rendered | #690 |
| early rheumatoid arthritis | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| knockout polymorphism | #695 |
| muscle glucose | #695 |
| igg antibodies | #696 |
| paam | #696 |
| anas | #697 |
| luminex | #697 |
| disease hla | #698 |
| mice model | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| quantitative trait | #704 |
| inbred | #704 |
| complete freund | #706 |
| histopathological analysis | #707 |
| fibroblastlike synoviocytes | #707 |
| extracellular trap | #708 |
| estradiol female | #710 |
| specific cells | #710 |
| igl | #712 |
| posttranslational | #713 |
| predetermined | #716 |
| spleens | #716 |
| mice lacking | #717 |
| antibodies patients | #718 |
| acute bout | #718 |
| lymphocyte depletion | #719 |
| regulatory function | #720 |
| proliferative response | #720 |
| deficiency syndromes | #721 |
| buf | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| macrophages mice mice | #725 |
| human hand | #725 |
| dmaema | #728 |
| cd1d | #728 |
| mhc molecules | #729 |
| th2 cytokine | #729 |
| ccps | #729 |
| cdk6 | #730 |
| administrated | #732 |
| cns inflammation | #732 |
| cholesterol metabolism | #732 |
| animals antigens antigens | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| net formation | #736 |
| rats treatment | #736 |
| locus | #737 |
| cheeks | #739 |
| operates | #740 |
| c57bl | #740 |
| species specificity | #741 |
| cd5 cells | #741 |
| nkt | #742 |
| tissue destruction | #742 |
| cell responses | #743 |
| vivo mice | #743 |
| immunologic deficiency | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| autoantibodies autoimmunity | #749 |
| nonobese diabetic mice | #749 |
| intensity interval | #749 |
| keratinocyte | #749 |
| transferred | #751 |
| preclinical phase | #751 |
| control disease | #753 |
| ere | #755 |
| tlr activation | #755 |
| hapten | #755 |
| metabolomic | #755 |
| mice anti | #757 |
| autoantibodies type | #758 |
| disease protection | #758 |
| phenotypic differences | #758 |
| hyperinflammatory | #759 |
| reacted | #759 |
| linkage region | #760 |
| knockout tlymphocytes | #760 |
| ifngamma production | #761 |
| ccp | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| cells apcs | #773 |
| redox signal | #773 |
| hkexchanging | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| diseases cell | #778 |
| fab fragment | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| development autoimmunity | #782 |
| pathogenic role | #782 |
| arthritis osteoarthritis | #782 |
| nox1 | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| reduced incidence | #790 |
| inflammatory lesions | #790 |
| transgenic receptors antigen | #790 |
| peptide fragments | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| cell humans | #794 |
| antibodies directed | #794 |
| interval training | #796 |
| neutrophil function | #796 |
| neutrophil extracellular | #796 |
| pathogen free | #797 |
| lymphocyte proliferation | #798 |
| genes immunoglobulin | #798 |
| carbohydrate moieties | #800 |
| polyi | #801 |
| matrix proteins | #801 |
| blymphocyte chain genes | #802 |
| innate adaptive immunity | #802 |
| thy1 | #802 |
| monoclonal binding | #802 |
| helper cells | #805 |
| count male | #805 |
| induces | #805 |
| redox control | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| function mutation | #811 |
| catabolism | #811 |
| strains receptors | #812 |
| acc1 | #812 |
| resident cells | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| arginines | #817 |
| ctb | #817 |
| auricle | #820 |
| leads | #820 |
| cd8 antigens | #821 |
| collagen cross | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| humoral immune response | #824 |
| electroporated | #824 |
| colocalizes | #824 |
| prominently | #825 |
| genetic environmental | #825 |
| psoriasis psoriatic arthritis | #825 |
| response animals | #826 |
| muscle training | #826 |
| chondroid | #827 |
| growth factor beta | #829 |
| class antigen | #829 |
| producing | #830 |
| effects immune | #830 |
| cross reactivity | #834 |
| lpr | #841 |
| inbred c57bl | #841 |
| peyers patches | #842 |
| immunoglobulin mice | #842 |
| diabetic nod | #844 |
| therapeutic approaches | #844 |
| chronic active | #845 |
| il25 | #845 |
| inflammatory arthritis | #846 |
| mice transgenic | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| lymphocyte | #852 |
| antigen cell | #852 |
| leukocyte migration | #854 |
| new possibilities | #854 |
| ms275 | #855 |
| tcell receptors antigen | #855 |
| importantly | #856 |
| alveolar mice mice | #856 |
| strongest association | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| factor anti | #867 |
| knockin mice | #867 |
| mice reduced | #867 |
| mediated inflammatory | #867 |
| strongest | #868 |
| cross reactive | #868 |
| hinge region | #869 |
| parietal cells | #869 |
| lentiviral | #869 |
| lnc | #872 |
| immune tolerance | #873 |
| dextran sulfate | #873 |
| lower expression | #874 |
| parasitemia | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| synovial fluid patients | #878 |
| fcγri | #878 |
| arthritis inflammatory | #879 |
| adoptive | #881 |
| antigen4 | #881 |
| systemic autoimmune diseases | #882 |
| pregnancy animal | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| genetic dissection | #891 |
| psoriasis vulgaris | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| inflammation mediators | #897 |
| intranasal administration | #897 |
| ctla4 antigen | #898 |
| interleukin1alpha | #898 |
| phosphatase receptor | #902 |
| partly | #904 |
| granulocytes | #904 |
| inception cohort | #905 |
| γδ cells | #906 |
| infiltrations | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| immunoglobulin levels | #911 |
| liu | #911 |
| single injection | #911 |
| chromosome 16 | #912 |
| mitochondrial ros | #913 |
| lectin pathway | #913 |
| pneumonitis | #914 |
| ciita | #914 |
| enolase | #915 |
| allelic variation | #915 |
| proliferate | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| psoriatic arthritis psa | #924 |
| antibodies antibody | #924 |
| neutrophil chemotaxis | #924 |
| chromosome mapping | #925 |
| cd200 | #925 |
| fluorobenzene | #925 |
| phenotypic analysis | #926 |
| nkt cells | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| citrulline | #933 |
| hydratase | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| arthritides | #938 |
| lymphocyte activation | #938 |
| synovia | #939 |
| 1040 | #939 |
| analysed | #940 |
| rns | #940 |
| immune reactivity | #940 |
| disease model | #941 |
| genetic analysis | #941 |
| collagen structure | #941 |
| vitro stimulation | #941 |
| mediated autoimmune | #944 |
| sciatic nerves | #945 |
| association hla | #945 |
| mice mice | #947 |
| inflammatory pathways | #948 |
| fluid patients | #948 |
| clinical observations | #948 |
| humanized mice | #949 |
| vivo | #950 |
| riii | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| levels ros | #962 |
| mhc peptide | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| monoclonal antigens | #967 |
| animals cytokines | #967 |
| cells lymphocytes | #967 |
| cytotoxic tlymphocytes | #967 |
| lower frequency | #969 |
| cell transfer | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| w5 | #982 |
| genes chromosome | #982 |
| lymphocytes | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| macrophages cells | #991 |
| knockout models | #991 |
| immunodominance | #992 |
| allergic contact dermatitis | #992 |
| cells reactive | #993 |
| transgenic expression | #994 |
| 510 | #994 |
| patients rp | #994 |
| cartilage bone | #995 |
| hej | #995 |
| spontaneously | #997 |
| knee joints | #997 |
| formyl peptide | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| expands | #1004 |
| aggravate | #1004 |
| processing presentation | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| cyclic peptides | #1012 |
| nrc | #1012 |
| 95 stroke | #1013 |
| interleukin21 | #1013 |
| model multiple | #1015 |
| igg | #1015 |
| direct comparison | #1015 |
| cellular composition | #1016 |
| cells mast | #1016 |
| nerve roots | #1016 |
| aged arthritis | #1017 |
| melatonin levels | #1019 |
| patients early | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| baseline 24 months | #1031 |
| dr1 | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| parental strain | #1050 |
| myelin proteins | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| gamma delta | #1055 |
| inflammatory macrophages | #1055 |
| immune defense | #1056 |
| antigens differentiation | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| lymphocytes cells | #1062 |
| sterile inflammation | #1062 |
| morula | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| disease humans polymorphism | #1069 |
| oxazoles | #1069 |
| role immune | #1069 |
| decidua | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| key steps | #1080 |
| adjuvant cfa | #1080 |
| reestablishment | #1082 |
| lymphoid cells | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| uppsala | #1089 |
| haplotypes | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| molecular mimicry | #1115 |
| subdominant | #1115 |
| fibril | #1115 |
| clinical disease | #1116 |
| sclerosis myelin | #1116 |
| deamidation | #1117 |
| cd5 | #1117 |
| genetic factors | #1117 |
| antitoxin | #1117 |
| disulfide | #1117 |
| animal immunity | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| predisposing | #1128 |
| foreign antigens | #1128 |
| humans lymphocyte | #1128 |
| cells ifn | #1128 |
| isomerase | #1128 |
| dissected | #1130 |
| treatment day | #1132 |
| skeletal muscle fibers | #1132 |
| superantigen | #1134 |
| cryosections | #1135 |
| immune response | #1135 |
| glucosyl | #1136 |
| vivo administration | #1136 |
| overlapped | #1136 |
| c57 | #1137 |
| peptide sequence | #1138 |
| underline | #1138 |
| anticardiolipin antibodies | #1139 |
| editorial | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| helpers | #1149 |
| treatment animals | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| lxr | #1161 |
| inactivating | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| stainings | #1168 |
| demonstrating | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| models disease | #1178 |
| inflamed tissues | #1178 |
| 10b | #1179 |
| recombinant interferon | #1180 |
| preponderance | #1180 |
| genetic background | #1181 |
| destructive | #1182 |
| chemiluminescent | #1182 |
| arginine residues | #1184 |
| disease haplotypes humans | #1186 |
| objective investigate | #1186 |
| synovial fibroblasts | #1188 |
| lymphocytes cell | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| rat human | #1192 |
| splenic cells | #1192 |
| antiphospholipid | #1193 |
| primary sjögrens syndrome | #1195 |
| infiltrates | #1195 |
| cells rheumatoid | #1199 |
| antibodies mabs | #1200 |
| antibody | #1200 |
| basic mechanisms | #1200 |
| susceptibility | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| onset progression | #1212 |
| predisposition disease | #1212 |
| c5a | #1213 |
| rationales | #1214 |
| singlecell | #1214 |
| hdacs | #1217 |
| critical issues | #1218 |
| chronic inflammation | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| adaptive immune response | #1223 |
| mononuclear | #1223 |
| compared wt | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| antimicrobial peptides amps | #1229 |
| linkage analysis | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| subsets lymphocytes | #1233 |
| aps | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| ltb | #1253 |
| animal | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| differentiation lymphocyte | #1263 |
| mesenteric lymph nodes | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| adenine dinucleotide | #1269 |
| suppress | #1269 |
| suppressive function | #1270 |
| molecular pathogenesis | #1270 |
| rheumatoid arthritis patients | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| claudin4 | #1274 |
| eae model | #1274 |
| rats mice | #1275 |
| chromosomal regions | #1275 |
| inducer | #1279 |
| rattus norvegicus | #1282 |
| becn1 | #1282 |
| staphylococcal | #1283 |
| c4a | #1283 |
| hla molecules | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| peripheral cells | #1297 |
| day pregnancy | #1297 |
| serm | #1297 |
| production anti | #1299 |
| nadph oxidase activity | #1299 |
| data protein | #1300 |
| publication animals antigens | #1300 |
| restimulation | #1305 |
| hdac3 | #1307 |
| model experimental | #1307 |
| peptide library | #1309 |
| social isolation | #1310 |
| ali | #1310 |
| fab2 | #1312 |
| generated | #1313 |
| phagocytic cells | #1313 |
| introgressed | #1314 |
| lymphoproliferation | #1315 |
| permissive | #1315 |
| detailed characterization | #1316 |
| increased susceptibility | #1316 |
| immune | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| immunoglobulin isotypes | #1321 |
| hydrolyzes | #1321 |
| phagocytes | #1322 |
| healthy human subjects | #1322 |
| intrathymic | #1322 |
| submandibular | #1323 |
| collagen types | #1323 |
| aureus infections | #1325 |
| acute phase proteins | #1327 |
| valuable tool | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| human igg | #1330 |
| receptor 2 | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| thymectomy | #1335 |
| identically | #1335 |
| new therapies | #1336 |
| rats rats | #1336 |
| acute phase response | #1338 |
| induction phase | #1341 |
| cells mice | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| elimination | #1361 |
| alp | #1361 |
| position | #1361 |
| regulatory genes | #1362 |
| believed | #1364 |
| disease activity score | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| shared | #1375 |
| trait | #1375 |
| betad | #1375 |
| membrane glycoproteins | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| abrogates | #1383 |
| immunogen | #1383 |
| surface cells | #1384 |
| rats humans | #1388 |
| exacerbation | #1388 |
| variable region | #1389 |
| suffer | #1389 |
| clinical signs | #1390 |
| cd2 | #1390 |
| regulatory treg | #1390 |
| human patients | #1392 |
| squalene | #1392 |
| feto | #1393 |
| phage display | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| inbred mice | #1397 |
| disease outcomes | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| joint disease | #1403 |
| early patients | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| humans immune | #1417 |
| activation neutrophils | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| alpha1 | #1458 |
| cell activation | #1458 |
| monoclonal | #1460 |
| knockout rats | #1461 |
| proinflammatory responses | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| ccr6 | #1467 |
| opens | #1467 |
| pfp | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| immune deficiency | #1474 |
| cartilage cell | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| responses animals | #1482 |
| specific gene | #1482 |
| markers genetic | #1483 |
| blisters | #1483 |
| initiate | #1486 |
| inflammatory diseases | #1486 |
| genetic regulation | #1486 |
| cells lung | #1486 |
| stroke 95 | #1487 |
| host defence | #1489 |
| hormone release | #1489 |
| donated | #1490 |
| mice day | #1491 |
| human cartilage | #1491 |
| inbred rats | #1491 |
| humoral immune | #1497 |
| myelin | #1499 |
| emphysematous | #1499 |
| treatment inflammatory | #1504 |
| regulatory effects | #1504 |
| monocytes neutrophils | #1504 |
| vivo vitro | #1505 |
| specific monoclonal | #1505 |
| joint arthritis | #1507 |
| eluate | #1507 |
| mimicking | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| earlier studies | #1525 |
| lia | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| unexpectedly | #1547 |
| production macrophages | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| copy variations | #1563 |
| neuroimmunomodulation | #1563 |
| 4 humans | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| guerin | #1567 |
| matrix components | #1567 |
| immunoglobulin humans | #1568 |
| mammalian embryo | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| pineal | #1574 |
| cytotoxic lymphocyte | #1574 |
| independent | #1577 |
| cochran | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| factor beta | #1597 |
| conserved | #1597 |
| directed | #1597 |
| defines | #1598 |
| cell mediated | #1600 |
| adoptive transfer | #1600 |
| f1 | #1600 |
| twins | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| cells th17 | #1607 |
| estriol | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| chronic inflammatory diseases | #1617 |
| immunity animals | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| humans immunoglobulin | #1622 |
| anaphylatoxin | #1622 |
| c57bl 6 | #1622 |
| differently | #1625 |
| unreactive | #1626 |
| antigen | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| immunohistology | #1635 |
| c3b | #1635 |
| collagen fibers | #1639 |
| lund | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| p6 | #1644 |
| abrogated | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| defence | #1658 |
| linked | #1658 |
| commonly | #1660 |
| complement receptors | #1660 |
| staphylococcal enterotoxin | #1661 |
| immune complexes | #1661 |
| transporter type | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| immunologic epitopes | #1673 |
| pathogenic cells | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| complement c5a | #1686 |
| cd206 | #1686 |
| cocktail | #1689 |
| auto | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| agouti | #1694 |
| ido1 | #1694 |
| classical pathway | #1696 |
| transgenic mice | #1696 |
| severity | #1701 |
| 5 months | #1704 |
| triple | #1704 |
| animals autoantigens | #1704 |
| precede | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| treg cells | #1711 |
| disulfiram | #1711 |
| beta chains | #1712 |
| erosions | #1712 |
| mice neutrophils | #1714 |
| sjögrens syndrome | #1719 |
| ankylosis | #1719 |
| evoke | #1720 |
| tolerance | #1721 |
| pulmonary aspergillosis | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| myelin proteolipid | #1729 |
| mutant mice | #1729 |
| drug targets | #1732 |
| analysis protein | #1734 |
| immune responses | #1734 |
| 369 | #1734 |
| staphylococcal infections | #1736 |
| sicca | #1737 |
| phagocytic | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| prophylactic treatment | #1744 |
| 626 | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| zap70 | #1748 |
| alternative pathway | #1748 |
| strain mice | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| dr2 | #1766 |
| inhibitory receptors | #1766 |
| higher frequency | #1770 |
| triggering | #1770 |
| multiple genes | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| ll37 | #1784 |
| articular cell | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| dogma | #1794 |
| render | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| disease pathogenesis | #1801 |
| polymorphism genetic | #1801 |
| rat models | #1802 |
| cd19 antigens | #1803 |
| rechallenge | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| immunogenic | #1810 |
| predisposed | #1810 |
| activated lymphocytes | #1811 |
| complement pathway | #1811 |
| elucidation | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| nonfunctional | #1817 |
| pregnancy rats | #1817 |
| promoting | #1818 |
| il2r | #1818 |
| ossification | #1818 |
| blymphocyte | #1819 |
| intravenously | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| myelin sheath | #1825 |
| hydroxylated | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| subsequently | #1846 |
| clinical score | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| genetic variance | #1854 |
| specific immunity | #1854 |
| cd8 lymphocytes | #1856 |
| macrophages neutrophils | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| structural basis | #1864 |
| aggravation | #1864 |
| lacrimal apparatus | #1865 |
| rats groups | #1871 |
| silastic | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| subsequent development | #1879 |
| cartilages | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| tcr repertoire | #1903 |
| lymphatics | #1903 |
| indicating | #1905 |
| complexity | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| gammadelta | #1910 |
| mediated | #1910 |
| enzyme linked | #1911 |
| cell maturation | #1912 |
| cells neutrophils | #1912 |
| interferon gamma | #1914 |
| chromosome | #1916 |
| erythematosus sle | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| 721 | #1924 |
| anti | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| trypanosoma brucei | #1937 |
| animals lymphocytes | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| prevented | #1950 |
| subclasses | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| snakes | #1957 |
| perforin | #1957 |
| agp | #1959 |
| mmc | #1962 |
| iga igg | #1967 |
| levels serum | #1967 |
| pinocytosis | #1967 |
| edition | #1967 |
| possibilities | #1969 |
| fcγ receptor | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| synovial tissues | #1979 |
| carp | #1979 |
| ova | #1980 |
| inbred cba | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| cell clone | #1985 |
| disease pathology | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| rats effects | #2008 |
| contact dermatitis | #2008 |
| reverted | #2008 |
| prototypic | #2011 |
| abca1 | #2016 |
| response infection | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| mabs | #2028 |
| cytokine secretion | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| mesenteric lymph | #2035 |
| conformational epitopes | #2035 |
| beta gene | #2035 |
| 4 tlr4 | #2041 |
| factor mif | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| hypergammaglobulinemia | #2050 |
| oestrogens | #2050 |
| castration | #2053 |
| cell function | #2053 |
| species signal | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| innate inflammation | #2058 |
| increased frequency | #2058 |
| dramatically | #2059 |
| activation complement | #2061 |
| vitro vivo | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| proteomics analysis | #2072 |
| hyaluronoglucosaminidase | #2072 |
| mdsc | #2076 |
| mature cells | #2077 |
| polyradiculoneuropathy | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| complement | #2094 |
| methotrexate mtx | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| αβ | #2100 |
| bioreactor | #2100 |
| suggested | #2102 |
| evokes | #2103 |
| led | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| pulmonary inflammation | #2122 |
| glycan | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| selective estrogen | #2141 |
| target tissues | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| extracellular calcium | #2146 |
| subphenotypes | #2146 |
| bound | #2147 |
| h2d | #2147 |
| circulating monocytes | #2149 |
| immunohistochemical analysis | #2151 |
| 129 strain mice | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| late stages | #2165 |
| moabs | #2165 |
| rheumatoid biomarkers | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| psoriatic arthritis | #2184 |
| dynorphins | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| interleukin2 | #2216 |
| therapeutic effects | #2216 |
| activation cells | #2217 |
| animal mice mice | #2217 |
| naïve | #2219 |
| galactose | #2220 |
| regulates | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| mammalian | #2232 |
| shrna | #2232 |
| neutralized | #2233 |
| governs | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| reduced susceptibility | #2239 |
| autoimmune conditions | #2239 |
| ctla4 | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| inflammatory phenotype | #2248 |
| cholera toxin | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| mph | #2274 |
| progeny | #2274 |
| immunospot | #2278 |
| antigenic | #2279 |
| murine | #2279 |
| neutrophil apoptosis | #2280 |
| mice treatment | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| determining | #2296 |
| modified proteins | #2296 |
| histological evaluation | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| drastically | #2315 |
| genetic basis | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| hydroxylation | #2320 |
| barré | #2320 |
| inflammatory mechanisms | #2321 |
| sera | #2325 |
| throughput nucleotide | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| reciprocal | #2353 |
| receptor α | #2353 |
| ethylenes | #2358 |
| specific igg | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| lectins type | #2366 |
| acrylamides | #2366 |
| sex hormone | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| eliminated | #2374 |
| wf | #2374 |
| immunogens | #2375 |
| peptides derived | #2375 |
| lymphotoxin | #2375 |
| genetic selection | #2376 |
| treatment rheumatoid arthritis | #2376 |
| cxcl1 | #2382 |
| amps | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| mouse model | #2386 |
| contaminating | #2386 |
| phenotypes | #2391 |
| sidechain | #2391 |
| receptor transforming | #2392 |
| knock | #2394 |
| syngeneic | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| p38 mapk | #2400 |
| inflammatory reaction | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic receptors | #2420 |
| genetic studies | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| acute phase | #2430 |
| suggestive evidence | #2430 |
| lentivirus | #2430 |
| unmodified | #2431 |
| cytokines chemokines | #2432 |
| collagen fibrils | #2432 |
| cko | #2432 |
| lymphocytes cd4 | #2432 |
| cells antigens | #2434 |
| agents arthritis | #2440 |
| early phases | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| receptors complement | #2450 |
| b6 | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| animals cd4 | #2473 |
| administration intranasal | #2473 |
| axotomy | #2477 |
| translational modifications | #2477 |
| additively | #2477 |
| quantitative | #2480 |
| class | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| alleviated | #2502 |
| albeit | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| chemokines cytokines | #2519 |
| dichotomous | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| microsatellite markers | #2534 |
| pathogenicity | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| kynurenine | #2563 |
| plp | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| transferring | #2573 |
| fine | #2573 |
| passive | #2574 |
| dying cells | #2575 |
| rp patients | #2575 |
| tumor models | #2576 |
| incomplete | #2577 |
| quantitative traits | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| peritoneal macrophages | #2591 |
| antibody levels | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| onset | #2603 |
| antiinflammatory properties | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| antinuclear | #2663 |
| submandibular gland | #2663 |
| functional impact | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| invading | #2670 |
| brucei | #2670 |
| n22 | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| ease | #2683 |
| new therapeutic strategies | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| day treatment | #2697 |
| allelic | #2697 |
| igg3 | #2698 |
| genetic variations | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| biased | #2730 |
| ifngamma | #2730 |
| lymphocyte subsets | #2730 |
| post partum | #2731 |
| lamina propria | #2735 |
| fumigatus | #2735 |
| serum anti | #2738 |
| fragment | #2743 |
| vav | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| human leukocyte | #2774 |
| tyrosine phosphatase | #2774 |
| cytolysis | #2777 |
| qtls | #2777 |
| strong evidence | #2777 |
| detectable | #2780 |
| enigmatic | #2780 |
| iga igm | #2780 |
| genetically | #2782 |
| finemapping | #2785 |
| explanation | #2785 |
| treated rats | #2786 |
| alcoholic steatohepatitis | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| inbred mrl | #2798 |
| current review | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| beta tgf | #2848 |
| bind | #2848 |
| th1 response | #2852 |
| demyelinating | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| treg cell | #2859 |
| dependent cell | #2859 |
| interleukin receptors | #2864 |
| antibodies antinuclear | #2864 |
| polymorphonuclear | #2864 |
| splenocytes | #2865 |
| characterising | #2865 |
| interleukin33 | #2869 |
| rats inbred strains | #2869 |
| cyanogen bromide | #2874 |
| disease characterized | #2875 |
| guillain | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| reveals | #2885 |
| clone cells | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| costimulatory molecules | #2895 |
| tgfbeta | #2895 |
| innate immune responses | #2896 |
| dce | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| linked immunosorbent | #2911 |
| enhancement | #2911 |
| studying | #2918 |
| diseases disease | #2920 |
| shortly | #2920 |
| ergometry | #2921 |
| allogenic | #2921 |
| vaccine development | #2925 |
| steadily | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| expression macrophages | #2944 |
| injections | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| suppressed | #2967 |
| histocytochemistry | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| time points | #3009 |
| indoleamine | #3009 |
| cells female | #3010 |
| innate | #3014 |
| therapeutic strategies | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| accelerating | #3033 |
| lung inflammation | #3033 |
| macrophage migration | #3036 |
| t‐cell | #3039 |
| endo | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| model human | #3083 |
| irrespective | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| inhibitory factors | #3092 |
| glutamic | #3092 |
| parvalbumins | #3093 |
| receptor 4 | #3098 |
| inbred balb mice | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| psoriasis | #3142 |
| receptors tlrs | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| propria | #3155 |
| molecule | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| precedes | #3185 |
| cell specific | #3185 |
| blockage | #3187 |
| tissue specific | #3191 |
| dynorphin | #3191 |
| pertussis toxin | #3192 |
| cells rats | #3193 |
| adult mice | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| erbeta | #3211 |
| antiinflammatory | #3211 |
| phagosomes | #3212 |
| nitroarginine | #3212 |
| abs | #3216 |
| cells animals | #3224 |
| publication arthritis | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| macrophage | #3247 |
| collagenous | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| inflammation interferon | #3278 |
| proteoglycans | #3278 |
| sch | #3280 |
| arthralgia | #3283 |
| nephritis | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| models genetic | #3298 |
| igg1 | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| adaptations | #3309 |
| proteins mice | #3309 |
| elicits | #3314 |
| characterise | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| beta receptors | #3325 |
| publication animals | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| mechanistic studies | #3395 |
| levels inflammatory | #3395 |
| macroporous | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| early phase | #3413 |
| haptens | #3413 |
| positions | #3418 |
| nk cells | #3419 |
| erythematosus systemic | #3419 |
| neutrophil activation | #3421 |
| reacts | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| proving | #3434 |
| receptor type | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| obscure | #3448 |
| humans immunization | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| h5n1 | #3470 |
| patients sle | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| multimers | #3491 |
| inflammatory mediators | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| classical | #3505 |
| developed | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| 267 | #3528 |
| deoxyguanosine | #3528 |
| germline | #3529 |
| phenotypically | #3529 |
| predispose | #3532 |
| lacrimal | #3534 |
| micrometer | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| regulatory cells tregs | #3540 |
| cyclosporins | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| interesting | #3580 |
| gamma | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| triggered | #3597 |
| compared wild | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| potential roles | #3624 |
| cleave | #3624 |
| genetic association | #3629 |
| attenuate | #3633 |
| rp | #3633 |
| mapping chromosomes | #3634 |
| genetic | #3637 |
| valuable | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| gene deletion | #3657 |
| enhances | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| tolllike receptor | #3665 |
| clinical severity | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| synovitis | #3708 |
| publication animals humans | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| contributing | #3754 |
| mediate | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| type 4 | #3763 |
| biomedicine | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| jakob | #3786 |
| th17 | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| integrins | #3822 |
| superoxide | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| mmp9 expression | #3839 |
| puerperal | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| postulate | #3858 |
| il17 | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| prominent | #3887 |
| glycoside | #3887 |
| kinase2 | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| neutrophils | #3947 |
| affect | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| associate | #3975 |
| disrupted | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| stimulate | #3992 |
| heavy chains | #3992 |
| ifn β | #3999 |
| question | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| superoxide dismutase | #4018 |
| chondrocytes | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| higher expression | #4034 |
| influences | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| produce | #4072 |
| fragments | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| requirement | #4076 |
| stat4 | #4076 |
| plethora | #4077 |
| glycoprotein | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| drives | #4126 |
| regulatory cells | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| ici | #4207 |
| porphyromonas gingivalis | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| kidneys | #4244 |
| macrophage infiltration | #4244 |
| granulocytic | #4249 |
| continuously | #4250 |
| chondrosarcoma | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| denominator | #4270 |
| day1 | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| dermatitis | #4285 |
| experimental mice | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| provocation | #4303 |
| molecular modeling | #4303 |
| sciatic | #4307 |
| shares | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| cell populations | #4317 |
| receptors interleukin2 | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| fungal infection | #4364 |
| glutamine | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| penetrance | #4381 |
| caused | #4381 |
| cell clones | #4396 |
| mucous | #4402 |
| disease chronic | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| receptor beta | #4434 |
| disturbed | #4434 |
| closer | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| thickened | #4503 |
| neutralizing antibodies | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| extracellular ca2 | #4576 |
| homing | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| igg antibody | #4613 |
| interact | #4613 |
| ros levels | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| positive selection | #4658 |
| fashion | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| chains | #4681 |
| langerhans | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| lymph | #4707 |
| protecting | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| alveolar macrophages | #4776 |
| e4 | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| displaying | #4809 |
| osteoclastogenesis | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| paw | #4821 |
| cd4 cd8 cells | #4821 |
| cytokines | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| interferon γ | #4852 |
| matrix ecm | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| naturally occurring | #4962 |
| disease process | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| eosinophilia | #5004 |
| innate immune | #5004 |
| modulates | #5011 |
| isotype | #5012 |
| wt | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| expand | #5026 |
| vimentin | #5026 |
| enhancing | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| linkage | #5067 |
| th1 cells | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| alum | #5087 |
| autologous | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| elispot | #5112 |
| occurs | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| beta2 | #5238 |
| serves | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| mucus | #5258 |
| cognate | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| detects | #5277 |
| osteoclast | #5277 |
| erosion | #5278 |
| therapeutic intervention | #5280 |
| prolactin | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| key component | #5301 |
| drug humans | #5301 |
| neutralization | #5301 |
| amino | #5310 |
| suggestion | #5312 |
| staphylococcus aureus | #5312 |
| anhydrases | #5315 |
| c57bl 6j | #5320 |
| manner | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| mice molecular | #5402 |
| positive lymphocytes | #5402 |
| tnf α | #5411 |
| antiinflammatory agents | #5417 |
| epigenetic mechanisms | #5417 |
| adversely | #5418 |
| fulvestrant | #5420 |
| activation | #5420 |
| dendritic | #5428 |
| compartments | #5429 |
| antigens surface | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| reproduced | #5507 |
| histological analysis | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| abolished | #5660 |
| explants | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| numbers | #5685 |
| antioxidant defense | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| progression disease | #5697 |
| cytokine expression | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| frozen | #5808 |
| linking | #5808 |
| b16 | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| hyaluronan receptors | #5875 |
| deleted | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| low doses | #5925 |
| bronchoalveolar lavage fluid | #5925 |
| ics | #5932 |
| subclass | #5941 |
| identifying | #5941 |
| depend | #5947 |
| genomic regions | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| immunity | #6010 |
| glyburide | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| cleared | #6074 |
| tumor infiltrating | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| uncoupling | #6115 |
| bone diseases | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| susceptibility gene | #6171 |
| responses | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| instances | #6210 |
| cell functions | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| minor | #6320 |
| allowed | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| remitting | #6355 |
| borrelia burgdorferi | #6355 |
| cell biology | #6355 |
| virgin | #6356 |
| microsatellite | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| inoculation | #6477 |
| genetic variants | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| synergy | #6523 |
| chronic | #6523 |
| nitrite | #6523 |
| share | #6539 |
| played | #6540 |
| proteins animals | #6559 |
| apc | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| proteases | #6588 |
| rheumatic | #6588 |
| expression genes | #6603 |
| toll | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| parenchyma | #6650 |
| regulation | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| melatonin | #6683 |
| animals antioxidants | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| pups | #6747 |
| normal levels | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| interleukin18 | #6782 |
| helpful | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| intra articular | #6825 |
| induced acute | #6825 |
| cterminal | #6829 |
| eosinophil | #6829 |
| cd19 | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| aspergillosis | #6852 |
| case control | #6852 |
| lymphoid tissues | #6854 |
| periodontal disease | #6855 |
| participates | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| translational | #7020 |
| degrade | #7020 |
| mimic | #7025 |
| assay elisa | #7033 |
| fewer | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| target cells | #7063 |
| genome wide | #7063 |
| heterogeneous | #7071 |
| subjected | #7072 |
| aureus | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| chemokines | #7411 |
| interleukin6 | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| hydrocarbon | #7610 |
| appeared | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| graft survival | #7661 |
| component | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| diagnostics | #7735 |
| bacterial toxins | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| mer | #7772 |
| activates | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| direct effects | #7991 |
| tregs | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| ascertained | #8077 |
| factor signal | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| tetramer | #8088 |
| appearing | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| prolongation | #8108 |
| homozygosity | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| bovine | #8133 |
| nash | #8133 |
| latest | #8134 |
| definition | #8141 |
| macrophages peritoneal | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| elevated | #8167 |
| conditioned | #8167 |
| harbor | #8170 |
| characterize | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| genetic associations | #8225 |
| sulphate | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| differ | #8295 |
| disease genome | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| peptide1 | #8316 |
| 11 | #8316 |
| aspergillus fumigatus | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| vh | #8363 |
| boronic | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| residue | #8401 |
| poly | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| notion | #8424 |
| advancement | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| drug development | #8539 |
| phenotype | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| constitutive expression | #8717 |
| vigorous | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| 4 weeks | #8792 |
| homozygous | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| human serum | #8808 |
| occasionally | #8808 |
| parotid | #8809 |
| chemically | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| strengthen | #8941 |
| hypothalamo | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| pitfalls | #8967 |
| subpopulation | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| chemoattractant | #9019 |
| adrenocorticotropic | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| differentially | #9131 |
| human | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| innate immunity | #9233 |
| started | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| offer | #9255 |
| orphan | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| immunofluorescence | #9519 |
| hormonal | #9519 |
| cyclosporin | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| dramatic | #9694 |
| slight | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| livers | #9753 |
| humanized | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| microscopic | #9784 |
| adhesion cell | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| infectious | #9804 |
| lowered | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| cells patients | #10110 |
| virulence factors | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| cell signaling | #10143 |
| kappa | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| belonging | #10857 |
| saline | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| multifunctional | #10904 |
| phagocytosis | #10904 |
| avoid | #10909 |
| ineffective | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| pivotal | #10926 |
| secondary | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| subcutaneously | #10984 |
| immunoassay | #10984 |
| characterization | #10986 |
| governing | #10998 |
| septic | #11000 |
| ethanol | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| scid mice | #11030 |
| occurrence | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| male | #11167 |
| innate immune response | #11167 |
| osteoarthritis | #11176 |
| influx | #11177 |
| receptors | #11177 |
| subsequent | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| alteration | #11627 |
| frequently | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| controls | #11730 |
| psychotic | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| reveal | #11966 |
| animals bone | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| downstream | #12107 |
| protection | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| switched | #12181 |
| quiescent | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| myd88 | #12222 |
| histologic | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| toxic | #12231 |
| mesenteric | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| rats treated | #12596 |
| suppressor | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| medullary | #12637 |
| cells natural | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| fetuses | #12665 |
| chronic diseases | #12665 |
| cdnas | #12679 |
| adenine | #12679 |
| p38 mitogen | #12681 |
| 6 weeks | #12681 |
| investigation | #12697 |
| instance | #12709 |
| persistent | #12729 |
| alveolar | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| tibia | #12813 |
| initiated | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| p38 | #14329 |
| bovine serum | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| kinases animals | #14452 |
| paracrine | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| risk developing | #14724 |
| substances | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| methylated | #15945 |
| neurodegeneration | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| respiratory | #16585 |
| node | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| establishing | #16709 |
| negatively | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| immunoreactive | #16859 |
| clinically | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| types | #17505 |
| allowing | #17505 |
| fibrous | #17515 |
| transcriptase | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| avian | #18345 |
| net | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| processing | #18609 |
| hyaluronan | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| cerebrospinal | #18788 |
| aim | #18788 |
| created | #18803 |
| balanced | #18823 |
| cultured | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| adrenal | #19553 |
| cytoskeletal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| 28 | #19979 |
| cns | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| successful | #20952 |
| 10 | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| detect | #24963 |
| sarcoidosis | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
रिपोर्ट चलाएं | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| के लिए जाना जाता है Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| के लिए जाना जाता है Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| के लिए जाना जाता है Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| के लिए जाना जाता है Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| के लिए जाना जाता है Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| के लिए जाना जाता है Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| के लिए जाना जाता है Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| के लिए जाना जाता है Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| के लिए जाना जाता है Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| के लिए जाना जाता है Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| के लिए जाना जाता है Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| के लिए जाना जाता है Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| के लिए जाना जाता है Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
के लिए प्रमुख लोग Rheumatoid Arthritis
दुनिया में शीर्ष kols
एक खोज वाक्यांश का चयन करें rheumatoid arthritis , rheumatoid arthritis patients , rheumatoid arthritis treatment , rheumatoid arthritis risk , rheumatoid arthritis study
Rikard Holmdahl:विशेषज्ञ प्रभाव
जिसके लिए अवधारणाएंRikard Holmdahlप्रत्यक्ष प्रभाव है:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:कोल इम्पैक्ट
अन्य लेखकों के काम से संबंधित अवधारणाएं जिनके लिएfor which Rikard Holmdahl प्रभाव है:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
क्या यह आपकी प्रोफ़ाइल है? अपनी प्रोफ़ाइल का दावा करें यूआरएल कॉपी करें अपनी प्रोफ़ाइल के लिए लिंक एम्बेड करें |